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SUMMARY 
The interactions of proteins with RNA are ubiquitous in human cell biology and fundamental 
to most if not all of life as we know it. Proteins and RNA interact for the purpose of gene 
expression, where genetic information is encoded within RNA, which serves as template for 
protein in messenger RNA, as scaffold for the trimming of other RNA within the spliceosome, 
as a catalyst for the production of protein within the ribosome, and as component of various 
other processes, many of which we are only beginning to understand. Central to our 
understanding of such processes is the interplay between proteins and RNA. Protein-RNA 
interactions are often disrupted by conventional extraction methods and need to be stabilized 
through crosslinking in order to be appreciated by transcriptomic or proteomic methodology. 
Crosslinking typically occurs through UV irradiation, which covalently connects protein bound 
to RNA. However, currently there is no universal method for the extraction of protein-
crosslinked RNA available, so that insights can only be gained for certain subsets of the 
transcriptome or individual RNA-binding proteins, respectively. In this thesis a new method 
for the extraction of protein-crosslinked RNA from UV-crosslinked cells is described. In order 
to demonstrate the comprehensive usefulness of the approach, which was termed XRNAX, it 
is applied for the resolution of several proteomic and transcriptomic problems. First, XRNAX 
is employed for the purification of ribonucleotide-crosslinked peptides identifying known and 
unknown protein-RNA interfaces. Next, a comprehensive draft for the human RNA-binding 
proteome is derived applying XRNAX to three commonly used cell lines. The same approach 
is applied for the differential quantification of RNA-binding during a timeline of arsenite-
induced translational arrest in human cells. Additionally, XRNAX is combined with CLIPseq to 
monitor the RNA exosome component EXOSC2 processing pre-ribosomal RNA during arsenite 
stress. At last, XRNAX is used along with TMT-SILAC in order to derive protein half-lives of the 
human RNA-bound proteome. Half-lives of the RNA-bound proteome are found on average 
1.75 fold increased in comparison to the total proteome. For validating the stabilization of 
protein-RNA complexes, ribosomal assemblies are purified from human cells using polysome 
profiling and protein half-lives assessed with TMT-SILAC. Stabilization is confirmed, however, 
only for ribosomal proteins in 80S ribosomes within the 80S or polysome fractions. Further 
experiments interfering with ribosome biogenesis, the proteasome and autophagy are 
distilled into a model for the turnover of ribosomal proteins and ribosomal assemblies. 
In summary, this thesis describes new methodology and biological insight on protein-RNA 
interactions in human cells. 
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ZUSAMMENFASSUNG 
Die Interaktionen von Proteinen mit RNA sind allgegenwärtig in der menschlichen Zellbiologie 
und fundamental für das meiste, wenn nicht das gesamte, uns bekannte Leben. Proteine und 
RNA interagieren zum Zweck der Genexpression, während welcher genetische Information in 
RNA codiert wird, welche als Vorlage für Messenger RNA, als Gerüst zur Beschneidung anderer 
RNA innerhalb des Spliceosomes, als Katalysator zur Produktion von Protein innerhalb des 
Ribosomen und als Komponente einer Vielzahl anderer Prozessen dient, viele welche wir erst 
beginnen zu verstehen. Zentral für unser Verständnis solcher Prozesse ist das Zusammenspiel 
zwischen Proteinen und RNA. Protein-RNA Interaktionen werden durch konventionelle 
Extraktionsmethoden oftmals getrennt und müssen deshalb durch Crosslinking stabilisiert 
werden, um durch Methoden der Transcriptomic oder Proteomic erfasst zu werden. 
Crosslinking wird typischerweise durch UV Bestrahlung herbeigeführt, welche RNA-
gebundene Proteine kovalent mit dieser verbindet. Allerdings ist derzeit keine universelle 
Methode zur Extraktion von RNA, die an Protein gecrosslinkt ist, verfügbar, sodass Einsichten 
nur für bestimmte Teile des Transcriptoms bzw. für einzelne RNA-bindende Proteine erlangt 
werden können. In dieser Doktorarbeit wird eine neue Methode zur Extraktion von Protein-
gecrosslinkter RNA aus UV bestrahlten Zellen beschrieben. Um die allgemeine Nützlichkeit 
diese Methode zu demonstrieren, welche XRNAX genannt wurde, wurde sie auf verschiedene 
Probleme der Transcriptomic und Proteomic angewendet. Zunächst wurde sie zur 
Aufreinigung von Ribonukleotid-gecrosslinkten Peptiden verwendet, welche Aufschluss über 
bekannte und unbekannte Oberflächen zwischen Proteinen und RNA gewähren. Folglich 
wurde XRNAX auf drei gemeinhin verwendete Zelllinien angewendet, um einen 
vollumfänglichen Entwurf über das RNA-bindende Proteom abzuleiten. Die gleiche 
Herangehensweise wurde verwendet, um RNA Bindung differentiell in einer Zeitreihe zu 
messen, in welcher translationaler Arrest in menschlichen Zellen durch Arsen herbeigeführt 
wurde. Darüber hinaus wurde XRNAX mit CLIPseq kombiniert, um die Prozessierung von pre-
ribosomaler RNA durch EXOSC2, einer Komponente des RNA Exosoms, während des 
Arsenstresses zu verfolgen. Zuletzt wurde XRNAX in Verbindung mit TMT-SILAC verwendet, 
um die Proteinhalbwertszeiten innerhalb des menschlichen RNA-bindenden Proteoms zu 
bestimmen. Es wurden Halbwertszeiten des RNA-gebundenen Proteoms festgestellt, welche 
im Durchschnitt 1.75 fach über denen des gesamten Proteoms liegen. Zur Validierung dieser 
Stabilisierung von Protein-RNA Komplexen wurden ribosomale Komplexe aus menschlichen 
Zellen durch Polysome Profiling aufgereinigt und Proteinhalbwertszeiten mittels TMT-SILAC 
bestimmt. Die Stabilisierung wurde bestätigt, allerdings nur für ribosomale Proteine innerhalb 
der 80S Ribosomen aus der 80S oder Polysomen Fraktion. Weiterführende Experimente zur 
Störung der ribosomalen Biogenese, des Proteasoms und von Autophagie wurden in ein 
Modell integriert, welches die Umsetzung von ribosomalen Proteinen und ribosomalen 
Komplexen beschreibt. 
Zusammenfassend beschreibt diese Doktorarbeit neue Methodik und biologische 
Erkenntnisse zu Protein-RNA Interaktionen in menschlichen Zellen. 
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INTRODUCTION 
PROTEIN-RNA INTERACTIONS ARE UBIQUITOUS 
RNA is polymerized by a protein, i.e. RNA polymerase, and as soon as it comes into being 
wrapped into protein.1 RNA-binding proteins are essential companions of messenger RNA 
(mRNA), which is spliced2, capped2, polyadenylated and exported3 from the nucleus to the 
cytoplasm of eukaryotic cells (for review see4). Within the cytoplasm more RNA-binding 
proteins responsible for nonsense-mediate decay check the quality of the message during the 
first round of translation, which is carried out by a massive assembly of more RNA-binding 
proteins – the ribosome (for review see5). Other RNA-binding proteins locate to the 
untranslated regions of mature mRNA and influence its stability6, rate of translation7 and even 
subcellular localization8. Messenger RNA only accounts for a low percentage of the total RNA 
in a cell, which in mammals is less than 5 % (per weight).9 Non-coding RNA (ncRNA) makes up 
for the most part of the transcriptome and especially ribosomal RNA (rRNA) contributes often 
more than 80 % (per weight). In ribosomes the intricate assembly of ribosomal proteins along 
with rRNA creates an enormous molecular machine, which itself binds to mRNA in order to 
polymerize new protein. Importantly, RNA fulfils here a structural role, however, is also 
responsible for the catalytic activity of the ribosome by contributing the peptidyl transferase 
centre.10,11 Another macromolecular assembly with enzymatic activity is the spliceosome, 
which assembles splicing factors around five highly abundant ncRNAs called small nuclear 
RNAs (snRNAs) U1-U5.12 Non-coding RNAs are conventionally classified by their length, so that 
snRNAs fall into the category of small RNAs, i.e. smaller 200 nucleotides. The spliceosome 
excises intronic sequences from pre-mRNA and is therefore essential during eukaryotic gene 
expression. There are more small RNAs conferring cleavage, prominently small interfering 
RNAs (siRNAs), which recruit nucleases of the Argonaut family to RNA molecules with 
complementary sequence in the process of RNA interference.13,14 Cleavage only occurs when 
the siRNA exhibits perfect complementary towards its target.15,16 Small RNAs with imperfect 
complementarity can be endogenously expressed (so-called micro RNAs (miRNAs)) and 
regulate protein expression through a combination of translation repression and mRNA 
destabilization.17 All these actions are accomplished by the interplay of these RNAs with their 
cognate RNA-binding proteins. Other small RNAs are involved in the targeted modification of 
other classes of RNA. Small nucleolar RNAs (snoRNAs) recruit modifying enzymes, such as RNA 
methylases, to rRNA or snRNA and thereby confer RNA modifications to specific sequences 
motifs within these RNA species.18,19 RNA sequences can also be used as template for the 
production of DNA as in the case of telomerase. The protein component of telomerase is a 
reverse transcriptase that uses the RNA component of the complex for the extension of 
chromosome ends.20 Telomerase RNA is more than 400 nucleotides long, thus, is considered 
a long ncRNA (lncRNA). RNA sequencing studies have revealed that beside long, protein-
coding RNA eukaryotic cells produce thousands of long, non-coding RNA transcripts (for 
review see21). These lncRNAs have very little coding potential and proteomic22 or ribosome 
profiling studies23 confirmed that most of them are not translated into protein. However, they 
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fulfil important and diverse functions by interacting with cognate protein (for review see24). 
How many of the thousands of lncRNAs expressed in a cell are functional remains elusive. 
Nevertheless, fundamental and regulatory important functions have been described for some 
lncRNAs, which have made it very clear that even if only a small percentage of them is 
functional, they will still have a profound effect on the function of cells. This is especially the 
case because lncRNAs are primarily located in chromatin where they interact with and 
regulate the behaviour of chromatin modifying proteins. An illustrative example for such a 
lncRNA in mammals, which directly affects genomic regulation, is Xist. Xist is expressed from 
one of the two X chromosomes in a female cell, leading to transcriptional shutdown of the 
entire other X chromosome25 – a process referred to as X chromosome inactivation26. While 
the effect of Xist was observed early, it was not until very recently that its exact mode of action 
could be described. Importantly, mass spectrometry (MS) - based proteomics revealed that 
Xist recruits the chromatin modifier SPEN (also known as MINT or SHARP).27,28 Consequent 
experiments showed that SPEN recruitment to the target X chromosome leads to 
deacetylation and successive transcriptional shutdown. Another prominent example is the 
lncRNA HOTAIR, which was shown to shut down genes during development by recruiting 
proteins of the PRC2 complex to specific sites in the HOX locus.29 These are only two early 
examples of profound genomic regulation mediated by lncRNAs and many more examples 
have been described over the last years (for reviews see21,24,30,31). Already in 1975 it was 
recognized that purified chromatin contains twice as much RNA than DNA.32 While our 
growing understanding of the DNA component of chromatin has taught us about the genome, 
our growing understanding of the RNA component of chromatin seems to teach us more and 
more about its regulation. The sheer number of different RNA species leaves the number of 
processes potentially regulated by them unlimited. From the protein perspective this 
regulatory potential is not delimited. As will be discussed in the following, in human cells more 
than 1000 proteins have been found to interact with RNA so far (for review see33). Many of 
these proteins are known to be involved in processes unrelated to classic RNA biology, which 
suggests functions of protein-RNA interactions far beyond the canonical understanding. An 
emerging concept in this regard is the formation of membrane-less organelles by liquid-liquid 
phase separation (for review see34). Protein-RNA interactions have emerged as central in this 
context because prime examples for phase-separated organelles come from macroscopic 
protein RNA assemblies, such as nucleoli35, p-bodies36 or stress granules37. Liquid-liquid phase 
separation is a very powerful concept because it is able to explain the often-observed 
assembly of specific complexes, which have a specific protein composition, while the 
individual proteins in the complex do not specifically bind to one another. Formation of these 
organelles appear to rely on the presence of specific sequence features called intrinsically 
disordered regions (IDRs) in proteins inducing phase separation.38 The same regions have 
been shown to interact with RNA, however, proteins carrying IDRs often also carry classical, 
globular RNA-binding domains.39 In vitro proteins carrying IDRs and even the IDRs themselves 
can phase-separate independently of RNA, however, in the presence of RNA they phase-
separate at much lower concentrations.37,40 Recently, a novel granule type has been 
described, which offered an intriguing example on how phase-separation can organize 
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molecular assembly from specific protein and RNA components. TIS11B forms phase-
separated granules in human cells, which sequester mRNAs encoding membrane proteins, 
thereby mediating their localization.41 The future will show in how far other new or known 
assemblies are phase-separated. What is clear already, however, is that protein-RNA 
interactions are central to the process.34 
In summary, these examples demonstrate the vital importance of protein-RNA interactions in 
most aspects of human cell biology. While this thesis project is primarily focused on human 
cells, we mention here that of course protein-RNA interactions are fundamental to other 
organisms as well. Only to mention one example with importance to human health, many 
viruses and especially RNA viruses rely on interactions with proteins within themselves and 
within the host cells they infect. All this makes clear that in order to understand any organism 
one has to understand protein-RNA interactions.  
CURRENT METHODOLOGY FOR THE INTERROGATION OF PROTEIN-RNA 
INTERACTIONS 
In this thesis project new methodology is explored, which serves the extraction and analysis 
of protein interacting with RNA or RNA interacting with protein, respectively. To get a better 
understanding of what the technological challenges for any such endeavours are, the 
following summary enumerates methodology that has been used and its individual 
contribution so far. Conceptually, protein-RNA interactions can be approached from a protein-
centric or RNA-centric perspective, which means proteomic technologies such as MS or RNA-
sequencing are used (for review see42). Unified approaches, which sequence both protein and 
RNA at the same time do not currently exist. However, there is evidence that MS-based 
proteomics hold the potential for intersecting these two disciplines. Details will be discussed 
when we talk about the common shortcomings of all presently available methods. 
 
RNA SEQUENCING-BASED METHODOLOGY 
Protein-centric ways for investigating protein-RNA interactions try to enrich one specific 
protein in order to find out what its RNA interaction partner is. Most protein-centric 
methodologies for the investigation of protein-RNA interactions today work in vivo and 
typically in UV-crosslinked cultured monolayers of cells. However, one powerful in vitro 
approach for determining binding features of a purified RNA-binding protein is RNA bind-n-
seq.43 The method developed from systematic evolution of ligands by exponential enrichment 
(SELEX)44,45 and the realisation that massively-parallel sequencing offers a resolution that 
makes much of SELEX obsolete. During SELEX a target, for example a purified RNA-binding 
protein, is immobilized and subjected to a random pool of RNA sequences. Non-specific RNA 
is washed away and bound RNA is reversed transcribed, PCR amplified, in vitro transcribed 
into RNA and again subjected to the same immobilized protein. During many rounds of 
selection this evolutionary process leaves only sequences carrying the optimal binding motif 
for the specific protein behind (if an optimal binding motif exists and the protein does not 
simply bind any RNA). SELEX was developed at a time when massively-parallel sequencing did 
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not exist, so that the pool of RNA sequences was eventually cloned into E.coli and single 
colonies picked in order to determine the most common sequences by Sanger sequencing. 
One flow cell in a standard Illumina sequencing run today has the ability to detect more than 
one billion sequences in one experiment. RNA bind-n-seq harnesses this ability by reducing 
the enrichment steps to a single one, thereby allowing for the detection of secondary motifs 
and even semi-quantitative statements on the binding strength of some sequences over 
others. Therefore, RNA bind-n-seq offers a clean and parameter-reduced environment for the 
in vitro interrogation of fundamental RNA-binding features of a protein (and potentially other 
substances). 
In vivo methods for the detection of RNA sequences bound by one particular protein go back 
to the observation that antibodies from patients with lupus erythematosus are able to 
precipitate RNA-binding protein along with six different species of small RNAs.46 Biologically, 
this observation became pivotal in the years afterwards when those small RNAs were termed 
snRNAs and the protein they assemble with the spliceosome. However, on the technological 
side this led to the development of RNA immunoprecipitation or RIP, where one protein is 
enriched from a cellular lysate using a specific antibody, in order to identify the RNA species 
that come along with it. RNA is sticky and RNA-binding proteins tend to bind to other RNA-
binding proteins47, so that the conclusiveness of RIP was in most cases limited. A denaturing 
approach was required, however, obstructed by the fact that RNA-binding proteins lose their 
RNA cargo as soon as they are denatured. Attempts that used formaldehyde crosslinking in 
order to stabilize protein-RNA interactions did for the most part not improve the purity of RIP 
because formaldehyde also crosslinks other proteins (or DNA) to the bait. This problem was 
solved by the introduction of UV-crosslinking to RIP, which heralded the era of crosslinking 
and immunoprecipitation or CLIP.48  
As UV-crosslinking is vital not only to CLIP but large parts of the technological developments 
pursued in this thesis project, we take here an excursion into this field. UV-crosslinking is 
widely used in RNA-biology, however, many of its fundamental features remain poorly 
understood. That UV-light crosslinks protein to nucleic acids was first suspected in 1962 when 
the germicidal activity of UV was investigated.49 Initially, the assumption was that thymidine 
dimers were the lethal mutation to the E.coli genome introduced by UV, however, a much 
better correlation was found with crosslinked protein.50 In the coming years the photo-
adducts of the crosslinking process towards DNA and RNA bases was interrogated. The first 
photo-adduct to be identified was a uracil-cysteine crosslink (5-5-cysteine-6-hydrouracil) 
purified from a UV-crosslinked solution of uracil with cysteine49 and later DNA or RNA51 with 
cysteine, respectively. Importantly, for a cysteine-containing peptide crosslinked to a uridine, 
this would mean an adduct mass identical to the mass of uridine. In experiments with cysteine 
and polyuridine oligomers or yeast total RNA, both crosslinked equally well and by far better 
than oligomers composed of any other nucleotide. Later a more systematic approach showed 
that all 20 naturally occurring amino acids could be UV-crosslinked to polyuridine 
oligonucleotides, however, some more efficient than others.52 Already in these early studies 
it was observed that purine bases do not crosslink efficiently and the main crosslinking bases 
are pyrimidines. This was later confirmed in studies using UV lasers53. Until now a 
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comprehensive catalogue of crosslinking adducts does not exist. However, the photochemical 
process underlying UV-crosslinking of protein and nucleic acids has been further studied, so 
that a number of general statements can be made (for review see54): UV light excites 
nucleotide bases, which convert over a singlet or triplet state to cation radicals. Reducing 
agents such as mercaptoethanol are able to supress crosslinking so that the actual crosslinking 
reaction is expected to occur via the radical state of the base, however, the exact mechanism 
remains unknown. Interestingly, recently it was shown that the reducing agent dithiothreitol 
can bridge uridine crosslinks to cysteine-containing peptides.55 Other recent studies on uridine 
indicate that two reaction mechanisms might exist, one fast and direct reaction of the radical 
and one slow via a photohydrate.56 In vitro crosslinking yields, i.e. how much of the protein in 
an experiment ends up crosslinked to RNA, range between 5-20 %. This means UV-crosslinking 
in contrast to formaldehyde crosslinking is sparse, producing RNA that is mostly free of protein 
and only sporadically interrupted by protein crosslinks. Damage to nucleic acids at low 
intensity UV irradiation (UV lamp) are primarily uridine or thymine dimers, respectively, at 
high intensity irradiation (laser) the induction of single-strand breaks. Photodamage to 
proteins seems negligible at the wavelengths usually used for crosslinking (>240 nm). 
Crosslinks are stable to heat and alkaline conditions, however, some might be acid labile. 
Before UV-crosslinking of cultured cells, they are transferred onto ice in order to prevent any 
immediate cellular response against UV irradiation, which typically takes less than one minute 
to reach the conventional crosslinking energy with the conventional equipment. This is 
another advantage over formaldehyde crosslinking, which is inefficient if not performed at 
ambient temperatures and takes several minutes to occur. 
UV-crosslinking and CLIP became very popular and widely used, so that today scores of 
variations to the CLIP protocol exist (for review see57). Some of these variations are redundant 
or rarely used, so that we only discuss the most important additions to the protocol since its 
inception. Notably, there are reports for formaldehyde-based CLIP protocols58, however, they 
are not commonly used because of the drawbacks described above. The initial CLIP protocol48 
crosslinked cells with UV, lysed them, fragmented RNA by partial RNase digestion, 
immunoprecipitated the RNA-binding protein NOVA, radiolabelled the RNA fragments that 
came along with NOVA, resolved the denatured protein-RNA complexes on an SDS-PAGE and 
blotted them onto nitrocellulose. Subsequently, the radioactive band representing the 
molecular weight of NOVA could be excised from the membrane, thereby excluding 
contaminations from any other RNA-binding protein or free RNA. RNA fragments were cloned 
into E.coli and individual clones selected for Sanger sequencing. The last step yielded several 
hundred sequences, which was an obvious point for improvement upon the introduction of 
massively-parallel sequencing. This led to the introduction of HITS-CLIP (high-throughput 
sequencing CLIP), which pushed the recovered sequences into the hundred thousands.59 HITS-
CLIP was very successful, however, some proteins could not be UV-crosslinked efficiently, 
although it was clear that they must be specific RNA-binders. In order to improve crosslinking, 
the photoactivatable nucleotide 4-thiouridine (4SU) was identified, which is readily taken up 
by cells from the culture media and incorporated into their transcriptome. 4SU crosslinks at a 
wavelength of 365 nm, whereas conventional crosslinking is performed at 254 nm. PAR-CLIP 
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(photoactivatable-nucleotide-enhanced CLIP) was able to retrieve sequences for some key 
proteins binding to small RNAs, which were under heavy investigation in the context of RNA 
interference, however, previously impossible to crosslink.60 PAR-CLIP brought along another 
unanticipated advantage, which was a sequence conversion from uridine to cytidine at 
positions crosslinked to protein. This so-called T to C conversion, presumably introduced by 
an error of reverse transcriptase at these positions, could be used to locate the protein-RNA 
interaction site with nucleotide precision. In the case of 254 nm crosslinking reverse 
transcriptase most often dissociates upon encounter of the crosslinking site. This led to the 
development of individual nucleotide CLIP (iCLIP), which mapped these dissociations events 
using a special protocol for the preparation of the sequencing library.1 While iCLIP claims to 
have better resolution than PAR-CLIP because it potentially resolves crosslinking at every 
nucleotide and not only at uridines, the observation that 254 nm UV primarily crosslinks 
uridine qualifies this claim. Effectively, both protocols have been very successful and widely 
used. Further additions to CLIP after these developments primarily concerned reproducibility 
and feasibility. CLIP protocols up to this point involved radioactive labelling and cumbersome 
gel-based, sequencing library preparations. For the encyclopaedia of DNA elements (ENCODE) 
a CLIP variation was developed, which tried to strip down the process to the point where CLIP 
experiments could be easily scaled in number while making them more reproducible. 
Enhanced CLIP (eCLIP) was developed, which not only simplified the procedure but also 
introduced an input control, so that better significance testing could be performed on 
potential binding sites.61 So far ENCODE holds eCLIP data for over 300 RNA-binding proteins, 
which is an invaluable resource and important for understanding the big picture of RNA 
regulation in a cell (www.encodeproject.org). 
Concerning other crosslinking technologies there has been one recent development using the 
APEX system.62 APEX2 is an enzyme that can be genetically encoded and fused to any other 
desired protein. Upon addition of biotin-phenol and hydrogen peroxide the fusion protein will 
produce biotin radicals, which will diffuse and react to protein within 10 nm range before they 
decay. Fused to cellular localization signals the APEX system can be used to retrieve proteins 
with specific subcellular localization.63 In combination with formaldehyde crosslinking, this 
can retrieve RNA as well and thereby allows for determining the subcellular composition of 
transcriptomes.64 Alternatively, the APEX system has been used along with 4SU and 365 nm 
UV-crosslinking in a very recent approach called proximity-CLIP. Proximity-CLIP not only allows 
for the retrieval of the subcellular transcriptome, but also to give the occupancy of all RNA-
binding proteins on the retrieved transcripts. In the latter variation of the protocol, 
biotinylated proteins are UV-crosslinked to RNA and partially RNase digested. Subsequently, 
only the RNase-protected fragment is sequenced. This is markedly different to a classical CLIP 
experiment, which immunoprecipitates one individual RNA-binding protein and tries to find 
its location on the transcriptome. Here, the entirety of RNA-binding proteins on the transcripts 
is retrieved and their combined binding sites collapsed to a protein occupancy profile. Before 
proximity-CLIP (which is a misleading name because it does not entail immunoprecipitation), 
only one other method had tried to determine the global occupancy of RNA-binding proteins 
on the transcriptome. During protein occupancy profiling, cells are subjected to 4SU and UV-
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crosslinked at 365 nm wavelength.65,66 Their polyadenylated transcriptome is precipitated 
using poly(dT)-beads along with crosslinked protein. The crosslinked protein-RNA complexes 
are released by partial RNase digestion leaving RNase-protected fragments intact, which are 
then ammonium acetate precipitated, resolved by SDS-PAGE and blotted onto nitrocellulose. 
Precipitation and blotting should only retain protein-bound RNA thereby eliminating 
fragments, which were initially not occupied by protein. After sequencing the number of T to 
C conversions at a specific position are used to quantify their occupancy by protein. In how far 
T to C conversions are a quantitative measure of protein occupancy was never shown and 
protein occupancy profiling was never widely used. Proximity-CLIP is not limited to 
polyadenylated RNA and uses read counts for the quantification of protein occupancy, which 
is an established method for occupancy in the chromatin field. The biological insight presented 
so far with the method is limited, so that future studies will need to show its usefulness. 
Nevertheless, a method tracking the protein occupancy on the global transcriptome in a 
quantitative way is conceptually very appealing, especially in the context of perturbation 
experiments resolved in a timecourse. 
 
MASS SPECTROMETRY-BASED METHODOLOGY 
RNA-centric methods for the identification of RNA-binding proteins enrich RNA in order to 
identify the proteins that come along with it. Methodology here can be subdivided in a similar 
fashion as the sequencing methodology above. Methods exist for the identification of proteins 
binding to one particular RNA species and for the identification of proteins binding to the 
entire transcriptome, or at least parts of it, as we will see in the following. For the unbiased 
detection of protein interactors today MS is used, however, for validation purposes or in the 
case of very low abundant proteins antibody detection might be favoured. The sensitivity of 
MS has improved greatly over the years so that today femtomolar amounts of protein can be 
quantified on a standard basis. Still, MS in contrast to sequencing cannot rely on sample 
amplification by PCR, so that the usual limitation of MS is sample amounts. This is especially 
true in the case of an experiment that tries to identify proteins specifically binding to one 
particular species of RNA. The dynamic range within the transcriptome is tremendous, with 
some few RNA species, such as rRNA, being very abundant and dominant. This has important 
consequences for the enrichment that is necessary to detect any protein binding specifically 
to RNA.  One HeLa cell is estimated to have several million ribosomes, for simplicity say one 
million. Consider a case in which one would like to find proteins binding an RNA species with 
1000 copies per cell. In order to detect proteins, which do not exclusively bind this particular 
RNA, more than 1000 fold enrichment over the background will be required. RNA-binding 
proteins are rarely specific and often bind degenerate motifs67, so that enrichment in 
combination with low amounts are the main limitations in such studies. We will discuss how 
current methods overcome this limitation, but first take a look at sample preparation 
strategies for the enrichment of one particular RNA (for review see68). The first in vitro report 
for the purification of proteins from one particular RNA species again comes from the field of 
splicing, where HeLa lysates were incubated with an in vitro transcribed RNA transcript, which 
had been labelled with biotin-UTP.69 Here, before streptavidin enrichment lysates had to be 
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fractionated by glycerol gradient centrifugation. The spliceosome is a fairly stable and 
abundant complex, which binds to its target sequence with high specificity, however, a double 
purification was required indicating how delicate such experiments are. In the years after this, 
in vivo methods were developed that introduced an RNA sequence tag, which could be 
specifically recognized by a protein on a solid support and thereby precipitated. Most 
commonly used are the MS270 or PP771 system, both encoding for stem loops recognized by 
bacteriophage proteins. These proteins, carrying an affinity tag for later enrichment, can be 
expressed along with the RNA, which is tagged with one or several repeats of the stem-loop. 
Similar systems with RNA aptamers exist, where only the tagged RNA needs to be expressed, 
which itself binds to streptavidin72 or streptomycin73 immobilized on beads. Either one of the 
approaches requires ectopic expression of the RNA of interest, which needs to be altered in 
its sequence in order to carry the affinity tag. In order to target endogenous transcripts there 
are currently two strategies available, the first of which is still very much in its infancy, 
however very promising because of its versatility. The endonuclease Cas13a from Leptotrichia 
wadei can be engineered to lose its nuclease activity and targeted RNA transcripts using 
conventional CRISPR guide RNAs. A study shows that targeting is highly specific and can be 
used to enrich individual RNA sequences.74  However, so far the system has not been used in 
combination with crosslinking and for the identification of RNA-binding proteins, so that 
future studies will have to demonstrate its usefulness. Established and successfully applied 
methods for the identification of proteins binding to individual, endogenous RNA species use 
biotinylated oligonucleotide probes, which are annealed after lysis of the cells and captured 
on streptavidin beads. In 2015 three independent studies characterized the Xist 
interactome27,28,75 with oligonucleotide probes and MS, two of which came to similar 
conclusions about the mechanism by which Xist leads to X chromosome inactivation27,28. Of 
the latter two, CHIRP-MS uses formaldehyde crosslinking, whereas RAP-MS uses UV-
crosslinking. Conceptually, both methods use a similar approach for the identification of 
specific RNA-binders among RNA-binders common to other RNA species in a cell. Both 
methods apply their enrichment protocol to several highly expressed non-coding RNAs and 
compare their interactome to the one identified for Xist. Thereby, they overcome the above-
mentioned enrichment problem by finding the common background of a couple of RNAs, in 
order to see specific enrichment of proteins for the individual candidate RNA. From an MS 
perspective, RAP-MS (RNA antisense purification coupled with MS) is the more reasonable 
approach, which uses SILAC-based quantification for this purpose, whereas CHIRP-MS 
(comprehensive identification of RNA-binding proteins by MS) works label-free and uses a 
seemingly arbitrary ranking system of peptide counts. CHIRP-MS has not found convincing 
application after its initial report, whereas more recently RAP-MS was successfully used in 
combination with iTRAC for mechanistic studies on the lncRNA NORAD76.  
To screen for proteins binding not only to one single transcript but the entire transcriptome, 
one method called interactome capture has dominated the field over the last years (for review 
see77). Interactome capture goes back to a study in 1979, which showed that also mRNA 
crosslinks to protein. In a follow-up paper polyribosomes were purified in a sucrose gradient 
and UV irradiated for crosslinking. Subsequently, polyadenylated RNA was annealed to 
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poly(dT) probes and non-crosslinked protein washed away. Crosslinked proteins were 
released with RNase and an SDS-PAGE identified six of them. After the protocol had been 
picked up again in 2012, two groups independently identified the specific interaction of 
approximately 800 proteins using MS.65,78 Today interactome capture uses poly(T) DNA or LNA 
probes, which are immobilized on beads in order to capture polyadenylated RNA from lysates 
of UV-crosslinked cells. After stringent washing, proteins are released with RNase and 
subjected to MS. A non-crosslinked control is either analysed in separate78,79 or under the use 
of SILAC combined with the crosslinked sample65. Obviously, the method does not capture 
protein-RNA interactions transcriptome-wide but is restricted to polyadenylated RNA. 
Interactome capture has been very successful in cataloguing RNA-binding proteins, as will be 
discussed below. However, so far only one study used the method successfully for the 
differential quantification of RNA-binding between conditions.80 
Several recent approaches try to overcome interactome capture’s limitation to 
polyadenylated RNA. One method using 4SU and UV-crosslinking is identification of RNA-
binding regions (RBR-ID). RBR-ID is based on the observation that MS data from UV-
crosslinked samples has oftentimes significantly reduced intensities for peptides in known 
RNA-binding domains. This makes sense because crosslinked peptides have a different mass 
and are unfortunately not easily detected as we will see in the following. By inverting this 
observation, RBR-ID compares peptide intensities between crosslinked and non-crosslinked 
samples in order to predict RNA-binding. Unfortunately, differences are oftentimes only 
minute – an expected consequence of the low efficiency of UV-crosslinking – so that the initial 
study had to use very lax statistical cut-offs and did not correct for multiple testing. This would 
further indicate that RBR-ID does not have the potential for making quantitative statements 
on RNA-binding between conditions. A direct method for the identification of proteins 
interacting with the entire transcriptome is capture of the newly transcribed RNA interactome 
using click chemistry (RICK). RICK pulse-labels the transcriptome with the clickable ethynyl 
uridine (EU) and then uses 254 nm UV light to crosslink RNA-binding proteins to it. 
Subsequently, EU-labelled RNA can be captured using standard click-chemistry, thereby co-
purifying crosslinked protein, which is identified by MS. If RICK could be used for differential 
quantification of RNA-binding is not clear from the data presented in the initial study, because 
the degree of enrichment is never clearly specified. However, the method works with 
relatively small amounts of cells (30 million) even at very short labelling pulses, so that further 
development might be promising. For the discovery of RNA-binding proteins another 
computational method was presented recently, which capitalizes on the observation that 
immunoprecipitation followed by MS (IP-MS) of RNA-binding proteins enriches primarily 
other RNA-binding proteins, even after RNase digestion.47 This suggests that RNA-binding 
proteins primarily bind other RNA-binding proteins. Support vector machine obtained from 
neighbourhood associated RBPs (SONAR) uses this observation for machine learning on in 
BioPlex protein-protein interaction datasets, where it learns from known RNA-binding 
proteins how they are connected in order to identify new RNA-binding proteins. 
We also want to mention orthogonal organic phase separation (OOPS). The method was 
developed back-to-back with the methodology explored by us in this doctoral thesis, which 
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we termed protein X-linked RNA eXtraction (XRNAX). OOPS81 and XRNAX82 were published in 
the beginning of 2019 as new methods for the identification and quantification of protein-
RNA interactions in UV-crosslinked cells. Both methods are based on TRIZOL extraction, a 
method further explored below, so that we refer to the Results section of this thesis for further 
introduction to OOPS. However, we note here that both OOPS and XRNAX were able identify 
similar sets of proteins as RNA-binding, which are so far the most comprehensive 
representations of the human subproteome binding to the transcriptome independent of 
polyadenylation.  
The last and so far least developed aspect in the study of RNA-binding proteins using UV-
crosslinking is the protein-RNA crosslinking site. This has a number of reasons, one of which 
has been mentioned before and concerns the chemistry of UV-crosslinking. Crosslinking 
adducts between ribonucleotides and amino acids are for the most part unknown, so that in 
an MS experiment it is unclear what masses to look for eventually. This is complicated by the 
multiplicity of the problem, because in principle all four bases might crosslink to all 20 amino 
acids. For an MS experiment that means at least four variable modifications on 20 amino acids, 
which overchallenges the capabilities of conventional search algorithms by far. From the 
perspective of crosslinking chemistry, getting a systematic understanding of the crosslinking 
adducts is not easy because UV-crosslinking yields are low. Consequently, even for very plain 
in vitro experiments of one pure protein incubated with pure RNA, it is not feasible to produce 
UV-crosslinked protein to the scale necessary for NMR. From the perspective of MS, 
nucleotide-crosslinked peptides are not well-behaved under the standard methodology used 
for normal peptides and no systematic optimization of the MS methodology has been possible 
so far because nucleotide-crosslinked peptides are not easily purified. On a systems level the 
problem remains the same, i.e. currently there is no universal approach available for the 
purification of protein UV-crosslinked to RNA, which could be used for benchmarking studies. 
Most of our knowledge on nucleotide-crosslinked peptides comes from one relatively recent 
study, which used interactome capture for their purification.83 Here TiO2 enrichment was used 
after interactome capture, when proteins crosslinked to RNA had been released from the 
poly(dT) beads through RNase. TiO2 is typically used for phosphoproteomics, however, is also 
able to enrich nucleotide-crosslinked peptides through the phosphate on the nucleotide. 
Specialized software had to be developed to analyse the MS data, which identified 60 
nucleotide-crosslinked peptides from 35 highly abundant human proteins. This rather 
sobering result demonstrates what the combined effects of the above-mentioned problems 
amount to. Nevertheless, it demonstrates that MS is in principle capable of sequencing 
peptides crosslinked to one or several nucleotides, which in the future might lead to 
simultaneous sequencing of both protein and RNA in UV-crosslinked peptide-oligonucleotide 
hybrids. Interactome capture as well as TiO2-enrichment do not scale well, because they use 
fairly expensive beads, so that a systematic optimization for the purification and detection of 
nucleotide-crosslinked peptides using this strategy is hardly feasible. This is why some 
methods have tried to find ways around their purification. As mentioned above, their elusive 
behaviour has even prompted methods such as RBR-ID to use their absence in MS data for 
calling RNA-binding proteins.84 Another such method is RBDmap, which extends interactome 
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capture to purify protein crosslinked to polyadenylated RNA, which is digested with LysC or 
ArgC, respectively.39 This leaves behind a crosslinked peptide on the captured RNA, which, 
depending on the enzyme used, might still harbour another arginine or lysine. This peptide 
can be released with trypsin and is identified by MS in order to map its crosslinked neighbour, 
which remained on the RNA. Thereby, RBDmap does not even try to identify the crosslinked 
peptide, but uses its neighbours to map protein-RNA interaction sites. Another interesting in 
vitro study uses heavy isotope labelling of one particular RNA species, which is incubated and 
UV-crosslinked with one particular protein, in order to create a unique mass label.77 
Consequently, peptide doublets separated by a defined mass indicate in the MS RNA-
crosslinked peptides, which can be specifically selected for fragmentation. If translated into 
an in vivo study, this approach could teach us a lot about the behaviour of nucleotide-
crosslinked peptides during MS. 
This summary of the presently available proteomic methodology for the interrogation of 
protein-RNA interactions illustrates chances but also shortcomings, which primarily lie on the 
side of sample preparation. We will discuss this observation further below, when we talk 
about the aims of this thesis project. 
CURRENT UNDERSTANDING OF RNA-BINDING PROTEOMES 
MANY HUMAN PROTEINS INTERACT WITH POLYADENYLATED RNA 
RNA-binding domains are among the most frequently occurring domains in the human 
proteome. In fact, the RNA recognition motif (RRM) is one of the most frequently occurring 
domains among all eukaryotes.85 Therefore, many proteins could be classified as RNA-binding 
from their sequence even before MS studies began to screen for them.86 Specifically, about 
700 proteins in the human genome can be identified as RNA interactors from their sequence 
features (for review see86,87). However, interactome capture has added hundreds of proteins, 
which based on their sequence features had not been expected to bind RNA (for review see33). 
Each of the initial interactome capture studies in HEK29365 and HeLa78 cells returned about 
800 proteins, 300 of which had not been known to interact with RNA. Within this group of 
proteins no clear enrichment for a particular cellular function became apparent. This was later 
confirmed in a survey study that compared proteins identified through interactome capture 
in yeast and human cells, which found the function of this group enigmatic.88 Of note, this 
study and previous ones implicitly suggested that metabolic enzymes were enriched within 
the experimentally determined  human RNA interactomes. In fact, this is not the case, so that 
metabolic enzymes actually occur less frequently in the HeLa RNA-binding proteome78 than 
their occurrence in a deep HeLa total proteome89 would predict. Nevertheless, on the domain 
level two important observations were made. The first was an enrichment of DNA-binding 
domains also within the RNA interactome, which was especially true for proteins of the zinc-
finger type.65 This was further highlighted by protein-interaction network analysis, which 
found several DNA-related processes enriched for mutually interacting RNA-binding 
proteins.65 Conceptually, this was an important observation because it indicated that the 
interaction of some proteins with DNA could be modulated, guided or disrupted by RNA. As 
we will see in the following, a number of these functions were later shown to occur and the 
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concept keeps on gaining traction. Another observation was an enrichment for IDRs, which 
occurred much more frequently in the RNA-binding proteomes than in the total proteome. 
Notably, this was the case for the group of proteins carrying canonical RNA-binding domains, 
but also for the ones that did not. Later RBDmap and RBR-ID showed systematically that IDRs 
not only occur more frequently in RNA-binding proteins but also interact with RNA, thereby 
constituting a new kind of non-globular RNA-binding domain. 
A census of RNA-binding proteins, which curated RNA-binding proteins from a combination of 
in silico and experimental discovery approaches, including the overlap between the two initial 
interactome capture studies, came to an estimated number of 1542 proteins for the combined 
human RNA-binding proteome.87 A current meta study, which collected human interactome 
capture datasets to integrate them into a superset of mRNA-binding proteomes, showed 55 
% identity with this list.33 Both, the curated census and the interactome capture superset, had 
more than 600 proteins unique to themselves. On the one hand, this illustrates the ability of 
experimental approaches, such as interactome capture, to discover protein-RNA interactions, 
which are not easily predicted by computation. On the other hand, it shows that interactome 
capture is limited in some way, so that it cannot procure the re-discovery of a fair number of 
computationally predicted RNA-binding proteins. As polyadenylated RNA makes up for less 
than 5 % of a mammalian cell9, it is likely that these RNA-binding proteins might interact with 
the other 95 %. 
 
MANY EMERGING REGULATORY FUNCTIONS ARE BASED ON INTERACTIONS WITH NON-
POLYADENYLATED RNA  
As mentioned earlier, many lncRNAs are emerging with important functions in genome 
regulation (for review see24). While many of these RNAs can be found in a polyadenylated 
form, a recent quantitative study showed that for the most lncRNA species polyadenylation is 
not efficient, so that their dominant form is present non-polyadenylated.90 Furthermore, 
there are well-documented cases of very highly expressed lncRNAs, such as MALAT1, which 
are never polyadenylated but stabilized through 3’ secondary structures.91 This indicates that 
in order to monitor protein interactions with these RNAs a more comprehensive approach 
than interactome capture is required, because interactome capture depends on 
polyadenylation. In general a number of non-coding, non-polyadenylated, highly expressed 
RNAs, such as 7SK RNA, are known to be involved in the canonical pathways controlling 
transcription (for review see92). However, more and more reports show how RNA in general 
can influence the behaviour of chromatin modifying proteins in regulatory ways, too. For 
example, for the PRC2 complex it was shown that its RNA-binding antagonizes its chromatin 
binding, so that actively transcribed genes repel the complex, thereby repelling transcriptional 
shutdown by it.93 Nascent transcripts only get polyadenylated at the very end of transcription, 
when the polyadenylation signal emerges, so that for the most part nascent transcripts are 
non-polyadenylated and cannot be interrogated through interactome capture. Another 
process important in this context is RNA-templated DNA repair.94 For DNA double-strand 
breaks (DSBs) in transcribed genes it was shown that the non-homologous end joining 
pathway can overcome its error-prone function when nascent RNA is employed as a template, 
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which results in error-free DNA repair.95 These are examples from the field of genome 
regulation, however, there are obviously many other important interactions involving non-
polyadenylated RNA, especially in the context of splicing, translation or RNA interference, 
some of which have been mentioned above. 
 
MANY ORGANISMS MAKE DIFFERENT USE OF POLYADENYLATION 
This thesis project is about the interrogation of protein-RNA interaction in human cells. 
However, protein-RNA interactions are fundamental to other organisms as well, so that new 
methodology developed to understand the human RNA-binding proteome could also benefit 
the understanding of other RNA-binding proteomes. This is especially true for the RNA-binding 
proteomes of prokaryotes. Among eukaryotes, interactome capture has led to a relatively 
thorough description of the mRNA-binding proteome with studies in human, mouse, fish, fly, 
yeast, plants and several protists (for review see33). Prokaryotic RNA-binding proteomes are 
understudied in this regard, because their transcriptome is not polyadenylated in the way 
eukaryotic transcriptomes are, which makes them inaccessible to interactome capture. While 
poly(A) tails in eukaryotes stabilize mRNA transcripts, in prokaryotes polyadenylation is 
believed to occur mostly on RNA breakdown products, recruiting nucleases and accelerating 
their degradation (for review see96). However, their share of the total transcriptome can 
amount to significant proportions form 2 % in E.coli to 10 % in B.subtilis. The length of poly(A) 
tails is with 1-50 nt much smaller than in eukaryotes, where the average length lies around 
200 nt. While longer tails do occur in prokaryotes the bulk of transcripts carries a tail smaller 
10 nt. Interestingly, polyadenylation is not limited to mRNA but also occurs on rRNA, especially 
23S rRNA, which in E.coli can carry polyadenylation on 10 % of all transcripts. Notably, similar 
observations have been made for organellar RNA in eukaryotes. Human mitochondrial mRNA 
is polyadenylated, however, through a pathway reminiscent of bacterial polyadenylation. 
Yeast mitochondrial mRNA only carries a very short poly(A) tail of eight nucleotides.  
That interactome capture has not been successfully used in any bacterial species so far 
witnesses the fact that prokaryotic polyadenylation is too short for efficient enrichment. Thus, 
methodological developments beyond interactome capture could provide new insights into 
prokaryotic protein-RNA interactions, which so far remain unexplored. Considering that many 
extremely selective and potent antibiotics interfere with protein-RNA interactions in the 
bacterial ribosome (for review see97), this should be a worthwhile endeavour. 
AIM OF THIS THESIS PROJECT AND BIOLOGICAL QUESTIONS 
Major efforts over the last years have been assigned to cataloguing RNA-binding proteins in 
various organisms and under various conditions (for review see33). While these catalogues 
have given much insight on RNA-binding as a molecular function, they have given little insight 
on how RNA-binding influences the behaviour of proteins. The challenge ahead lies in the 
differential quantification of protein binding to RNA between conditions. 
In order to find out how RNA-binding proteins regulate particular processes it would be 
important to know how dynamic their interaction with RNA is in the first place. A number of 
well-documented processes exist, leading to significant alterations in the subcellular 
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distribution of cellular RNA and RNA-binding proteins, which could be used to investigate this 
question. For example, arsenite stress is a well-documented inducer of translational arrest 
and macroscopic protein-RNA complexes called stress granules (for review see81). Therefore, 
quantifying protein-RNA interactions during arsenite stress should answer questions about 
how regulated and conditional RNA-binding is. Do RNA-binding proteins simply sit on RNA or 
do they increase or decrease binding depending on the cellular conditions? 
As outlined above, many essential protein-RNA complexes exist, some of which are assembled 
from a large number of protein components. Studies on protein half-lives have suggested that 
proteins in complexes are more stable than in their free from.98 A method that detects 
proteins on RNA quantitatively could also ask questions about the half-lives of these proteins. 
For example, are proteins in protein-RNA complexes more stable than in their free form? 
This thesis project started out from the realisation that current progress in the field of protein-
RNA interactions and RNA biology in general is hampered by the lack of a universal method 
for the purification of protein-crosslinked RNA. From a proteomics perspective this means that 
currently there is no method available, which allows for the quantification of protein-RNA 
interactions between conditions transcriptome-wide. As outlined above, available methods 
are either limited to a small percentage of the transcriptome or do not allow for differential 
quantification or both. Furthermore, none of those methods allows for the purification of 
protein UV-crosslinked to RNA in a way that is scalable. This is an important shortcoming 
because our knowledge about protein-RNA crosslinks is still in its infancy, mainly due to their 
poor accessibility. Consequently, an inexpensive and scalable way of purifying protein 
crosslinked to RNA would allow for much better understanding of the substance itself, apart 
from enabling new ways for quantitative proteomics.  
Aim of this thesis project was to develop a universal extraction method for protein-crosslinked 
RNA from UV-crosslinked human cells. This was realized in a method termed XRNAX, which is 
described in the first chapter of this thesis. In this first chapter we apply XRNAX to a number 
of proteomic and transcriptomic applications and answer the question how dynamic binding 
of the RNA-binding proteome is during arsenite stress. Apart from that, we discover an 
exceptionally fast and severe form of ribophagy induced by arsenite. 
In the second chapter of this thesis we turn to the question of protein stability in protein-RNA 
complexes. We apply XRNAX in order to derive protein half-lives on RNA and validate our 
findings in polysome profiling experiments. Apart from confirming that proteins bound to RNA 
are generally more stable, we find evidence for the exchange of ribosomal proteins from 
mature and translation competent ribosomes. 
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RESULTS 
COPYRIGHT DISCLAIMER 
The work presented in this thesis was conducted by me, Jakob Trendel, supervised by my 
advisor Jeroen Krijgsveld. The pronoun “we” used in this thesis denotes to me, my supervisor 
and if applicable collaborators. Work performed by collaborators is specifically highlighted in 
the text. The first chapter of this thesis, “XRNAX As Platform for Interrogating Protein-RNA 
Interactions”, summarizes work that has been published in Trendel et al., The Human RNA-
Binding Proteome And Its Dynamics During Translational Arrest, Cell, 201882. Figures for this 
first part have been adapted from this publication (i.e. Figures 1-6 and S1-S6), which will be 
openly accessible after expiry of the embargo period on this thesis. Additionally, a preprint of 
the publication is available on bioRxiv under the title Trendel et al., The Human RNA-Binding 
Proteome And Its Dynamics During Arsenite-Induced Translational Arrest, bioRxiv, 201899. As 
this first thesis chapter describes the exact same data as presented in these two 
publications82,99, we refrain from continuous and repetitive citation. Nevertheless, we 
emphasize the fact that the original intellectual effort originated and was laid out in these two 
papers. Data from the second chapter of this thesis, “Comparing Protein Half-Lives Inside and 
Outside of Protein-RNA Complexes”, has not been published and is originally presented in this 
thesis. However, we note here that plans exist to publish this work as well, which might or 
might not happen before expiry of the embargo period on this thesis. 
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The first chapter of this thesis is dedicated to Martin Trendel, who taught me that it is okay to 
think different. And if you don’t think so, that’s okay. 
CHAPTER 1: XRNAX AS PLATFORM FOR INTERROGATING PROTEIN-RNA 
INTERACTIONS 
The first chapter of this thesis is devoted to XRNAX, a method for the extraction of protein-
crosslinked RNA from UV-crosslinked cultured cells. The development of XRNAX is described 
along with benchmarking experiments and four dedicated applications. These applications are 
the identification of protein-sequences interfacing with RNA, the discovery of RNA-binding 
proteomes, the differential quantification of RNA-binding within a proteome and the 
identification of RNA-sequences interfacing with one particular protein. The presented 
findings have been originally published in Trendel et al.82, which serves as a reference for the 
entire chapter. 
 
EXTENDING TRIZOL EXTRACTION TO PROTEIN-CROSSLINKED RNA 
THE BEHAVIOUR OF PROTEIN-CROSSLINKED RNA DURING CONVENTIONAL TRIZOL EXTRACTION 
The standard extraction method for total RNA from cultured cells or tissue is acid guanidinium 
thiocyanate–phenol–chloroform extraction100,101, or “TRIZOL” extraction. In a TRIZOL 
extraction cells are lysed with guanidinium thiocyanate and phenol containing buffer, which 
denatures their protein and nucleic acid content almost completely. Chloroform is added, 
which leads to phase-separation, so that the phenolic phase contains the protein and the 
aqueous phase contains the RNA. Notably, at low pH DNA collapses into the interphase 
between the aqueous and organic phase because its phosphate backbone is protonated and 
uncharged. RNA remains in the aqueous phase because of its additional polarity from the 3’ 
hydroxyl groups. In cases where genomic DNA has not been excessively fragmented, the RNA 
in the aqueous fraction of the extraction is very pure and can be separated to be alcohol 
precipitated. After alcohol precipitation extracts only contain RNA, so that the entire 
extraction and clean-up occurs in two steps of a few minutes, which has made TRIZOL very 
popular and widespread.  
In order to extract protein-crosslinked RNA from UV-crosslinked cells we wanted to make use 
of the powerful extraction and separation powers of TRIZOL. Figure 1B illustrates that using 
the original TRIZOL protocol there was no indication that RNA extracted from UV-crosslinked 
cells was crosslinked to protein. Furthermore, HPLC-MS did not detect significant amounts of 
protein in these extracts after they had been RNase and trypsin digested. This indicated that 
TRIZOL extraction had effectively removed protein-crosslinked RNA from the aqueous phase.  
EXTRACTION OF PROTEIN-CROSSLINKED RNA FROM UV-CROSSLINKED CELLS: XRNAX 
As protein-crosslinked RNA is a hybrid molecule we suspected that it had probably been 
dragged into the interphase, where its RNA part had access to the aqueous phase and its 
protein part access to the organic phase. In order to extract the protein-crosslinked RNA we 
discarded the aqueous phase and transferred the interphase to a new vial, where we  
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solubilized it in cycles of washes with increasing concentration of SDS (for details see 
methods). After solubilisation the interphase could be alcohol precipitated, DNase digested, 
again alcohol precipitated and subsequently taken up in any desired buffer or volume. When 
run on an agarose gel these extracts showed remarkably different behaviour than RNA 
extracted with the standard TRIZOL protocol (Figure 1B). Interestingly, RNA from these 
extracts showed a very extreme shift, which left most of it in the well. This shift could be 
reversed by proteinase K treatment, which led RNA to travel into the gel. RNase treatment did 
not leave any signal behind, indicating that the sole nucleic acid content of the extracts was 
RNA. Performing the entire extraction on non-crosslinked cells returned less than 1 % of the 
amount of RNA that crosslinked cells yielded. Furthermore, two different UV-crosslinking 
strategies led to the same result. Cells could either be crosslinked using UV at 254 nm 
wavelength or upon labelling of their transcriptome with the photoactivatable nucleotide 4-
thiouridine (4-SU) with UV of 365 nm wavelength. 
We named the method consisting of UV-crosslinking, lysis in TRIZOL, solubilization of the 
interphase in SDS-containing buffer and DNase digestion protein-Xlinked RNA extraction or 
XRNAX (Figure 1A, for details see method section). 
As mentioned in the introduction, another method using TRIZOL for the purification of 
proteins UV-crosslinked to RNA was developed while we developed XRNAX. OOPS81 also 
performs conventional TRIZOL extraction on UV-crosslinked cells and transfers the interphase 
to a fresh tube. However, instead of preparing the interphase for DNase digestion, OOPS 
solubilizes the interphase in TRI reagent again in order to repeat the conventional TRIZOL 
extraction. This process is repeated again, so that the interphase is dissociated in TRI reagent 
for a total of three times. Importantly, after three rounds of TRIZOL extraction the organic 
phase does not contain free protein anymore because it was removed in previous rounds. 
RNase is added to the aqueous phase and the sample incubated at 37 °C, so that protein 
crosslinked to RNA is released into the organic phase. The organic phase is collected, protein 
precipitated, trypsin digested and analysed by MS. 
THE RNA CONTENT OF XRNAX EXTRACTS 
To understand the composition of the RNA in XRNAX extracts we purified it further and 
sequenced it. Specifically, we digested XRNAX extracts from MCF7 cells crosslinked at 254 nm 
UV with proteinase K in order to make the entirety of RNA accessible for reverse transcription.  
We compared RNA obtained in this way to RNA treated in the identical fashion from non-
crosslinked MCF7 cells, which had been extracted using conventional TRIZOL extraction. In 
order to quantify also the contribution of rRNA to each extract we sequenced before and after 
rRNA depletion (RiboZero). As illustrated in Figure 1C, XRNAX doubled the proportion of non-
ribosomal RNA in comparison to TRIZOL extracted RNA and significantly increased the 
proportion of protein-coding RNA within this share. Moreover, mitochondrial ribosomal RNA 
was also depleted from XRNAX extracts by more than a factor of three.  
We proteinase K digested and sequenced RNA extracted with XRNAX from 365 nm UV-
crosslinked MCF7 cells, which had been exposed to 4-SU for 16 hours and compared it to RNA 
extracted with TRIZOL from the same cells without crosslinking. As visible in Figure S1B&C the 
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coverage for low abundant and medium abundant transcripts was much higher in XRNAX 
extracted samples. Consequently, sequencing of XRNAX samples discovered more than 6000 
transcripts, which had not been discovered in sequencing from TRIZOL extracted samples from 
the same cells including some 1500 protein-coding transcripts, 1500 pseudogenes and 1500 
long intergenic non-coding RNAs (lincRNAs) (Figure 1D). 
In summary our experiments showed that XRNAX extracts contained all the RNA biotypes also 
contained in TRIZOL-extracted RNA, which is considered the current gold standard of total 
RNA extractions.100 Surprisingly, and not previously anticipated, XRNAX extracts were skewed 
in their relative composition of RNA species in a favourable way, so that highly redundant 
transcripts such cytosolic or mitochondrial ribosomal RNA occurred less frequently. As we 
intended to use XRNAX for the interrogation of protein-RNA interactions we considered this 
an advantage because a more diverse pool of RNA potentially allows for the detection of a 
larger number of protein-RNA interactions. Moreover, having more copies of otherwise rare 
RNA species increases the chance for detecting rare protein-RNA interactions. Thus, we found 
the RNA makeup of XRNAX extracts ideally suited for the exploration of its interaction with 
protein. 
THE PROTEIN CONTENT OF XRNAX EXTRACTS 
To understand the protein composition of XRNAX extracts we RNase and trypsin digested an 
extract from MCF7 cells and subjected its peptide content to HPLC-MS analysis.  Gene 
ontology (GO) enrichment analysis revealed the term ‘RNA-binding’ most significantly 
enriched and next to ‘nucleic-acid binding’ the most populated term (Figure 1E). We used 
intensity-based absolute quantification (iBAQ102)  to compare the composition of XRNAX 
extracts to a total proteome of MCF7 cells, recorded using the identical MS method (two hour 
gradient QExactive). Figure S1A shows that XRNAX dramatically changed the relative protein 
compositions between the two samples. While proteins with the highest abundance in the 
MCF7 total proteome were histones, cytoskeletal proteins and metabolic enzymes, XRNAX 
extracts contained proteins of the HNRNP class next to splicing factors and other nuclear RNA-
binding proteins (Figure S1A). As ribosomal proteins and RNA are very abundant in human 
cells, we were interested if ribosomal proteins also occurred in high abundance in XRNAX 
extracts, thereby potentially masking proteins with lower abundance during proteomic 
analysis. Although some ribosomal proteins were among the most abundant ones, their 
combined iBAQ intensity only amounted to 7.9 % of the total iBAQ intensity. In comparison, 
ribosomal proteins made up 13.1 % of the integrated iBAQ of MCF7 total lysates.  A similar 
case could be made for histones, where the iBAQ intensity added up to 3.5 % in XRNAX 
extracts, whereas it was 13.6 % of total iBAQ intensity in MCF7 total lysates. The latter finding 
was important because TRIZOL interphases contain concentrated chromatin and histones 
reportedly bind RNA88.  
Comparing XRNAX extracts to total lysates showed that they were very different and indeed 
highly enriched in RNA-binding proteins. Moreover, XRNAX extracts were not dominated by 
one or several very abundant proteins but had a proteomic depth that was readily accessible 
by MS. 
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To control for unspecific and indirect protein-protein rather than direct protein-RNA 
interactions we employed stable isotope labeling in cell culture (SILAC103). Cells of one SILAC 
label were UV-crosslinked, while cells of another SILAC label were left non-crosslinked before 
both were combined and subjected to XRNAX. When we analyzed XRNAX extracts of this kind 
with a standard proteomic workflow we did see enrichment for peptides from the crosslinked 
SILAC channel, however, a majority of peptides did not show enrichment for either channel 
(Figure 1F). Many of these peptides without enrichment were derived from bona fide RNA-
binding proteins. We hypothesized that during the initial TRIZOL extraction of XRNAX RNA-
binding proteins from crosslinked and non-crosslinked cells were combined in the interphase 
to form aggregates. In the following alcohol precipitation steps these interactions had 
prevented non-crosslinked proteins from being removed. RNA-binding proteins are known to 
form very stable interactions among themselves and with RNA.38 In fact, a recently reported 
method for the discovery of RNA-binding proteins had made use of the observation that RNA-
binding proteins interact preferably with other RNA-binding proteins.47 
Following this hypothesis, we designed a denaturing cleanup procedure downstream of 
XRNAX. If protein was really UV-crosslinked to RNA, purifying RNA using silica columns should 
allow for the co-purification of UV-crosslinked protein, while removing free, non-crosslinked 
protein. Silica columns retained only small amounts of protein-crosslinked RNA under 
standard conditions. However, when we subjected XRNAX extracts to incomplete tryptic 
digestion beforehand, the same columns were able to retain much better. Figure 2A outlines 
the procedure, by which XRNAX extracts underwent a very short tryptic digestion of 30 
minutes at low trypsin/LysC concentrations. Subsequently, the digestion was stopped by 
addition of guanidinium chloride containing binding buffer, the sample completely denatured 
at 60 °C and purified on a silica column. Indeed, using this additional cleanup we found much 
more peptides much stronger enriched than before (Figure 1F & Figure S1D&E). These results 
demonstrated that the enrichment of protein via silica enrichment depended on UV-
crosslinking. In order to show that it also depended on RNA we treated an XRNAX extract from 
heavy SILAC cells with NaOH in the presence of Mg2+ in order to hydrolyze all RNA. After 
neutralizing the pH of the sample, we combined it with the identical amount of XRNAX extract 
from light SILAC cells whose RNA content was intact. After silica enrichment and MS we found 
a strong enrichment of light peptides, indicating that the enrichment does in fact depend on 
RNA, too. 
The combination of these experiments demonstrated that XRNAX extracts contained protein 
UV-crosslinked to RNA, which could be co-purified from free protein using standard silica 
affinity chromatography. 
 
INTERROGATION OF PROTEIN INTERFACING WITH RNA 
We employed XRNAX as a starting point for three applications, all of which we deemed 
impossible using established methodologies (Figure 2A). In each of those applications XRNAX 
served as an initial purification step, which was prefixed to a downstream proteomic or 
transcriptomic method. Firstly, we applied XRNAX for the purification of nucleotide-
crosslinked peptides and the localization of protein-RNA interfaces. Secondly, we affinity-
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purified RNA from XRNAX extracts for the co-purification of crosslinked protein under 
denaturing conditions. This allowed us to derive high-confidence RNA-binding proteomes 
from three cell lines and to quantify RNA-binding differentially upon arsenite stress in MCF7 
cells. Lastly, we performed CLIP-Seq experiments from XRNAX extracts, where we substituted 
RNase fragmentation with high-intensity sonication. 
This first paragraph will discuss how XRNAX can be used for the identification of nucleotide-
crosslinked peptides, which can serve as direct evidence for the RNA interaction of a peptide 
sequence within a protein. Using this methodology, we discovered a new RNA-binding 
domain. For the bioinformatic analysis and of this domain we collaborated with Ananth 
Prakash of Alex Bateman’s laboratory (EMBL-EBI Cambridge). For the experimental validation 
we received help from Rastislav Horos of Matthias Hentze’s laboratory (EMBL Heidelberg), 
who performed the presented polynucleotide kinase (PNK) assay. 
PURIFICATION AND DETECTION OF NUCLEOTIDE-CROSSLINKED PEPTIDES FROM XRNAX EXTRACTS 
In order to provide more evidence that XRNAX did extract protein that was crosslinked to RNA 
we focused on identifying the actual crosslinking site between the two. For this purpose, we 
attempted to purify peptide-RNA hybrids for the identification with MS, which would not only 
give direct proof for UV-crosslinking but also pinpoint protein-RNA interaction sites. One 
earlier study had successfully identified those hybrids, which were derived from interactome 
capture experiments.83 Although this study showed that identification is in principle possible, 
it also showed that it is not straightforward, when it reported 60 nucleotide-crosslinked 
peptides from 35 human proteins. In fact, since then detection of those peptides has turned 
out so challenging, that two recent approaches, RBDmap and RBR-ID, used their absence for 
inferring protein-RNA interaction sites.39,84 
RNA-binding proteins interact through a specific part of their peptide sequence – typically an 
RNA-binding domain – with the RNA molecule they reside on. Upon irradiation with UV-light 
RNA bases get activated and react to this close-by part of the peptide sequence.53 As this 
happens only sparsely, crosslinked proteins are believed to be connected to RNA only via one 
or few ribonucleotides.83,104 We hypothesized that if all protein of an XRNAX extract was 
digested with trypsin, only the UV-crosslinked peptides would be left covalently attached to 
the RNA. We digested an XRNAX extract from MCF7 cells with large excess of trypsin and 
purified its RNA content using standard silica columns (Figure 2A). This way we could wash 
away any free peptides and recover only the ones crosslinked to RNA. Subsequent RNase 
digestion left behind tryptic peptides attached to ribonucleotides. 
We were able to enhance the purity of our sample further by applying alkaline fractionation 
before standard acidic LC-MS detection. During high-pH fractionation residual RNA fragments 
– a major contamination during LC-MS detection –  eluted very early. However, nucleotide-
crosslinked peptides gained enough hydrophobicity to elute later and could be separated as 
such. 
DATABASE SEARCH FOR NUCLEOTIDE-CROSSLINKED PEPTIDES 
Very little is known about the chemical adducts formed between ribonucleobases and the 
amino acids in a protein upon UV-irradiation. In principle every combination of the 
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ribonucleotides A, U, G, C and any of the 20 amino acids has to be considered, when searching 
MS data for this kind of modifications. Kramer et al. had addressed this problem with 
dedicated software that used a priori assumptions for the chemical amino acid-nucleotide 
adducts, which they were trying to identify.83 We preferred to take an unbiased approach and 
decided to use the recently reported ultrafast, mass-tolerant search engine MSfragger105 to 
overcome this problem. Indeed, MSfragger identified an adduct mass of 324 Dalton, 
corresponding to uridine monophosphate (U), as well as an adduct mass of 306 Dalton, 
corresponding to cyclic uridine monophosphate (cyclic U), as the most dominant modification 
in our sample (Figure 2B). This was in accordance with the findings by Kramer et al., who had 
suffixed titanium dioxide enrichment to interactome capture for the enrichment of nucleotide 
crosslinked peptides. As interactome capture only purifies polyadenylated RNA we were not 
surprised that beside most peptides described in the latter study we found many novel ones, 
i.e. 178 peptides from 64 proteins, all of which were annotated as RNA-binding. Interestingly, 
peptides were exclusively detected crosslinked to U, cyclic U or permutations of di- and 
trinucleotide sequences carrying at least one U. Momentarily we cannot conclude if this 
resulted from only U crosslinking to protein or if crosslinking sites with other ribonucleotides 
were instable and thereby escaped MS/MS detection. Using high pH fractionation, we were 
able to decrease interference from free RNA, which led to the detection of 197 cyclic U-
crosslinked peptides from 93 proteins. Interestingly, in these MS runs we detected almost 
exclusively cyclic U crosslinked peptides and only very few peptides crosslinked to several 
nucleotides. This suggested that at pH=10 the charge on non-cyclic ribonucleotide crosslinked 
peptides had shifted them into the earlier fractions, which we had excluded because of their 
notorious contamination with RNA fragments. 
NUCLEOTIDE-CROSSLINKED PEPTIDES PINPOINT PROTEIN-RNA INTERFACES 
Most of the cyclic U-crosslinked peptides we could locate in RNA-recognition motif (RRM), K-
homology (KH) or cold-shock domains (CSD) within their host proteins (Figure 2C). Ninety 
percent of proteins identified were annotated as RNA-binding and more than 85 % of 
nucleotide-crosslinked peptides mapped to bona fide RNA-binding domains or ribosomal 
proteins, confirming that these peptides represented protein-RNA interfaces. Apart from 
classical RNA-binding domains we found glycine-rich regions frequently crosslinked. This was 
in accordance with earlier RBDmap and RBR-ID studies, which had found low-complexity 
regions abundantly involved in RNA-binding.39,84 The proteins with the most crosslinked 
peptides identified were HNRNPA2B1 (13), NCL (10) and HNRNPAB (8), all of which located to 
RRMs or glycine-rich regions (Figure S2A). Beside ribosomal proteins we found cyclic U-
crosslinked peptides for proteins, which are known to interact with non-coding RNA. For 
example we identified the interactors of Steroid Receptor RNA Activator (SRA RNA) SLIRP and 
SPEN (also known as SHARP, MINT).106 We could locate the RNA interaction site of SPEN to its 
RRM3, which reportedly is essential in SRA RNA-binding.107 RBDmap had located the 
interaction site of SPEN with polyadenylated RNA to its RRM1 39, suggesting that the two 
methods resolve alternative binding modes depending on the RNA biotype they capture. We 
encountered several instances where cyclic U-crosslinked peptides located to non-canonical 
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RNA-binding domains. In a number of instances these putative protein-RNA interaction sites 
pointed out interesting structural or functional properties. For example, we found the 
ribosome biogenesis factor LTV1 and located its RNA interface to a C-terminal coiled-coil 
region. Although no RNA-binding domain is known for LTV1 cryo-electron microscopy studies 
had indicated this region of the protein to interact with ribosomal RNA during pre-40S 
ribosome assembly.108 We found a nucleotide-crosslinked peptide in the SLED DNA-binding 
domain of SCML2A, which had been suspected to recruit polycomb repressive complex 1 
(PRC1) to genomic loci under the guidance of non-coding RNA. An in vitro study had found a 
region neighboring the SLED domain capable of binding the non-coding RNA HOTAIR.109 Our 
finding suggested that another binding mode existed, which might appear independent or in 
sequence of connected binding modes during RNA-guided recruitment. In yet another case 
we located a cyclic U-crosslinked peptide in the AAA+ ATPase domain of HNRNPU (also known 
as SAF-A). Only recently a study had reported the importance of this domain in HNRNPU’s role 
in chromosome organization and in vitro experiments with the isolated domain indicated that 
its ATP hydrolyzing activity is indeed stimulated in the presence of RNA.110 Our findings implied 
that the C-terminal region of the AAA+ ATPase domain interacted with RNA, suggesting that 
this stimulation might occur through RNA directly. 
To our great interest, we identified a nucleotide-crosslinked peptide in a domain of unknown 
function (DUF). Its host protein was the uncharacterized protein C7orf50, which had been 
reported as RNA-binding in HeLa cells before 78, however, did not carry any known RNA-
binding domains. C7orf50 had not appeared in the above mentioned RBDmap or RBR-ID 
study.39,84 Interactions in the STRING database suggested that it might be involved in ribosome 
biogenesis, which was supported by nucleolar localization reported from the Protein Atlas 
database111 (Figure S2C). Pfam annotated C7orf50 with only one domain, DUF2373, in which 
we identified a nucleotide-crosslinked peptide towards its C-terminal end. Using HMMER on 
the complete Uniprot database we were able to find 17 high confidence homologues with full-
length DUF2373 from twelve vertebrate species. These uncharacterized proteins shared high 
sequence similarity within the domain, including the C-terminal part where we found the 
putative RNA interaction site (Figure S2B). Using tertiary structure prediction, we could not 
derive a confident structural model for DUF2373 from known structures. However, DUF2373 
was predicted to fold into six alpha helices, which might assemble into an alpha-helical bundle.  
We expressed full-length C7orf50 and its DUF2373 in E.coli and performed in vitro agarose gel 
shift assays with the proteins, which had been incubated with total RNA from MCF7 cells 
(Figure S2F). In both cases we could confirm RNA-binding. Consequently, we transiently 
expressed FLAG-HA-tagged versions of the proteins in MCF7 cells and could show RNA-binding 
also in vivo with a PNK assay (Figure 2D). Notably, RNA-binding was decreased when DUF2373 
was mutated at sites, which had been computationally predicted to interact with 
polynucleotides. Additionally, we enriched transiently expressed FLAG-HA-tagged proteins 
from RNase digested XRNAX extracts of MCF7 cells. Interestingly, MSfragger identified 
ribonucleotide crosslinked peptides for full-length C7orf50, the wild type DUF2373 but not 
DUF2373 mutants. Our finding suggested that DUF2373 was a conserved vertebrate RNA-
binding domain for which we propose the name WKF in reference to the three most conserved 
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residues in its consensus sequence. This naming scheme has been adopted by the Pfam 
database. 
A comparison of amino-acid frequencies between all peptides crosslinked to cyclic U and all 
peptides identified in our control MCF7 total proteome showed a clear enrichment for 
phenylalanine, lysine and glycine in the crosslinked sequences (Figure 2E). As RNA might 
obstruct tryptic cleavage of crosslinked peptide sequences even if lysine is next to a 
crosslinked amino acid, we could not exclude that the enrichment in lysine was due to 
increased miscleavage and not crosslinking. However, arginine frequencies were identical 
between the two samples arguing that lysine might be directly involved in crosslinking. We 
searched our cyclic U crosslinked peptides with the motif search engine MEME and were able 
to identify the conserved RNP1 or RNP2 motif in 71 % of cases. Both motifs are rich in 
phenylalanine and known to be vitally involved in RNA recognition of the RRM.112 While this 
again confirmed that nucleotide-crosslinked peptides identified protein-RNA interfaces, it also 
pointed out the importance of phenylalanine in those interfaces during UV-crosslinking. A 
recent in vitro study had been able to identify the phenylalanine-uracil crosslinking adduct 
from the RRM of the splicing factor PTBP1 through isotopic labeling of RNA and protein.77 Our 
data suggested that this adduct might be common and causal for many UV-induced protein-
RNA crosslinks. In contrast to earlier studies that were limited to polyadenylated RNA83, 
XRNAX extracted ribosomal RNA, too. We identified cyclic U-crosslinked peptides from seven 
ribosomal proteins that we could locate in the cryo-EM structure of the human 80S ribosome 
(Figure S2E). Notably, for four out of six peptides that contained phenylalanine, we found 
phenylalanine in close proximity to a uracil base in the RNA sequence. 
In summary, our findings demonstrated that nucleotide-crosslinked peptides identified from 
XRNAX extracts could give insights to canonical and non-canonical protein-RNA interactions. 
These interactions suggested regulatory functions where RNA was employed for protein 
recruitment (in the case of SPEN, SLIRP and SCML2A) or modulation of enzymatic function (in 
the case of HNRNPU). Furthermore, nucleotide-crosslinked peptides gave structural insights 
as showcased for proteins in the ribosome and provided evidence for an entirely new RNA-
binding domain. 
 
DISCOVERY OF PROTEINS INTERACTING WITH RNA 
As demonstrated in the previous paragraph nucleotide-crosslinked peptides from XRNAX 
extracts are the most direct MS evidence showing protein-RNA interactions. However, what 
becomes obvious from the number of proteins identified in our but also previous studies83 is 
that these peptides are not easily detected and are typically derived from highly abundant 
proteins. In order to catalogue RNA-binding proteins interactome capture did not rely on 
these crosslinked peptides but on the enrichment of peptides from a UV-crosslinked sample 
over a non-crosslinked control.65,78 This way an RNA-binding protein can contribute many 
tryptic peptides, which do not necessarily need to be crosslinked directly to RNA, but rather 
indirectly by being connected to some crosslinked peptide within the complete sequence of 
the protein. Consequently, many more identifications can be made and many more proteins 
can be classified as RNA-binding, although the MS evidence is more indirect. The following 
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paragraph describes a SILAC-controlled strategy for cataloguing RNA-binding proteins, which 
we applied to three commonly used cell lines. We compare this catalogue to previous 
catalogues derived by interactome capture and describe commonalities and differences. 
SILAC-CONTROLLED ENRICHMENT FOR RNA-CROSSLINKED PROTEIN FROM XRNAX EXTRACTS 
Earlier experiments had shown that UV-crosslinked protein in XRNAX extracts could be 
purified from non-crosslinked protein using silica affinity chromatography. By employing this 
principle, we went on to derive a comprehensive draft of the RNA-binding proteome beyond 
the known and confirmed proteins binding to polyadenylated RNA. Again, we used SILAC to 
control for unspecific interactions of proteins that were not crosslinked to RNA. Therefore UV-
crosslinked cells of one SILAC label were combined with non-crosslinked cells of the 
complementary label. After XRNAX and silica column purification the enrichment was so 
strong that most of the peptides did not have any intensity in the non-crosslinked SILAC 
channel at all (Figure 1F). To classify peptides as crosslinked or not we decided on a stringent 
cut-off of 1000 fold, which was intentionally beyond the SILAC dynamic range of 
approximately 100 fold.113 We called peptides with such an enrichment super-enriched 
peptides and utilized them for the classification of proteins as RNA-binding. 
In order for silica columns to retain significant amounts of protein-crosslinked RNA we had 
established that XRNAX extracts needed to be partially digested beforehand. We optimized 
predigestion conditions towards detection of the maximal number of super-enriched 
peptides, which potentially discovered the maximal number of RNA-binding proteins. By 
varying the predigestion time at constant trypsin/LysC concentrations we came to the 
realization that there was no optimal predigestion time but that different predigestion times 
led to the identification of different super-enriched peptides. Nevertheless, for achieving 
maximum peptide diversity among super-enriched peptides there was an optimal 
combination of predigestion times. For the following analysis we prepared samples with 15 
and 30 minutes of partial tryptic digestion, which were purified and analyzed in separate. 
We noticed that another factor influencing peptide diversity was the growth state of cells used 
for our preparation. Confluent cells returned a different set of peptides than half-confluent 
cells did. While it intuitively makes sense that rapidly dividing cells have a different 
composition of their RNA-binding proteome than contact-inhibited cells, we wanted to 
integrate both these states in our analysis to derive the most general RNA-binding proteome 
for one cell line. Consequently, we decided to produce XRNAX extracts from half-confluent 
and confluent cells, each of which were subjected to silica purification after 15 or 30 minutes 
of partial tryptic digest, respectively. Thereby a collection of four independent samples was 
produced, each fractionated at high pH and analyzed in six fractions. In order to assess the 
reproducibility of this system we produced two independent sets of samples from MCF7 cells, 
swapping the SILAC-label for UV-crosslinked and non-crosslinked control cells. Figure 3A 
illustrates that, indeed, both sets of samples not only discovered a highly similar set of 
proteins through super-enriched peptides, but the number of super-enriched peptides 
identifying a protein was highly similar, too. 
Thus, denaturing silica purification of XRNAX extracts provided a way for the controlled and 
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reproducible discovery of RNA-binding proteins from SILAC-labeled cells. Furthermore, by 
using optimized predigestion conditions and cells of different growth states we were 
confident to use the system at its maximal potential. 
AN INTEGRATED DRAFT FOR THE HUMAN RNA-BINDING PROTEOME FROM THREE CELL LINES 
We applied our enrichment scheme to three commonly used human cells lines, which had 
been subject of interactome capture studies before – MCF7, HeLa and HEK293. To classify 
proteins identified in one cell line as RNA-binding we only considered proteins that were 
detected with at least two unique super-enriched peptides. This presented us with high-
confidence RNA-binding proteomes of 1207 proteins for MCF7, 1239 proteins for HeLa and 
1357 proteins for HEK293 cells, among of which 858 were shared by all three cell lines (Figure 
3B). 
For clarity we state here that in the following the term ‘poly(A) RNA’ and ‘poly(A) interactome’ 
refer to RNA that carries polyadenylation and the protein interactome of RNA that carries 
polyadenylation, respectively, which includes but is not limited to most mRNA molecules.114 
A comparison of HeLa interactome capture data from Castello et al. to the XRNAX-derived 
HeLa RNA-binding proteome illustrated the powers of XRNAX over interactome capture. 
XRNAX rediscovered 674 of the 846 proteins found by interactome capture and added almost 
600 more (Figure 3C). Although we applied a much more stringent enrichment cut-off for 
calling RNA-binding proteins than Castello et al. did, we were able to confirm some of the 
proteins that were earlier reported as ‘candidate mRNA-binder’.78 These proteins had been 
identified in HeLa interactome capture experiments but had failed to reach statistical 
significance. Proteins which appeared in this interactome capture dataset but not in our HeLa 
XRNAX interactome had significantly lower confidence levels in comparison to proteins, which 
had been discovered by both methods (Figure S3A). This indicated that XRNAX added 
sensitivity and specificity in comparison to previous methodology. 
We compared our XRNAX RNA-binding proteomes to other published poly(A) RNA 
interactomes and found extensive overlap (Figure 3D, top). Seventy five percent or more of 
proteins found in interactome capture studies were represented in our data, which allowed 
us to divide our RNA-binding proteome in two sections – the poly(A) interactome and the 
section that we designated the non-poly(A) interactome. Deep total proteome data for all 
three cell lines was readily available89, which we used as a background control in GO analysis. 
Unsurprisingly, this revealed strong enrichment for RNA-related terms in the poly(A) 
interactome (Figure S3B). GO term enrichment for the non-poly(A) interactome was 
problematic because of the high prevalence of proteins annotated as RNA-binding in the total 
proteome of the three cell lines. Most of these annotations were assigned in reference to the 
two initial interactome capture studies by Baltz et al. and Castello et al., both of which 
identified poly(A) RNA-binding proteins. Since at this moment we were not interested in 
poly(A) interactors, but non-poly(A) interactors, we removed the published poly(A) 
interactome from the background control. Consequently, we found strong enrichment for 
RNA-related terms for this part of the dataset as well. Interestingly, terms relating to non-
coding RNA such as rRNA, 7S RNA, tRNA, snRNA or snoRNA and the ribosome were especially 
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enriched. Moreover, some terms such as ‘aminoacyl-tRNA ligase activity’ or ‘ribonuclease 
activity’ we found only enriched in the non-poly(A) part of our interactomes. We were 
interested to see how much of the non-poly(A) interactomes could be explained by current 
GO annotations. For this purpose we collected RNA-related GO terms in 5 functional classes, 
i.e. ribosome & ribosome biogenesis, RNA-binding, RNA metabolism, transcription and 
nucleotide binding. Since many RNA-binding proteins carried annotations represented in 
several of those categories, we applied them hierarchically and removed proteins from our 
list as soon as they fit into one category (Figure 3D, bottom). Surprisingly, only approx. 30 % 
proteins of each non-poly(A) interactome did not carry an annotation that fit into any of the 
categories. In regard to the entire RNA interactomes derived by XRNAX, including the poly(A) 
and the non-poly(A) interactomes, this reflected approx. 15 % of proteins. 
Combining our findings from all three cell lines resulted in a collection of 1753 proteins that 
we named the integrated human RNA-binding proteome or ihRBP, containing 978 proteins (or 
70 %) of previous poly(A)-interactomes, and 775 in the non-poly(A)-interactome (Figure 3E). 
Comparison of the ihRBP to the census of RNA-binding proteins from Gerstberger et al., who 
had catalogued RNA-binding proteins by combining computational analyses with manual 
curation87 showed 55 % overlap. This confirmed an observation made in earlier studies that 
computational prediction of RNA-binding is often incomplete, because it can be independent 
of protein domains and involve intrinsically disordered regions (IDRs) 39,78,88. Many of those 
proteins were known interactors of non-coding RNA, such as POLR1A – catalytic core of RNA 
polymerase I – or translation initiation factors not previously identified by interactome 
capture like ABCE1, EIF2S3, EIF3B, EIF3J. Moreover, the non-poly(A) interactome contained 
numerous ribosomal proteins and 17 out of 23 amino-acyl tRNA synthetases represented in 
the ihRBP. We found proteins involved in micro RNA (miRNA) biogenesis such as DICER1, TSN 
and TARBP2 and the interactor of telomerase RNA PINX1. There were numerous proteins 
involved in rRNA and snRNA biogenesis most prominently the nuclear exosome components 
SKIV2L, EXOSC2, EXOSC3 and DIS3, as well as splicing factors such as SF3B3, LSM8, ESRP1 or 
CWC22. Finally, we found many transcription-associated proteins some of which are known 
to interact with 7SK RNA like HEXIM1, CCNT1 and CDK9. 
Thus, the ihRBP was a profound collection of human proteins evidently interacting with 
poly(A) and non-poly(A) RNA. The addition of proteins interacting with non-poly(A) RNA 
allowed us to interrogate questions, which earlier interactome capture studies were not able 
to ask. The first one of those questions was: What is the difference between the two? 
A NOVEL GROUP OF RNA-BINDING PROTEINS INTERACTING WITH NON-POLYADENYLATED RNA 
Growing evidence suggests that phase-separation of RNA-binding proteins organizes 
membrane-less macromolecular assemblies such as nucleoli 35 or Cajal bodies, and RNA 
granules 35,37,38 such as stress granules or P-bodies (for review see 34,115). Feric et al. had shown 
that nucleolar organization is driven by different surface tensions in protein droplets 
contributing to different subcompartments of the nucleolus. Importantly, they had concluded 
surface tension and viscoelasticity of protein droplets is a ‘sequence-encoded’ feature that 
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crucially determines participation of proteins in higher order structures as well as their 
behavior inside such structures. 
With the ihRBP we had the so far largest collection of experimentally derived human RNA-
binding proteins at our disposal. Furthermore, by intersecting our data with interactome 
capture data, we could divide this collection in two parts, a poly(A) and non-poly(A) 
interactome. We hypothesized that members of those groups must differ in their ‘sequence-
encoded’ information, so that they become part of different macromolecular assemblies that 
interact with different biotypes of RNA, i.e. poly(A) RNA or non-poly(A) RNA. Consequently, 
by comparing those two groups to each other we should be able to find out what the 
‘sequence encoded’ information was, that divided them. The first question we asked was how 
much sequence information was necessary to find any differences at all between the two 
groups. We approached this problem systematically by comparing low level sequence 
information – amino acid frequency – then adding sequence information step-wise by 
comparing dipeptide and tripeptide frequencies. Figure S3C illustrates that while amino acid 
frequencies were virtually identical between the two groups, differences became apparent 
when more peptide information was added, so that dissimilarities in tripeptide frequencies 
turned out significant (Wilcox ranksum test p=0.02). Notably, these dissimilarities did not arise 
from control sets of the same size that randomly sampled proteins from the ihRBP. 
Interestingly, proteins of the poly(A) interactome showed strong enrichment for tripeptides 
carrying permutations of amino acids known to contribute to IDRs, i.e. glycine (G), serine (S), 
asparagine (N), glutamine (Q), proline (P), glutamic acid (E), lysine (K), and arginine (R).116 
Some of those fairly abundant tripeptides like the motif RGG occurred more than five times 
more often in the poly(A) interactome than in the non-poly(A) interactome. To get a more 
detailed picture we limited the analysis to the eight IDR amino acids and compared hexamer 
frequencies between the two groups (Figure 3F & Figure S3D). Again, we found strong 
enrichment of some specific motifs in the poly(A) interactome. The strongest enrichment was 
for one with alternating occurrence of R and G, which occurred more than 10 times more 
frequently in the poly(A) interactome than in the non-poly(A) interactome. Motifs containing 
analogous alternations of either R and S or R and E were similarly enriched. Other tetramers 
especially often occurring in the poly(A) interactome carried an RGG motif or a poly-G stretch. 
Notably, the two groups did not simply differ in the appearance or absence of low-complexity 
motifs in general but differed in the appearance of those specific motifs. Other motifs, such 
as poly(E), poly(S), poly(P), poly(Q) or poly(K) stretches, occurred with very similar frequencies 
in both groups. Interestingly, proteins carrying those repeats were often associated with 
similar molecular processes independent of the biotype of RNA they bound to. For example, 
a common GO annotation for proteins carrying a poly(E) stretch was ‘chromatin organization’. 
These findings showed that, indeed, ‘sequence-encoded’ information did distinguish poly(A) 
binding from non-poly(A) binding proteins. Moreover, the sequences that distinguished them 
the most, were those low-complexity motifs that in numerous cases had been reported to 
drive liquid-liquid phase transition.35,37,38,117,118 For clarity we state here that poly(A) binding 
proteins had been reported to carry low complexity motifs with higher frequency than the 
rest of the human proteome before (for review see119). However, our comparison of the 
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poly(A) interactome to a very specific subset of the human proteome – the non-poly(A) 
interactome – added a functional consequence, which earlier studies were not able to derive. 
Next, we asked if properties of the global amino acid sequence of proteins in the poly(A) or 
the non-poly(A) interactome could separate them, too. For this purpose we compared 
hydrophobicity, isoelectric point, mass weight and charge state at pH=7 between the two 
groups (Figure S3E). We found that poly(A) binders were generally more hydrophobic and had 
a more alkaline isoelectric point (pI), whereas non-poly(A) binders were larger and often 
carried more negative charges. Especially pI and hydrophocity differed greatly between the 
groups, again showing that ‘sequence-encoded’ information distinguished them. 
Nevertheless, Figure 3G illustrates that the variance between them was great, too, so that 
neither pI nor hydrophobicity alone could point out one group over another. 
In summary we could show that poly(A) and non-poly(A) binding proteins differed in their local 
and global amino acid sequence features. While those differences were highly significant, no 
single feature was predictive for either category suggesting that in a cell their superposition is 
necessary to guide the assembly of poly(A) or non-poly(A) ribonucleoprotein particles into 
higher order structures. 
A comparison of interpro domains between the poly(A) and the non-poly(A) interactome 
revealed notable commonalities and differences between the groups (Figure 3H). Together 
with P-loop containing nucleoside triphosphate hydrolases, the RRM was the most abundant 
domain overall. Interestingly, proteins carrying RRMs were almost exclusively found in the 
poly(A) interactome. Among zinc finger proteins the RING-type domain was more prevalent 
with poly(A) binders, whereas the FYVE/PHD-type occurred more often in the non-poly(A) 
interactome. Some domains within the P-loop containing nucleoside triphosphate hydrolases 
were enriched in the non-poly(A) interactome, i.e. the ABC-transporter-like and the AAA+ 
ATPase domain. As expected, we found both classes of aminoacyl-tRNA synthetase domains 
strongly enriched in the non-poly(A) interactome. Surprisingly, the domain with the strongest 
enrichment in the non-poly(A) interactome was the bromodomain – a very rare domain 
among poly(A)-RNA binders. Many of these bromodomain-carrying proteins such as BRD2, 
BRD3, BRD4, BAZ1A, BRPF1, KMT2A, PHIP, TRIM33, ATAD2 and SMARCA4 were important 
histone modifiers 120. Interestingly, one very recent report had found the bromodomain itself 
to interact with enhancer RNA (eRNA), which leads to the recruitment of BRD4 to enhancers. 
We followed this lead and looked for proteins known to interact with chromatin in the non-
poly(A) interactome using the STRING interaction database. Several interesting clusters 
occurred, the first of which included RUVBL1, member of the NuA4 complex, RSF1 and the 
above-mentioned BAZ1A. We identified TP53 and the DNA-damage regulators TP53BP1, RIF1, 
MDC1, as well as BRCA1. TP53BP194 and BRCA1121 had been reported to interact with non-
coding RNA, whereas RNA-binding of TP53 had been controversial122 and for MDC1 and RIF1 
not previously described. Notably, we detected 25 super-enriched peptides for TP53BP1. 
Thereby it was one of the proteins discovered with the highest confidence among non-poly(A) 
interactors. Another cluster was identified around proteins involved in spindle pole assembly, 
such as BUB3, AHCTF1, CKAP5, PDS5A, KIF2C, KIF11 and CENPF. Again, none of these proteins 
had been reported to bind RNA before. The same was true for a different cluster around the 
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condensin complex, which included SMC2, SMC4, NCAPD2, NCAPD3, NCAPDG and NCAPG2. 
Finally, we could make out a cluster of proteins around POLR1A, i.e. RNA polymerase I. This 
included CHD1, member of the SAGA complex, ATRX, member of the ATRX:DAXX complex, 
and TTF1, the RNA polymerase I transcription termination factor. Except for POLR1A, we could 
not find previous reports for any of the proteins in this cluster to interact with RNA. 
As non-coding RNAs emerge as important regulators in genome regulation24, it becomes more 
important to find their protein interactors in order to get mechanistic insights to their action42. 
Our non-poly(A) interactome revealed RNA-binding for many important chromatin 
components, whose function could potentially be guided by RNA. 
 
QUANTIFICATION OF CHANGES IN THE INTERACTION OF PROTEINS WITH RNA 
Using a non-crosslinked control and SILAC had allowed for the discovery of over 1700 RNA-
binding proteins from three cell lines and well over a thousand proteins from each individual 
cell line. We hypothesized that instead of quantifying the enrichment of UV-crosslinked 
protein over a non-crosslinked control, XRNAX in combination with SILAC could quantify RNA-
binding differentially between two crosslinked populations of cells. Therefore, cells of one 
SILAC label should undergo a certain treatment before UV-crosslinking and should then be 
combined with untreated cells of the complementary SILAC label, which should also be UV-
crosslinked. In the first part of this paragraph we describe experimental findings 
demonstrating that this quantification is in fact possible and accurate if the background is 
considered and excluded. We then applied this quantification in a timeline experiment, where 
MCF7 cells were exposed to arsenite – an established stressor for the induction of 
translational arrest (for review see123,124). Serendipitously, we found that on the total 
proteome level arsenite induced a fast and severe form of autophagy, which selectively 
eliminated proteins associated with protein biosynthesis. While this finding showed the 
importance of controlling changes on the RNA-level with changes on the total proteome level, 
its details were only tangentially involved in the differential quantification of RNA-binding and 
will therefore be discussed in an autophagy ‘excursion’ annexed to this paragraph. 
BACKGROUND AND DYNAMIC RANGE FOR THE DIFFERENTIAL QUANTIFICATION OF RNA-BINDING 
WITH XRNAX 
Before quantifying the dynamics of the RNA-bound proteome during differential treatment 
we established that XRNAX was in fact able to assess RNA-binding quantitatively. To test this, 
we mixed decreasing amounts of UV-crosslinked MCF7 cells with non-crosslinked cells (both 
grown with heavy SILAC label), and combined this with a fixed amount of UV-crosslinked cells 
of a light SILAC label. Thereby, unmixed, UV-crosslinked cells represented 100 % RNA-binding, 
whereas dilutions with non-crosslinked cells represented decreased RNA-binding, e.g. a 1:4 
dilution 25 % RNA-binding (Figure S1G). For MS quantification, all samples were combined 
with a fixed amount of UV-crosslinked cells carrying a light SILAC label. Indeed, after 
processing samples via XRNAX and silica enrichment, most peptides were accurately 
quantified according to their dilution over two orders of magnitude. Additionally, there was a 
noticeable number of peptides that stayed constant, independent of how many cells were UV-
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crosslinked in their parent sample. A comparison to our earlier data revealed that peptides 
that showed quantitative foldchanges were exclusively found among the super-enriched 
peptides of the ihRBP. Vice versa, peptides that remained constant were found among the less 
enriched peptides that we had discarded while generating the ihRBP.  
In conclusion, this demonstrated that super-enriched peptides of the ihRBP provided a library 
of peptides that could be used for the accurate quantification of protein UV-crosslinked to 
RNA. By filtering for those peptides XRNAX could be used for the accurate quantification of 
changes in RNA-binding between conditions. 
DIFFERENTIAL QUANTIFICATION OF PROTEIN-RNA INTERACTION DURING TRANSLATIONAL ARREST 
We treated MCF7 cells with arsenite to study the effects of translational arrest on protein-
RNA interactions. Arsenite stress had been reported to effectively induce translational arrest 
followed by the formation of stress granules (for review see 123,124). In order to choose an 
adequate timescale, we monitored protein biosynthesis using azido homoalanine (AHA) 
labelling and SILAC in MCF7 cells (Figure 4A). During AHA-labelling nascent proteins 
incorporate the methionine analogue AHA to be captured by click-chemistry, which upon MS 
gives a direct measure for translation125,126. We compared protein biosynthesis in MCF7 cells 
during one hour of arsenite stress in comparison to an untreated control. Indeed, translation 
was heavily decreased in arsenite-treated cells after 60 minutes to 23% (median) compared 
to the untreated control. The timeline indicated that translational arrest was not immediate 
but occurred gradually with the biggest changes arising within the first 30 minutes of 
treatment. In the expectation that the largest changes in RNA-binding would also occur in 
these 30 minutes we chose a timeline with five points within this window. We also verified 
that arsenite did not compromise the chemical stability or induced major degradation of RNA 
directly. Accordingly, we did not observe noticeable changes in the amount or degree of 
degradation of total RNA extracted from cells that underwent arsenite treatment (Figure 
S4D&E). To quantify RNA-binding differentially MCF7 cells of one SILAC label were challenged 
with 100 µM arsenite and compared to untreated cells of the complementary label. In order 
to control for changes in the total proteome we quantified total proteomes at the same time 
points. After stringent filtering we obtained quantitative data for the association of 765 
proteins with RNA over all time points (Figure 5B). Correspondingly, 3489 proteins in the total 
proteome were reproducibly quantified over all time points (Figure 4B) and the intersection 
between the two datasets contained 633 proteins (Figure 5D). Firstly, we were interested in 
general trends in RNA-binding under arsenite stress. Figure 5A&B illustrate that most proteins 
remained constant in their interaction with RNA over all time points measured. In fact, 90 % 
quantiles after 30 minutes were within 0.77 - 1.21 foldchange between arsenite treated cells 
over control cells. Nevertheless, several proteins showed a distinct change in RNA-binding, 
most of them decreasing, whereas only one protein increased RNA-binding more than twofold 
– TP53BP1. The kinetic profile of proteins that changed their association with RNA was 
typically a steady incline or decline with the exception of the exosome component EXOSC2, 
which already showed significantly increased binding upon five minutes of arsenite stress, and 
then stayed constant. To control for abundances, we checked proteins from our RNA-binding 
 45 
analysis against the same proteins in our total proteome analysis (Figure 5C&D). Interestingly, 
in the total proteome data two groups emerged – one larger one that stayed unchanged over 
all time points and one smaller one that showed small but significant decrease of protein 
abundance over time. Figure 5C shows that this group made up approximately 25 % of 
proteins in the observation.  We compared changes in RNA-binding and changes in the total 
proteome directly, which allowed us to deconvolute the contribution of either component to 
our measurement (Figure 5E and Figure S5A). This revealed for the two proteins with the 
strongest increase in RNA-binding, TP53BP1 and EXOSC2, that their increase could be entirely 
contributed to the association with RNA, because their absolute abundance stayed constant 
over all timepoints. For the group of proteins that showed decreased RNA-binding a 
simultaneous decrease in total protein abundance was observed. However, at no timepoint 
this decrease in the total proteome outweighed and explained their much stronger 
dissociation from RNA. Three proteins with the strongest decrease in RNA-binding after 30 
minutes were the ribosomal proteins RPS28, RPS14 and RPS3. Since arsenite stress is known 
to induce translational arrest 123,124 we located the proteins in the cryo-EM structure of the 
human 80S ribosome to find out if their changed binding might relate to any of their structural 
features. Indeed, we found all three proteins in the cleft that channels mRNA through the two 
ribosomal subunits (Figure 5F). This allowed the assumption that a decrease in RNA-binding 
for those proteins might have been due to polysomes disassembling from mRNA upon 
arsenite-induced translational arrest. 127,128 Another protein with effectively reduced RNA-
binding was USP10, which reportedly has a key role in stress granule formation.124 To get a 
better understanding of translational control during our time course experiment we examined 
RNA-binding and proteomic changes for all eukaryotic translation initiation factors (EIFs) in 
our analysis (Figure S5B). A general trend within the group was a steady decrease in protein 
abundance, so that after 30 minutes of arsenite treatment there was a 40-50 % reduction in 
total protein, while for most EIFs RNA-binding stayed basically constant. Two exceptions were 
EIF2S2 and EIF2D, which notably are not members of the same complex (despite confusingly 
similar names). EIF2S2, also known as eIF2-b and core component of the EIF2 complex 
involved in 43S preinitiation complex formation (for review see129), increased binding steadily 
over all timepoints, although its protein abundance decreased significantly. In fact, by 
normalizing its increase in RNA-binding with protein abundance, we found its effective 
increase in RNA-binding with 2.8 fold after 30 minutes stronger than for any other protein in 
the experiment. EIF2D, also known as Ligatin and not member of the canonical EIF2 
complex130, decreased RNA-binding. However, its effective RNA-binding after normalization 
to protein abundance was unchanged for all timepoints. A third protein standing out was 
EIF4A3, which did not show any changes in abundance or RNA-binding at any timepoint. 
EIF4A3 is the RNA-binding component of the exon junction complex and thereby only 
tangentially involved in translation initiation 131, which might explain why it did not share the 
same behaviour as the other EIFs.  
Our data illustrated that quantification of RNA-binding using XRNAX was able to recapitulated 
processes known to occur during translational arrest. Moreover, it identified protein players 
and mechanisms that future studies may address in more detail. 
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previously not known to be involved in the cellular response to arsenite, suggesting novel  
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EXCURSION: ARSENITE INDUCES MASSIVE AND SPECIFIC AUTOPHAGY ON A TIMESCALE OF MINUTES 
Our control data for the normalization of RNA-bound protein to total protein had revealed 
that the MCF7 proteome split up in two parts during the response to arsenite. While most 
proteins retained their abundance constant a subset showed steady decrease, which resulted 
in significantly reduced levels of those proteins after 30 minutes. Turning away from only the 
RNA-binding proteome and now looking at all proteins quantified (Figure 4B), we asked which 
proteins were affected and performed rank-based GO enrichment analysis. For a list of 
proteins ranked from most decreased to least decreased upon arsenite stress we found very 
significant enrichment for the process ‘translation initiation’. Figure 4C tracks the terms with 
the most extreme enrichment for molecular function over all timepoints. Notably, after 5 
minutes of treatment ribosomal proteins were already affected to a degree that let them rank 
in a very significant way. We isolated proteins carrying the most enriched GO terms to analyse 
their behaviour over time (Figure 4D & Figure S4A&B). For ribosomal proteins we found two 
populations, only one of which changed over time. Closer examination revealed that the 
unaffected population were mitochondrial ribosomal proteins, whereas proteins of the 
cytosolic ribosome decreased in abundance without exception. As observed earlier EIFs were 
collectively affected with a kinetic similar to ribosomal proteins. In addition, other RNA-
binding proteins decreased in abundance, most of them directly linked to protein 
biosynthesis.  
These results showed that arsenite-induced translational arrest was followed by a specific 
protein degradation process. This degradation process affected the translational machinery 
and especially ribosomal proteins, which were reduced by up to 50 % after 30 minutes. 
Arsenite exposure had been shown to induce autophagy in cultured cells132,133 as well as in 
vivo134. These observations had been made on a timescale of several hours to days at high 
nanomolar to low micromolar arsenite concentrations. Buchan et al. had reported that stress 
granules are cleared by autophagy after high micromolar arsenite stress is relieved from 
cultured cells. We note that typical concentrations to induce translational arrest or stress 
granules in cultured cells range from arsenite concentrations of 40-1000 µM135,136. Our data 
indicated that high micromolar concentrations of arsenite induced a degradation process on 
the timescale of minutes. In order to get a better understanding of the arsenite-induced 
degradation process we performed a titration experiment from 0-1600 µM arsenite. We 
treated MCF7 cells for 30 minutes with increasing doses of arsenite and compared their 
protein content to an untreated control using SILAC. Figure S4G illustrates the relationship 
between arsenite concentration and the degree to which protein in arsenite treated cells was 
degraded. Interestingly, the effect that we had observed before was even more extreme at 
higher doses of arsenite. Again, we found ribosomal proteins collectively among the most 
affected. We used their reduction as a function of arsenite concentration to generate a dose-
response model and found a good fit (Figure S4G, insert). Notably, these findings were readily 
reproducible in HeLa cells at very similar effective concentrations (Figure S4H). We noticed 
variability in the magnitude of the effect from cells that were not grown under the exact same 
conditions. This variance could be narrowed down to the growth state of cells, when we 
compared the degree to which arsenite-induced protein degradation affected cells that were 
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seeded at the same density but harvested in five consecutive days (Figure S4J). We chose a 
seeding density that produced confluent cells after 5 days for this purpose. Maximum 
degradation upon arsenite stress was observed on the third day, so during log-phase 
expansion and maximal growth.  
We asked what the underlying mechanism for the degradation process was and interfered 
with proteasomal and autophagic degradation, respectively. MCF7 cells that were pretreated 
with bortezomib showed the same degree of degradation as untreated cells upon 30 minutes 
of arsenite stress (Figure S4F). However, degradation was markedly decreased by 
pretreatment with the autophagy inhibitor spautin-1137 (Figure 4F and Figure S4F). Western 
blotting against the autophagy marker LC3 confirmed increased autophagic flux during the 
course of arsenite treatment, as indicated by increased conversion of LC3-I to LC3-II (Figure 
4E). Interestingly, the baseline autophagic flux of MCF7 cells in this growth state occurred to 
be high, however, it got markedly increased after 30 minutes of arsenite stress. We compared 
the effect of arsenite-induced degradation to rapamycin-induced degradation. Rapamycin by 
itself induced very modest degradation within 30 minutes of treatment (Figure S4K). However, 
for a list of most degraded to least degraded proteins, ranked GO analysis returned 
enrichment for very similar terms as seen for arsenite treatment (data not shown). 
Rapamycin-induced degradation could be augmented by additional arsenite stress, yet, 
combined treatment did not exceed the maximal degradation observed for arsenite stress by 
itself (Figure S4K). 
These findings showed that arsenite-induced degradation was a process of autophagy and 
independent of the proteasome. Protein degradation occurred on a timescale of minutes and 
depended in its intensity on the growth state of cells. Furthermore, arsenite-induced 
autophagy seemed to occur independent of MTOR control. 
 
INTERROGATION OF RNA INTERFACING WITH PROTEIN 
So far, we had used XRNAX for proteomic applications, however, we also wanted to explore 
the transcriptomic possibilities arising from the method. Conceptually, there were two 
approaches to this, both of which are presented in the following paragraph. The first approach 
was to map the interaction sites of one particular protein-of-interest with the transcriptome 
by prefixing XRNAX to a conventional crosslinking and immunoprecipitation and sequencing 
(CLIPseq) experiment. Here, the purity and concentration of XRNAX extracts give advantages, 
which will be discussed in more detail below. The second approach was to map the interaction 
sites not of one particular protein-of-interest but of the entire RNA-binding proteome with 
the transcriptome. In this case chemical biology was used to enrich all crosslinking sites from 
XRNAX extracts and their location in the transcriptome through sequencing. At the time this 
thesis was written this last section was still in the process of optimization so that the method 
will only be presented conceptually. However, from data produced in a proof-of-concept 
experiment our computational collaborator Michael Piechotta from the laboratory of 
Christoph Dieterich (University of Heidelberg) could show that the method, called PEPseq, was 
able to gather occupancy information of protein on the entire transcriptome. 
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XRNAX CLIPSEQ REVEALS INTERACTIONS SITES OF INDIVIDUAL PROTEIN SPECIES WITH THE 
TRANSCRIPTOME 
Having successfully employed XRNAX for the proteomic analysis of protein-RNA interactions, 
we next aimed to address this from the other side and identify RNAs that interact with a 
protein-of-interest. Therefore, we combined XRNAX with a protocol for CLIPseq. Conceptually, 
XRNAX as a sample preparation step prior to CLIPSeq is advantageous for a number of reasons: 
1) Contaminants like DNA, which could physically obstruct immunoprecipitation or mask 
target protein in chromatin complexes, are eliminated. 2) Sample volumes are reduced from 
millilitres to microliters, thereby allowing for higher antibody concentrations. 3) RNA 
fragmentation can be supplemented by ultrasonication, thereby circumventing cumbersome 
optimization and potential biases of RNase treatment 138. 
We selected Lamin B1 (LMNB1) as a CLIP-target in order to validate it as a novel RNA-binder, 
which we had identified among the proteins with the highest number of super-enriched 
peptides in the non-poly(A) interactome of MCF7 cells. We fragmented RNA in an XRNAX 
extract using ultrasonication and immunoprecipitated LMNB1 in a variation of the eCLIP 
protocol61 (Figure S6A). In this protocol an aliquot of the sample from which the 
immunoprecipitation originally occurred is later separated on an SDS-PAGE along with the 
immunoprecipitated sample itself. This so-called size-matched input control is treated just like 
the actual sample. This has the advantage that after sequencing it can be used to calculate the 
enrichment of specific locations in the transcriptome over this input control. Additionally, we 
used unique molecular identifiers (UMIs) for sequencing, which are RNA-sequencing adaptors 
with randomized parts. The randomized parts can be used to exclude PCR duplicates from the 
sequencing data and thereby identify enrichment even for very short or redundant sequences. 
Without UMIs it is impossible to say if identical reads were produced during PCR, i.e. during 
sample preparation, or if the protein-of-interest tends to bind one particular sequence 
especially often. This becomes important for small RNAs such as snRNAS, snoRNA etc. because 
there are only so many ways to fit a 50 nucleotide read into a 60-200 nucleotide sequence and 
make it unique. XRNAX CLIPseq on LMNB1 showcased the importance of this when RNA-
sequencing identified various non-coding RNAs significantly enriched over the size-matched 
input control, primarily snoRNAs but also other small nuclear RNAs (Figure 6A). This was in 
agreement with previous reports showing that Lamin B, with a canonical function in the 
nuclear lamina, is also structural component of nucleoli where its presence is required to 
maintain nucleolar integrity during ribosome biogenesis.139 
The experiments demonstrated that XRNAX extracts could serve as input in CLIPseq 
experiments, and thereby could be applied for the discovery and validation of novel RNA-
binding proteins by MS and RNA-sequencing from the same sample.  
Our differential quantification of RNA-binding had shown that EXOSC2 (also known as RRP4) 
increased its interaction with RNA already after five minutes of arsenite stress (Figure 5B). 
Since this temporal behaviour stood out among all other proteins, we decided to investigate  
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further. EXOSC2 is one component of the non-catalytic ‘lid’ of the exosome, which is distinct 
from the catalytic core that degrades RNA140. In fact, we also detected the core protein 
EXOSC10, which exhibited a similar yet less pronounced RNA-binding kinetic than EXOSC2. We 
performed immunohistochemistry and confocal microscopy to locate EXOSC2 upon arsenite 
stress in MCF7 cells (Figure 6B). Under normal conditions EXOCS2 was located in the cytosol 
as well as the nucleus. After five minutes of arsenite stress much less EXOSC2 was found in 
the cytosol, whereas nuclear localization remained, a situation that persisted throughout the 
30 minutes of the experiment. Total proteome data had shown that the overall abundance of 
EXOSC2 (or any other exosomal protein) was not affected by arsenite stress, from what we 
concluded that EXOSC2 redistributed to the nucleus. Since the change in RNA-binding (Figure 
5B) coincided with nuclear localization (Figure 6B) after 5 minutes of arsenite stress, we 
wanted to learn more about the RNA transcripts EXOSC2 associated with during this process. 
Therefore, we performed XRNAX CLIPseq for untreated MCF7 cells and compared this to cells 
treated with arsenite for 5 minutes and 30 minutes. Indeed, we identified particularly nuclear 
transcripts, which increased their association with EXOSC2 upon arsenite stress. Moreover, 
we could confirm observations made in yeast were the exosome has been associated with 
tRNA degradation and snoRNA processing141 – both RNA biotypes with high abundance in our 
data. As the RNA exosome is known to participate in processing of rRNA (for review see142) we 
were especially interested to find RMRP (adj. p-value = 4.8E-12) among the transcripts with 
the highest read count beside rRNA itself. RMRP is the RNA moiety of RNase MRP, which 
cleaves the internal transcribed spacer 1 (ITS1, Figure 6C) during 5.8S rRNA maturation.143 
CLIP-seq of various RNA exosome components in yeast has revealed that up to 70 % of 
exosome targets are pre-rRNA.144 We identified similar numbers in human cells where on 
average 65 % (σ=13 %) of unique reads from the EXOSC2 immunoprecipitation mapped to 
ribosomal transcripts. Except for the 5S rRNA, eukaryotic rRNA is transcribed into one large 
transcript – the 45S pre-rRNA – and subsequently trimmed into 18S, 5.8S and 28S rRNA by 
nucleases including the RNA exosome.142 We analysed read coverage of the 45S pre-rRNA by 
EXOSC2 and found very significant enrichment for specific regions (Figure 6C). Most 
significantly enriched during all time points of arsenite stress were segments 3’ of the mature 
5.8S transcript, which is the main region known to be degraded by the exosome during 
canonical 5.8S rRNA maturation. Interestingly, in untreated cells two peaks showed significant 
enrichment, each indicating processing intermediates known as 7S and 6S pre-rRNA145. After 
30 minutes of arsenite stress and increased import of EXOSC2 into the nucleus both 
intermediates showed much weaker enrichment so that the peak indicating the smaller 6S 
species was in fact not discernible from background anymore.  A similar observation could be 
made for the segment 5’ of the mature 18S transcript, which is known to be degraded 
cooperatively by the exonuclease XRN2 and the exosome.146 Both observations implied that 
import of EXOSC2 drove rRNA processing, consequently eliminating transient intermediates 
such as the 6S or 7S pre-rRNA. 
Our data suggested that EXOSC2 was imported into the nucleus upon arsenite stress in order 
to promote rRNA maturation. These findings demonstrated that XRNAX CLIPseq could also be 
applied to examine biological questions differentially, i.e. between conditions. 
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PEPSEQ REVEALS TRANSCRIPTOME-WIDE OCCUPANCY OF PROTEIN ON RNA 
With XRNAX CLIPseq we had shown the occupancy of individual proteins on the 
transcriptome. This can be powerful for finding out the function of these individual proteins, 
however, says little about the state of the transcriptome as a whole. Conceptually, finding the 
occupancy of all protein on RNA is interesting because it could indicate hotspots of protein-
RNA interactions, which could only be discovered by sheer luck (or in hundreds of CLIPseq 
experiments61) when looking at each protein individually. In the case of DNA the problem is 
reversed by the fact that it is wrapped into protein, i.e. histones, over the entirety of its length. 
Nevertheless, for protein-DNA interactions methods such as DNase, MNase or ATACseq have 
become invaluable tools in assessing accessibility, thereby indicating regulation of the 
genome.147 While RNA is believed to be covered by protein, too, the expected conformations 
are much more heterogenous because a histone-like protein uniformly covering RNA has not 
been found (for review see4). Furthermore, each RNA molecule can engage in protein-RNA 
interactions individually, in contrast to DNA, which by being a massive molecule has little 
flexibility in terms of location or interaction partners. Mapping and quantifying protein-RNA 
interactions transcriptome-wide seems especially promising between conditions, where 
occupancy can be linked to function. For example, in the case of arsenite-induced translational 
arrest protein occupancy is expected to be reduced in the coding regions of mRNA. While this 
intuitively makes sense, other changes in protein-RNA interactions during arsenite exposure 
are not easily predicted, yet, might be biologically relevant. For example, what happens to the 
occupancy in rRNA during the autophagic destruction of ribosomal protein? What happens to 
protein-occupancy during stress-granule formation?  
Previously, only one method had tried to look at global protein-RNA interactions on the 
transcriptome level. Baltz et al. had explored protein-occupancy through sequencing in their 
initial interactome capture study. Here, polyadenylated RNA was captured on poly(dT) beads 
from lysates of 365 nm UV-crosslinked cells, RNA fragmented with RNase and protein-RNA 
complexes run on an SDS-PAGE before blotting onto nitrocellulose. RNA was released with 
proteinase K and subjected to small RNA sequencing.65 Eventually, the quantitative measure 
for protein-occupancy was derived from T to C conversions, an established sequencing 
artefact arising from 4-SU crosslinking. The method was later applied differentially for 
comparing protein-occupancy between HEK293 and MCF7 cells.66 An obvious drawback of the 
procedure is its limitation to polyadenylated RNA. Furthermore, the postulated quantitative 
properties were never experimentally established and it remained unclear why quantitation 
needed to be done from T to C conversions and not read counts. 
Our previous experiments had shown that photo-crosslinked protein in XRNAX extracts was 
covalently attached to RNA. From the perspective of RNA this meant that crosslinking sites 
were flagged by protein. As RNA does not have primary amines, this also meant that 
crosslinking sites were tagged with at least one primary amine at the N-terminus of the 
protein, maybe several ones in case the protein contained lysine residues. We hypothesized 
that we could digest all the protein in an XRNAX extract with proteinase K, purify the RNA with 
silica columns and label the remaining peptide-snippet crosslinked to RNA with biotin using 
N-hydroxysuccinimid (NHS) chemistry (Figure S6B). Protein digestion was necessary to remove 
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excess amino residues and to allow for efficient purification of peptide-crosslinked RNA on 
silica columns. After fragmentation we could capture biotinylated RNA fragments with 
streptavidin beads, so that subsequent RNA sequencing would map all protein-RNA 
interaction sites present at the moment in time when cells were crosslinked. Agarose gel 
electrophoresis in Figure S6C illustrates that this enrichment strategy worked and enriched 
crosslinked RNA from MCF7 XRNAX extracts but not non-crosslinked RNA from the same cells 
extracted with conventional TRIZOL. However, it also illustrates that purification on beads 
comes with a background that is not easily removed through washing. This problem is known 
from CLIPseq experiments where newer variations of the protocol use a cleavable tag on the 
protein-of-interest, which selectively releases RNA fragments from the beads only if the 
protein they are attached to is degraded.148,149 We optimized the method, which we termed 
peptide-enhanced protein-occupancy sequencing or PEPseq further to decrease background 
and handling steps. To do so, we used 4-SU crosslinking, whose crosslinks have been shown 
to cause read-through and T to C conversions instead of termination as UV265 nm crosslinks 
do (for review see57). Additionally, we replaced the initial proteinase K digestion with trypsin 
digestion. Trypsin left longer peptide sequences behind, which after coupling to beads could 
be cleaved with proteinase K. This made elution more specific but also possible at more gentle 
conditions, because releasing biotin-conjugated RNA from streptavidin beads, as initially 
conceptualized, required boiling in formamide. Since now elution could be performed with 
proteinase K, we refrained from biotin completely and coupled trypsin-digested, silica 
purified, ultrasonicated RNA from XRNAX extracts directly to NHS-activated beads. As a 
control we used the processed XRNAX extracts before reaction to NHS-beads. Thereby, and in 
combination with UMI sequencing, read counts could be used to compute enrichment of 
particular transcriptomic regions over the input control. We applied this version of PEPseq to 
MCF7 cells, which had been treated with arsenite for 0, 15 and 30 minutes.  
At the time this thesis was completed RNA sequencing was unfortunately not completed and 
data could not be presented. However, we wanted to present the concept of PEPseq, which 
could become a valuable addition to the family of XRNAX-derived protocols. 
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The second chapter of this thesis is dedicated to Christina Milz, who taught me that everything 
in life has a half-life. So better be quick, or half of it is gone. 
CHAPTER 2: COMPARING PROTEIN HALF-LIVES INSIDE AND OUTSIDE OF 
PROTEIN-RNA COMPLEXES 
XRNAX has opened new possibilities for the proteomic quantification of protein-RNA 
interactions. In the following chapter XRNAX is applied to investigate if RNA-binding affects 
the stability of a protein. This question arose from data presented in the previous chapter, 
where upon arsenite-induced autophagy RNA-bound protein seemed overall less affected by 
degradation than proteins in the total proteome. Arsenite induced a strong autophagic effect, 
which led to markedly decreased total levels of specific proteins on a timescale of minutes. 
This reduction was induced by the addition of arsenite, i.e. a process was induced on top of 
the normal protein homeostasis or an out-of-equilibrium state was created. In the following 
chapter we want to turn to the question if proteins in protein-RNA complexes are more stable 
in the equilibrium state, too. A recent report by McShane et al.98, which quantified protein 
half-lives in mouse and human cells, found that proteins in complexes often showed two 
degradation kinetics, one rapid initial one and one much slower kinetic as soon as the protein 
became ‘old’. This supported a model by which proteins in complexes were produced super-
stochiometric in regard to the complex itself, so that protein in the complex became stabilized 
whereas superfluous protein became rapidly degraded. These correlative findings, combined 
with our observation for the arsenite-induced protein turnover of protein-RNA complexes led 
us to the working assumption that proteins in protein-RNA complexes are stabilized. Notably, 
to our knowledge nobody has been able to measure protein half-lives in protein-RNA 
complexes so far. Therefore, measuring protein half-lives using XRNAX could not only provide 
an answer to the question if RNA-binding proteins are stabilized on RNA, but additionally could 
provide experimental evidence for the model by McShane et al., which so far has been based 
on a correlation. 
 
PROTEIN HALF-LIVES OF THE TOTAL PROTEOME 
In order to have a general reference for protein half-lives in the MCF7 proteome we initially 
determined half-lives of proteins from total lysates. During this reference process the MS 
methodology and cell culture prerequisites were established so that subsequent experiments 
measuring half-lives in RNA complexes could be performed under reproducible conditions. In 
the first part of this paragraph the MS methodology for this purpose is detailed. 
Measuring half-lives requires a mathematical model to be fit on the MS data so that 
parameters can be derived from which half-lives can be computed. Standard models for 
protein synthesis and degradation typically require a system to be in equilibrium, i.e. in the 
case of the proteome of a cell, just as much protein should be produced as is degraded. Since 
the system we were interested in – fast dividing MCF7 cells – was not in equilibrium the second 
part of this paragraph describes a normalization strategy for half-life MS data called PEN, 
which allows for relative comparisons of half-lives even for cells that are out of equilibrium. 
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Gregor Mönke from the laboratory of Alexander Aulehla (EMBL Heidelberg) helped us 
understand and simulate the consequences of PEN. 
 
DETERMINING PROTEIN HALF-LIVES USING TMT-SILAC 
Out-of-equilibrium states of the proteome can be followed through quantification of absolute 
protein amounts in cells undergoing a perturbation. For example, in the case of arsenite-
induced autophagy this would be the reduction of translation-related proteins by up to 50 % 
over the time course of 30 minutes. For cells in a state of equilibrium, however, by definition, 
the amounts of protein do not change, so that measuring degradation of a protein is not 
possible by measuring its absolute amount. Instead, a labelling strategy has to be applied, so 
that old protein can be distinguished from new protein. The classic labelling strategy for 
determining protein half-lives uses radioactively labelled amino acids in the culture media 
(typically 35S methionine), which are incorporated into the proteome during a pulse, followed 
by a chase of ‘cold’ media (for review see150). By fitting a decay function to the radioactive 
signal which remains in the cells’ proteome over the course of time, one can estimate the half-
life of all proteins or one specific one after immunoprecipitation. A very recent adaptation of 
this methodology was applied by McShane et al., who used a pulse-chase approach with the 
non-radioactive methionine analogue azidohomoalanine (AHA), which can be specifically 
purified using copper-based click-chemistry125. Detection occurred in this case not through 
autoradiography but through MS, thereby enabling the proteome-wide quantification of 
protein degradation. AHA-labelling allows for very short labelling times, and consequently for 
determining half-lives of very short-lived proteins. However, earlier MS-based proteomic 
studies for determining half-lives used SILAC-based strategies151–154. In the case of SILAC a 
pulse-only instead of a pulse-chase setup is preferred. During a pulse-only experiment (in the 
following called pulsed SILAC) light cells are switched to heavy media and harvested after 
defined timepoints. Degradation is then assessed through the decay of one light peptide in 
comparison to the emerging cognate, heavy peptide153,154. This approach comes with the 
drawback that both SILAC channels are subject to change so that none of them can be used 
for normalization between timepoints. In an ideal case of cells in perfect equilibrium, where 
synthesis equals degradation, this should not affect the measurement, because timepoints 
can be normalized to the combined signal of heavy and light. However, a perfect state of 
equilibrium is practically never achieved in normal cell culture of dividing cells. This becomes 
problematic for a number of reasons, which are further explored below. Methodologically, 
however, it led to the development of an advanced triple SILAC strategy, where medium SILAC 
cells are switched to a heavy label and compared to a separate standard of light SILAC cells155. 
Here, degradation could be quantified independent of synthesis for the first time, by relating 
signal from the changing medium or heavy channel to the constant light channel. In either 
strategy the analysis required a considerable amount of measurement time, because samples 
are taken for up to five timepoints, which needed to be analysed in separate. Recently, 
multiplexing of these measurements was achieved using tandem-mass-tag (TMT) labelling on 
top of a two channel SILAC strategy.156,157 For the purpose of the work presented here we 
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applied this MS3-based quantification method established by Zecha et al.157 as outlined in 
Figure 7A. In principle this strategy allows for multiplexing of up to ten timepoints in one series 
of measurements (in our case seven to nine timepoints combined and analysed in 16 fractions 
on two hour gradients). Much like earlier SILAC-based approaches, the TMT-SILAC approach 
allows for determining protein synthesis and degradation kinetics in the same measurement. 
As an example, take the time course illustrated in Figure 7A where heavy SILAC cells are 
switched to light SILAC media for a timeseries of seven points. For simplicity consider a protein 
represented by a single tryptic peptide. On the MS1 level this peptide will be represented by 
a light and a heavy precursor, where light represents all the protein synthesized over all 
timepoints and heavy all the protein that is being degraded over all timepoints. These 
precursors will be selected for fragmentation individually, i.e. one after the other. Upon 
fragmentation the TMT reporter ions allow for discrimination and quantification of the 
individual timepoints within one measurement (MS3 instead of MS2 quantification of the TMT 
reporter reduces bleed over between the TMT channels, which avoids distortion of the 
quantification or the so-called ‘ratio compression’158). Therefore TMT-SILAC has a significant 
advantage regarding data completeness over earlier pulsed SILAC strategies. During a pulsed 
SILAC experiment early timepoints of the synthesis channel or late timepoints of the 
degradation channel have low intensity. Therefore, when measuring timepoints separately in 
a pulsed SILAC experiment early timepoints will have missing values for proteins which are 
slowly produced, whereas late time points will have missing values for proteins which are 
rapidly degraded. As TMT quantification is typically very complete, this problem is resolved in 
a TMT-SILAC experiment where peptides of all timepoints are collapsed into one precursor, 
which is selected for fragmentation and quantified on the MS3 level. Zecha et al. 
demonstrated that a TMT-SILAC setup in comparison to a pulsed SILAC setup almost doubles 
the number of successfully derived protein half-lives. 
For determining total proteome half-lives in MCF7 cells we decided to combine the 
experimental setups from McShane et al., who used seven timepoints within 32 hours, and 
the TMT-SILAC MS3 methodology from Zecha et al., both illustrated in Figure 7A. Ultimately, 
we decided for a TMT-SILAC-based approach and against the AHA-based approach since in 
later experiments we planned to determine half-lives of proteins on RNA using XRNAX, which 
had been optimized for SILAC. 
 
NORMALIZING PROTEIN HALF-LIVE DATA FOR DIVIDING CELLS 
While TMT-SILAC resolves issues of data completeness it does not resolve the more 
fundamental issue of data normalization and model fitting in dividing cells. These issues are 
based on the fact that the proteome of proliferating cells is not in equilibrium. This becomes 
intuitively apparent when one considers that only new cells can be produced if protein 
synthesis outweighs protein degradation, because new cells need to be made from new 
protein. The consequences of this for a pulsed SILAC experiment are illustrated in Figure 7B. 
In the case of equilibrium, decay equals synthesis, so that the flux of protein simply maintains 
a steady but functional proteome. As soon as there is growth and proliferation of cells, an  
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additional process is put on top of proteome maintenance. This brings about a certain 
distortion of TMT and SILAC data, which will be discussed in the following in order to introduce 
a new way of normalizing data before curve fitting. 
TMT quantification as applied here works under the assumption that all ten channels contain 
the protein content of identical amounts of cells, so that reporter ion intensities directly 
quantify differences between the channels or between those ten individual populations of 
cells. In praxis this assumption is flawed because the total amount of peptides (representing 
the proteome of a certain number of cells) in each channel is never identical. Zecha et al. 
confronted this problem by normalizing all ten channels to a common total intensity of all 
reporter ions (both SILAC heavy and light) with a constant factor. This means every channel is 
given the same total intensity of all proteins. Considering the model in Figure 7B, this is a 
misrepresentation of the actual protein amounts produced over time through proliferation. 
The ultimate effect is a distortion of the relative reporter ion intensities between timepoints. 
This becomes obvious in a comparison between timepoint 0 hours and 32 hours in Figure 7B, 
where the true relative amount of blue protein between the two timepoints is 9 : 1. If all 
channels are normalized to the same intensity the relative amounts between the time points 
are diluted to 18 : 1. Zecha et al. corrected for that distortion in their fitting model, which 
considers proliferation of cells on top of protein maintenance. The model was originally 
described by Welle et al.156, who conducted the first proof-of-concept study for half-life 
measurements using TMT-SILAC, which works under four prerequisites: “1.) Protein synthesis 
is a zero-order process with respect to protein concentration. 2.) Protein degradation occurs 
at a constant fractional rate that is uniform for the entire protein pool. Thus, protein 
degradation can be modelled as a first order process with respect to protein concentration. 
3.) The total protein concentration of each cell does not change during the experimental time-
course and the system is at steady-state.” Welle et al. subsequently formalize their model in 
the two following differential equations:  
 𝐸1:	 𝑑(𝑝𝑟𝑜𝑡𝑒𝑖𝑛./0)𝑑𝑡 = −4𝑘067 + 𝑘09:; ∗ 𝑝𝑟𝑜𝑡𝑒𝑖𝑛./0 𝐸2:	 𝑑(𝑝𝑟𝑜𝑡𝑒𝑖𝑛>6?)𝑑𝑡 = 𝑘@A> − 4𝑘067 + 𝑘09:; ∗ 𝑝𝑟𝑜𝑡𝑒𝑖𝑛>6? 
 
Where kdeg is the degradation constant by which old protein is degraded, ksyn is the synthesis 
constant by which new protein is produced and kdiv is the cell division constant by which cells 
divide. Under the assumptions proteinold(0) = proteinsteady-state and under the assumption that 
proteinnew(0) = 0, Welle et al. solve these equations to: 
 𝐸3:		𝑝𝑟𝑜𝑡𝑒𝑖𝑛./0(𝑡) = 𝑝𝑟𝑜𝑡𝑒𝑖𝑛@C6D0AE@CDC6	 ∗ 	 𝑒E4FGHIJFGKL;	∗	C  𝐸4:	𝑝𝑟𝑜𝑡𝑒𝑖𝑛>6?(𝑡) = 𝑝𝑟𝑜𝑡𝑒𝑖𝑛@C6D0AE@CDC6	 − 	𝑝𝑟𝑜𝑡𝑒𝑖𝑛@C6D0AE@CDC6	 ∗ 	 𝑒E4FGHIJFGKL;	∗	C 
 
Where proteinsteady-state refers to the combined amount of protein, which stays unchanged 
over the course of the experiment. This formalism violates rather obviously their own 
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prerequisite 3.) in two ways. First, cells in a steady-state system will not divide, because no 
new material is produced. That means for a dividing system the assumption proteinold(0) = 
proteinsteady-state is false. Second, the reason why an additional constant for cell division is 
introduced is because of the dilution effect on the SILAC channel representing old protein. 
That means this constant implies that the concentration of proteins in cells does change over 
time through dilution. 
Introducing a cell division constant that is added to the degradation constant implicitly defines 
cell division as a zero-order process on top of protein production necessary for maintenance. 
While this does not comply with the steady-state prerequisite necessary for solving the set of 
differential equations E1 and E2, Figure 7B shows that the intuition of the model does make 
sense. The dilemma can be summarized by saying that only in an equilibrium state half-lives 
can be calculated from the model formalized in equations E1 and E2, however, dividing cells 
are not at equilibrium and therefore not eligible for analysis by this model. Other studies 
circumvented this problem by focusing on non-dividing cells, which are arrested through 
contact inhibition156, serum starvation154 or by their nature as post-mitotic, primary cells159. 
This comes with a number of drawbacks, which in the case of primary cells is accessibility and 
the question in how far findings can be generalized from one very specialized cell type. In the 
case of serum-starvation or contact inhibition, the treatment itself is designed to take cells 
into a state where they do not prosper. This raises the question in how far observations made 
in this state are relevant for cell line systems, which are usually used under the exact opposite 
conditions, i.e. where contact inhibition is generally avoided and cells are tuned to proliferate. 
Therefore, we sought a method for data transformation, which can be used to analyze data 
from dividing cells with the above model. Instead of correcting half-lives after fitting data to a 
model, which is not suitable for it in the first place, we asked the question, how can we 
transform the data beforehand, so that it becomes suitable for the model?  
As mentioned earlier TMT channels usually differ in their total intensity because labeling the 
exact same amount of peptides is difficult. Zecha et al. corrected for this fact by multiplying 
each reporter intensity of a channel with a correction constant, so that the sum of all 
intensities was identical between channels. We took this idea further and broke it down to 
the single peptide level. In a system of non-proliferating cells only proteome maintenance 
exists as displayed in Figure 7B. This means at all timepoints the combined amounts of old 
peptide and new peptide add up to 100 %, thus, the summed heavy and light SILAC intensities 
of a peptide should add up to the same combined SILAC intensity over all timepoints. In order 
to transform data from dividing cells into the shape expected for non-dividing cells, we 
calculated correction factors for each peptide and each TMT channel. Specifically, for each 
timepoint this combined the light and heavy reporter ion intensities of an individual peptide 
and calculated a correction factor, which corrected all timepoints to the same intensity as 
present in the 32 hour timepoint. Correction could in principle occur towards any timepoint, 
however, the 32 hour timepoint had the most complete data, which allowed for deriving the 
most comprehensive list of correction factors. Consequently, after multiplication with the 
timepoint-specific correction factor, the combined reporter ion intensities of a peptide from 
the heavy and light channel was identical between timepoints. Also, these correction factors 
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could be applied to the SILAC channels independently as apparent from the following 
equation: 
 𝐸5: 4𝑇𝑀𝑇𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦9,T,UVWXYZ6D:A + 𝑇𝑀𝑇𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦9,T,UVWXY/97ZC; ∗ 𝑐9,T= 	𝑇𝑀𝑇𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦9,T,UVWXY/97ZC ∗ 	 𝑐9,T + 	𝑇𝑀𝑇𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦9,T,UVWXYZ6D:A ∗ 	 𝑐9,T  
 
Where TMTintensityi,j,SILAC denotes to the reporter ion intensity of a peptide i at timepoint j, 
which was derived from selection of a SILAC heavy or light precursor, respectively. ci,j denotes 
to the correction factor of the same peptide i at the same timepoint j. This meant that after 
calculation of these correction factors data from heavy and light precursors, i.e. synthesis and 
degradation, could be separated and subsequently corrected. We called this correction 
strategy PEN for pseudo-equilibrium-normalization. For a detailed description of the TMT-
SILAC MS data processing and PEN implementation refer to the Materials and Methods 
section. 
Interestingly, this per-peptide correction had a profound effect on data smoothness as visible 
in Figure 7C. Notably, most peptides after PEN showed strictly monotonous growth or decay, 
respectively, which could not have been accomplished by multiplying all intensities of a 
timepoint by a single correction factor as Zecha et al. had done. The increased smoothness 
improved the quality by which model fitting could be achieved very significantly (Figure 7C). 
Interestingly, PEN was more beneficial for fitting decay data so that 15 % more protein 
degradation half-lives with overall significantly better fits were derived in comparison to fits 
of uncorrected data. Furthermore, Figure 7D shows that synthesis half-lives (the amount of 
time required to double any amount of new protein) and degradation half-lives (the amount 
of time required to half any amount of old protein) had much better overlap if data was 
corrected with PEN. Using uncorrected data, both were derived in 43 % of cases, yet, using 
PEN-corrected data both were derived in 87 % of cases. Importantly, the direct comparison of 
synthesis and degradation half-lives in Figure 7D demonstrates that PEN succeeded in 
transforming measurements from proliferating cells into measurements alike to non-dividing 
cells, where synthesis and degradation are in equilibrium. While for uncorrected data the 
median ratio between synthesis and degradation half-lives was 0.87 (s=0.91), it was 1.00 
(s=0.62) for PEN-corrected data. Moreover, PEN-corrected half-lives ranged from 0.7 – 123.5 
hours, whereas uncorrected half-lives only ranged from 0.14 – 67.5 hours. Hence, PEN 
successfully transformed half-life measurements from proliferating cells into the desired form 
of pseudo-equilibrium and additionally had surprisingly beneficial effects regarding data 
smoothness, fitting, reproducibility between the SILAC channels as well as dynamic range. 
Since synthesis and degradation half-lives were basically identical in our data, we regarded 
them as replicate measurements and for simplicity continued to use their mean for all 
following analysis. We denote to this value with the general term protein half-life. 
The underlying aim of this study was to compare the half-life of proteins in the total proteome 
to their half-life in protein-RNA complexes. For this purpose, we used the identical cell line 
system, i.e. MCF7 cells, under identical culture conditions, i.e. a timeline of 32 hours after 
three days of expansion in culture. All following analysis of half-lives in the upcoming 
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paragraphs were relative comparisons within this system, so that we refrained from further 
correction of our data in respect to cell doubling times. We decided to proceed in this way 
because cell doubling times can vary significantly within the duration of an experiment (data 
not shown), so that the assumption of previous studies that cell division follows a zero-order 
process is not necessarily correct. Consequently, the protein half-lives presented here must 
not be seen as absolute values of time but rather as values of time in a coordinate system that 
transforms measurements of proliferating cells to measurements of cells in a steady state. In 
that sense, the derived synthesis and degradation constants and the resulting half-lives are 
the coalescence of proteome maintenance and growth as depicted in Figure 7B. Still, in order 
to understand the consequences of PEN better we simulated data for an ideal experiment of 
non-dividing cells. Therefore, synthesis and degradation were simulated for a range of half-
lives between 2 – 100 hours applying the model previously used to fit our measurements. 
Subsequently, this simulated data was subjected to PEN and again fitted to the same model. 
In this way we were able to compare true half-lives to half-lives after PEN. In the equilibrium 
case, i.e. when synthesis was equal to degradation, PEN correction led to an underestimation 
of half-lives by 6.1 % for a true half-life of 2 hours up to 15.2 % for a true half-life of 100 hours. 
Since in proliferating cells synthesis is expected to outweigh degradation, we repeated the 
simulation reducing synthesis half-lives by a defined factor towards the degradation half-life. 
As illustrated in Figure 7E, the smaller the ratio between synthesis and degradation half-life 
was, the more degradation half-lives were underestimated after PEN. Since the factor by 
which synthesis and degradation half-lives varied was not readily predictable for a certain 
protein, our simulation could not be used as a correction function. However, as visible in 
Figure 7C, half-lives derived from PEN-corrected data was well within the range and equally 
distributed as half-lives derived from uncorrected data. In summary our simulation showed 
that PEN leads to a modest underestimation of protein half-lives, which did not seem to distort 
the overall distribution of half-lives in a detrimental way. 
 
PROTEIN HALF-LIVES ON RNA 
To find out if RNA-binding affected protein stability we first compared half-lives within the 
total proteome of MCF7 cells. Figure 8A illustrates that half-lives of RNA-binding proteins in 
the total proteome did not differ to the overall half-lives of all proteins in the total proteome. 
Since for a number of RNA-binding proteins it is known that they are produced in excess over 
the complex they participate in160, we hypothesized that the excess of free protein over RNA-
bound protein might be masking a general trend among total proteome half-lives of RNA-
binding proteins (Figure 8B). The following paragraph describes how XRNAX was used to 
measure protein half-lives on RNA directly and how these half-lives compared to the ones 
found for the total proteome. 
 
DETERMINING PROTEIN HALF-LIVES USING XRNAX AND TMT-SILAC 
In order to determine half-lives of proteins bound to RNA we combined our TMT-SILAC 
strategy with XRNAX. Replicating the experimental setup for the determination of total  
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proteome half-lives, we took seven timepoints within 32 hours after switching MCF7 cells 
from one SILAC media to the other (two replicates were produced with label swap). 
Subsequently, cells were UV-crosslinked, protein-crosslinked RNA extracted with XRNAX and 
further purified with silica enrichment as described above. After RNase and trypsin digestion 
identical amounts of peptides for each timepoint were TMT-labeled according to Figure 7A. 
Using PEN we derived a total of 308 synthesis and degradation half-lives 221 of which were 
overlapping (Figure 8C). Notably, XRNAX SILAC-TMT data was much noisier than the total 
proteome dataset so that without PEN only 48 degradation half-lives could be derived. This 
again demonstrated the powerful normalization capabilities of PEN.  
 
COMPARING PROTEIN HALF-LIVES ON RNA TO THE TOTAL PROTEOME 
A direct comparison of protein half-lives in the total proteome to the ones derived with XRNAX 
showed that they were in fact different.  Half-lives of proteins on RNA were on average 
increased by a factor of 1.75 (Figure 8D), confirming our initial hypothesis that RNA-binding 
increases protein stability (Wilcox ranksum test p=1.0E-7). Many nuclear RNA-binding proteins 
of the HNRNP class exhibited substantial stabilization. In the most extreme case the half-life 
of HNRNPH2 was increased almost eight-fold from 10.5 in the total proteome to 82.1 hours 
when bound to RNA (Figure 8E). Interestingly, we found some cases of destabilization on RNA 
as well, including the protein SERBP1, which is the human orthologue of the ribosome 
hibernation factor Stm1 in yeast. 
We turned our attention towards two well-described protein-RNA complexes, the 
spliceosome and the ribosome. The half-lives of spliceosomal proteins were overall stabilized 
by a factor of 1.88, which was stronger than average (Figure 8D). Moreover, half-lives of most 
core spliceosome components were focused around a common half-life on RNA of 
approximately 20 hours, whereas more peripheral components had either shorter or longer 
half-lives (Figure 8E). While ribosomal proteins were on average stabilized on RNA, their half-
lives span over more than one order of magnitude (Figure 8D). This observation was surprising 
for a complex, which is generally believed to be produced at a specific stoichiometry and 
degraded by subunit (i.e. 40S and 60S)161. Interestingly, when looking at the protein 
components of each ribosomal subunit separately, stabilization primarily occurred for 
proteins in the small subunit but not in the large subunit (Figure 8F). 
In summary we were able to confirm that on average proteins in protein-RNA complexes were 
more stable. However, as illustrated in the case of the ribosome, this was not inevitably true 
for all proteins in a protein-RNA complex. Moreover, the question arose how it was possible 
that proteins in a well-defined complex such as the ribosome could have such a range of half-
lives, assuming the complex is usually degraded in bulk. 
 
PROTEIN HALF-LIVES IN RIBOSOMAL ASSEMBLIES 
Our analysis of protein half-lives had indicated a curious variance within the half-lives of 
ribosomal proteins on RNA. To find out more about what governs protein stability within 
protein-RNA complexes the ribosome appeared as an intriguing model. That was especially 
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true because established and refined methodology for the purification of ribosomal 
complexes, i.e. polysome profiling, was readily available. Since XRNAX extracted all RNA, the 
half-lives we had derived for ribosomal proteins were most likely a superposition of half-lives 
of ribosomal proteins in different assemblies. We decided to make use of polysome profiling, 
in order to deconvolute this superposition and find out if half-lives differed between those 
assemblies. The following work was done in collaboration with Matilde Bertolini from the 
laboratory of Bernd Bukau (ZMBH Heidelberg), who performed the polysome profiling 
experiments, from which the following data was derived. 
 
DETERMINING PROTEIN HALF-LIVES USING POLYSOME PROFILING AND TMT-SILAC 
Sucrose density gradient centrifugation is a well-established method for the purification of 
ribosomes and their subcomplexes. For this purpose, cell lysates are loaded on a sucrose 
cushion and subjected to several hours of ultracentrifugation. The sucrose cushion is prepared 
into a gradient of 5-45 % sucrose, into which components of the lysate migrate and align 
according to their own density. After centrifugation the solution can be aspirated from the 
top of the tube and be put into fractions. Here, UV-absorbance can help to detect ribosomal 
RNA in the fractions and be the guide for identifying known ribosomal assemblies.162 As visible 
in Figure 9, this process called polysome profiling very reproducibly allowed for preparations 
of the 40S subunit, 60S subunit, the combined assembly of the two subunits into the 80S 
ribosome and a polysome fraction. The polysome fraction contains two or more 80S 
ribosomes assembled on one mRNA molecule. As several ribosomes only assemble on an 
actively transcribed transcript, the polysome fraction contains translating 80S ribosomes. The 
80S fraction also contains translating 80S ribosomes on mRNA, so-called monosomes, but also 
empty 80S ribosomes. In yeast it was shown that the amount of empty ribosomes can be 
surprisingly high so that the majority of the ribosomes in the 80S fraction did in fact not carry 
mRNA.163,164 This is surprising because 80S ribosomes are generally believed to assemble from 
40S and 60S subunits on mRNA only upon translation initiation and disassemble again after 
translation termination (for review see129). So at present, it is unclear how these empty 
ribosomes assemble and what their purpose is. What is clear is that in yeast165 and human 
cells166 stress leading to translational arrest increases the pool of empty 80S assemblies, 
indicating that they could be derivatives of previously translating ribosomes. This is supported 
by the observation that puromycin collapses the polysome fraction, leading to an 
accumulation of 80S ribosomes in the 80S fraction, which do not disassemble further into 
small and large subunits.166 
Before determining half-lives of proteins in polysome profiling fractions we wanted to make 
sure that the method purified ribosomal proteins at reproducible amounts. Therefore, we 
performed polysome profiling with MCF7 lysates in triplicates. Figure 9B illustrates that using 
a modification of the SP3 protein cleanup procedure167 and label free quantification (iBAQ102) 
we were able to quantify ribosomal proteins for each polysome fraction in a highly 
reproducible way. Moreover, many non-ribosomal proteins were reproducibly detected in 
each fraction. With a variance of 10 % or less between replicates, proteins totaled to 1604 in  
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the 40S fraction, 1700 in the 60S fraction, 1841 in the 80S fraction and 2158 in the polysome 
fraction. Interestingly, variances for ribosomal proteins were the smallest in the 80S and 
polysome fractions, indicating that the stoichiometry of proteins here was especially similar 
between samples. A direct comparison between the fractions showed the expected allocation 
of ribosomal protein abundances (Figure 9C). The 40S fraction contained primarily small 
subunit proteins, whereas contamination of large subunit proteins had overall two orders of 
magnitude lower abundances. The 60S fraction contained at the foremost large subunit 
proteins with a somewhat stronger contamination of small subunit proteins. The 80S and 
polysome fractions had about equal abundances for small and large subunit proteins. 
Interestingly, while most proteins in the fractions had very similar abundances, each fraction 
had a number of significant outliers. We note here that label-free quantification with iBAQ is 
an intensity-based procedure, which does not use any absolute reference, i.e. a defined 
amount of a synthetic peptide standard. However, using such a standard it was recently shown 
in mouse cells that ribosomes can contain substoichiometric amounts of certain ribosomal 
proteins168, generally referred to as ‘ribosome heterogeneity’. The two most prominent 
examples in our analysis, which occurred reproducibly substoichiometric in the 40S, 80S and 
polysome fraction were RPS12 and RPS21. We tested if there were any changes in the 
stoichiometry between the 80S and polysome fraction and found only two cases in the small 
subunit, which showed significant changes between the two assemblies (Figure 9D). 
In summary our analysis showed that SP3 purification led to highly reproducible quantification 
of ribosomal proteins in polysome fractions. We proceeded in determining protein half-lives 
from polysome profiling fractions using the same TMT-SILAC approach as earlier. In order to 
increase the resolution of our analysis we collected nine timepoints within 32 hours after 
switching SILAC media. Applying PEN, we derived half-lives for 1486 proteins from the 40S 
fraction, 967 proteins from the 60S fraction, 575 proteins from the 80S fraction and 694 
proteins from the polysome fraction. Among all fractions half-lives for 95 cytosolic ribosomal 
proteins could be determined. 
 
COMPARING HALF-LIVES OF RIBOSOMAL PROTEINS IN POLYSOME FRACTIONS TO THE TOTAL 
PROTEOME 
To our great interest and as illustrated in Figure 10A half-lives of ribosomal proteins differed 
greatly between the fractions. Especially ribosomal proteins in the 80S and polysome fraction 
were strongly stabilized in comparison to the total proteome, but also in comparison to the 
40S and 60S fractions. While the median half-life of all ribosomal proteins in the total 
proteome was 10.1 hours, it was 26.9 or 23.8 hours in the 80S or polysome fractions, 
respectively. In the polysome fraction stabilization was stronger for ribosomal proteins of the 
large subunit in comparison to the small subunit, suggesting subunit-specific turnover. Minor 
stabilization in the subunit fractions was only significant for small subunit proteins in the 60S 
fraction. As small subunit proteins were assumed to be a contamination in the 60S fraction 
we speculate that this stabilization was artifactually created by bleed-over from the heavily 
stabilized 80S fraction. Interestingly, large subunit proteins in the 40S fraction were  
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significantly destabilized in comparison to the total proteome. This suggested that 60S 
proteins were actively removed from free small ribosomal subunits. In conclusion, half-lives 
of ribosomal proteins appeared to be heavily regulated depending on the assembly they 
participated in. This explained our initial findings for RNA-bound ribosomal proteins derived 
by XRNAX, which were a superposition of half-lives with contributions from all ribosomal 
complexes (Figure 8F).  
A direct comparison of protein half-lives showed that the stabilization effect did not result 
from the fact that different groups of ribosomal proteins were compared between the total 
proteome and each fraction (Figure S10A-B). Again, the 40S and 60S fractions showed a very 
similar distribution of half-lives as the same proteins in the total proteome. Interestingly, the 
destabilization of large subunit proteins in the 40S fraction only seemed to affect a certain 
subset, whereas another subset seemed unaffected (Figure S10A). Proteins in the 80S and 
polysome fraction were almost uniformly stabilized, although, to different degrees. As visible 
in Figure 10A and Figure S10C&D, this was concomitant with an increased variance of half-
lives within the 80S and polysome fractions. Comparing half-lives of the same ribosomal 
proteins between the total proteome, the 80S and the polysome fraction, the variance from 
the mean half-life in the total proteome was 25 %, in the 80S fraction 65 % and in the polysome 
fraction 42 %. We compared half-lives of ribosomal proteins in the 80S and polysome fraction 
directly and again found overall proteins more stable in the 80S fraction (Figure 10B). Which 
protein was more stable depended on the individual case, yet, proteins of the small subunit 
were more often more stable in the 80S fraction (70 % of small subunit proteins and 55 % of 
large subunit proteins were more stable in the 80S). As mentioned above and also visible in 
Figure S10D, this subunit effect was caused by the polysome fraction, where proteins of the 
small subunit were stabilized to a lesser degree than large subunit proteins. Interesting here 
was that this was not a uniform effect within the subunit but affected some proteins more 
than others. Importantly, half-lives of small subunit proteins in the 40S fraction and half-lives 
of large subunit proteins in the 60S fraction were not only shorter but also, they were in no 
apparent correlation with half-lives of proteins in 80S complexes (Figure S10E&F). That means 
half-lives of ribosomal proteins in the 40S and 60S assemblies were not scaled by a certain 
factor in comparison to 80S assemblies. Rather, some half-lives stayed the same, while others 
were stabilized when the ribosome was assembled from its subunits. 
Since RNA is the component of the ribosome, which determines much of its structural 
integrity11, we were interested in how far protein-RNA interaction influenced protein half-
lives within the stable complex. We selected the ten most and least stable proteins from each 
subunit of the 80S fraction (Figure 10C) and determined the size of the interface between each 
protein and the RNA in its subunit from the cryo-EM structure of the human ribosome (Figure 
10D). While there was no correlation between protein half-lives and RNA-interface size, there 
was a significant difference of RNA interface size between proteins of the large and small 
subunit. Both observations did not suggest that half-lives within the ribosomal subunits were 
governed by their interactions with RNA, but rather pointed towards an active and selective 
mechanism for protein exchange. 
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Our findings showed strong stabilization of ribosomal proteins in 80S assemblies, confirming 
our hypothesis that proteins are more stable as part of a protein-RNA complexes. 
Antithetically, this was not the case for the individual subunits in the 40S and 60S fractions. As 
the ribosome is a giant assembly, which follows an intricate line of biogenesis it was hard to 
say, which one of the two effects was the rule and which the exception. Furthermore, the 
question arose when is a protein-RNA complex seen as such by the cell? Is it only considered 
a complex when it is assembled into the 80S form and functional, i.e. is function the key to 
stability? The observation that the actual interface with RNA did not seem to influence 
stability and the fact that free small and large subunits were not stabilized at all, despite being 
defined protein-RNA complexes, pointed towards functionality as determining factor. This 
conclusion led us to derive a model for ribosome homeostasis presented in Figure 10E, which 
contains the subversive inference that empty ribosomes formed a pool of approved, 
translation-competent ribosomal subunits. This pool was distinct from free small and large 
ribosomal subunits, which had just emerged from the biogenesis pipeline and had never 
served in the act of translation. The model will be further discussed below. 
EXCHANGE OF RIBOSOMAL PROTEINS FROM TRANSLATION-COMPETENT RIBOSOMES 
Our analysis allowed for unseen insights into the homeostasis of the ribosome and revealed 
some surprising detail. Current models for ribosome homeostasis assume that ribosomes are 
degraded by subunit through autophagy (for review see161). Early indications for this were 
found in electron micrographs, which showed ribosomes among the major cargo of 
autophagosome (for review see169). In yeast it was shown that starvation led to the targeted 
destruction of ribosomes through autophagy170, which coined the term ‘ribophagy’ (for review 
see171). This effect was also seen in human cells, again under starvation or other stresses, 
whereas the autophagic flux for ribosomes under normal conditions was low.172,173 In C. 
elegans autophagic degradation of ribosomes was shown to occur during normal growth and 
was found important for nucleotide homeostasis.174 Thus, on the one hand it is clear that 
autophagy can lead to very significant degradation of ribosomes under stress, although, its 
contribution to ribosomal protein turnover under normal conditions has not been quantified 
in a comprehensive way. On the other hand, in human cells it was shown that proteasome 
inhibition leads to accumulation of ribosomal proteins in the nucleus.175 Moreover, in yeast it 
was demonstrated that an excess of ectopically expressed ribosomal protein is degraded by 
the proteasome.160 The assumption here is that during ribosome biogenesis ribosomal 
proteins are produced in excess and shuttle in and out of the nucleus, while the production of 
rRNA is the rate-limiting factor that controls biogenesis. An excess of ribosomal proteins is 
then degraded in the cytosol by the proteoasome.175 In how far excess ribosomal proteins can 
exchange from functional cytosolic ribosomes is unclear, as well as if selective extraction of 
ribosomal proteins from the complex exists. In an in vitro experiment with E.coli ribosomal 
proteins it was shown that damaged ribosomes can exchange protein components with 
additionally added isotope-labeled protein to become functional again.176 Conceptually, in 
vivo the ubiquitin-proteasome system would be more apt to this task because it degrades one 
protein at a time, unlike autophagy, which selectively engulfs part of the cytosol leading to 
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significant bystander-flux172. In conclusion, from the current state of the literature it was 
unclear if autophagy or the proteasome were the main contributor to turnover of ribosomal 
proteins from ribosomal complexes. 
We were especially interested in the question, why half-lives in 80S assemblies could show 
such a wide range, when they were assumed to be produced and destroyed in bulk. As the 
existence of any 80S assembly is the outcome of a series of complex, previous events, 
measuring exchange of proteins from 80S ribosomes in vivo is not trivial. From all we know, 
the existence of an 80S ribosome requires that it was assembled on an mRNA during at least 
one successful round of translation initiation. From an experimental view this is further 
complicated by the fact that ribosomes are continuously assembled in the nucleus to have 
their biogenesis completed in the cytosol (for review see177). Consequently, biogenesis and 
any putative exchange from already functional ribosomal complexes cannot be easily 
distinguished. To experimentally explore this, we decided to separate the two processes by 
inhibiting ribosome biogenesis. As mentioned earlier, the rate-limiting step in ribosome 
biogenesis is rRNA transcription.175 rRNA is transcribed by RNA polymerase I, which can be 
inhibited with the small molecule drug CX5461 (Figure S4F).178 We inhibited ribosome 
biogenesis in light SILAC MCF7 cells during six hours of CX5461 exposure in order to make sure 
that all pre-ribosomes in the biogenesis pipeline had exited. Then we switched to heavy media 
and continued treatment with the inhibitor for twelve hours. Any protein produced from this 
point on carried a heavy label and could not have been subject to ribosome biogenesis. As a 
control we used the same cells but switched to heavy media without continuing the inhibition 
with CX5461. Any protein produced in these control cells carried a heavy label and was subject 
to normal ribosome biogenesis and cytosolic turnover. Again, we used polysome profiling in 
order to resolve the different assembly states of the ribosomes and quantified their protein 
content using our optimized protocol. Notably, we refrained from measuring half-lives for this 
experimental setup, because inhibition of ribosome biogenesis by CX5461 is known to arrest 
cell growth178. Therefore, we did not expect a meaningful comparison between our sample 
and the control regarding protein half-lives and decided to quantify relative protein amounts 
between the two only at one distinct timepoint (12 hours). Figure 11A-D displays the effect of 
CX5461-mediated RNA polymerase I inhibition on the amounts of new protein incorporated 
into each polysome-profiling fraction. In the 40S fraction the ratio of new over old protein for 
most ribosomal proteins was a single digit percentage (Figure 11A, grey circle). Expectedly, 
this ratio was somewhat higher for the control, where ribosome biogenesis was uninhibited. 
A very similar offset, representing more new protein in the control, was observed in the 60S 
fraction (Figure 10B, grey circle). Notably, here the amount of new protein was overall ten 
times higher than in the 40S fraction. As the stoichiometry seemed highly similar between 
most of those new proteins and was dependent on CX5461 inhibition we assumed that this 
was residual ribosome biogenesis. Interestingly, however, a number of proteins showed a very 
distinct deviation from this pattern, and appeared at much higher amounts than this 
background. These could be categorized according to their behavior towards rRNA 
transcription inhibition. The first group showed very high amounts of new protein 
incorporated into each of the  
 72 
 
 73 
 
 74 
assemblies, at similar ratios as the background of non-ribosomal proteins and independent of 
CX5461. These proteins, namely RPS27A, RACK1, RPL10 and RPLP2, were readily exchanged 
from the subunits. Notably, this was also the case for the 80S and polysome fraction. In the 
latter two fractions a similar behavior was also shown by RPL38, however, at a lower rate. The 
next group showed increased incorporation of new protein dependent on the persistent 
inhibition of ribosome biogenesis. In the 40S fraction continued CX5461 inhibition increased 
incorporation of new RPS16 and RPS18 protein (Figure 11A). In the 80S fraction the 
incorporation of a whole number of proteins was strongly increased by continued CX5461 
treatment (Figure 11D). Notably, these were different to the ones changing in the 40S fraction. 
For example, there was strong exchange of RPS15A and moderate exchange of RPS2 from the 
80S assembly, whereas no increased exchange for these proteins was detected in the 40S 
fraction (Figure 11A&D). In the 60S fraction no inhibition-dependent exchange was observed. 
In the polysome fraction RPL11 showed the strongest exchange in the presence of CX5461. 
Overall the exchange of proteins was not as strong here as in the 80S fraction, however, 
markedly stronger than in the control. Proteins strongly exchanging from the 80S fraction did 
not exchange from the polysome fraction (e.g. RPS11, RPL10A, RPS2). In conclusion the 
experiments showed a curious finding, i.e. upon inhibition of ribosome biogenesis, there was 
increased exchange of specific ribosomal proteins from 80S assemblies. The fact that for some 
proteins exchange from 80S ribosomes was markedly increased in comparison to cells were 
ribosome biogenesis was intact indicated that this exchange might have occurred especially 
on old 80S complexes, which usually get replaced by new ones. 
A comparison between the previously assessed protein half-lives in polysome-profiling 
fractions and the incorporation of new protein into those fractions upon inhibition of 
ribosome biogenesis did not show any correlation (Figure S11A). This confirmed our initial 
assumption that expression of ribosomal proteins in freely proliferating cells or cells that 
underwent six hours of CX5461 treatment, respectively, was very different, so that protein 
half-lives from uninhibited cells must not necessarily inform about protein stability in cells 
were ribosome biogenesis was inhibited.   
We wanted to understand what protein degradation mechanisms were involved in the 
exchange. Therefore, we combined ribosome biogenesis inhibition with the inhibition of 
either the proteasome through bortezomib or autophagy through spautin-1. As illustrated in 
Figure 11E under CX5461 and spautin-1 inhibition exchange of ribosomal proteins from the 
80S fraction was even stronger than observed before. Interestingly, different protein 
components were exchanged as compared to the case were autophagy was uninhibited 
(Figure 11D). For example, the proteins RPL3 and RPL5 were unaffected in the uninhibited 
case, but strongly exchanged upon spautin-1 treatment. Vice versa, the proteins RPS15A, 
RPS11, RPS10A and RPL7 were only detected in their heavy form in the 80S fraction of cells 
that had not been treated with spautin-1. The proteins RPS2 and RPL8 were exchanged in both 
cases, yet, more extreme when autophagy was inhibited. Treatment with bortezomib 
reversed the effect we had initially observed, so that there was no increased exchange for 
RPS15A, RPS11 and RPS2 anymore after inhibition of the proteasome (Figure 11F). Figure 11G 
summarizes the findings for the 80S fractions and the proteins with the most significant 
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changes recurrently detected in all experiments. For the strongly exchanging group RPS27A, 
RACK1, RPL10 and RPLP2 inhibiting degradation mostly did not change their behavior, except 
for inhibition of the proteasome, where RPS27A exchanged even stronger. The only protein 
with a low percentage exchange rate, which was unaffected by any treatment was RPL38. 
RPL12 exchanged with a low percentage unaffected by ribosome biogenesis, but showed 
much decreased exchange upon proteasome inhibition. RPS2, RPL3 and RPL5 exchanged 
strongly under autophagy inhibition, however, much weaker under inhibition of the 
proteasome. Direct comparison of proteasome to autophagy inhibition showed that it was 
primarily these three proteins showing the largest differences (Figure S11B). Moreover, three 
other strongly exchanging proteins emerged, which had previously escaped our analysis 
because they did not show sufficient heavy signal in the control sample. These proteins – 
RPS3A, RPS26 and RPS15 – showed very significant exchange upon either proteasome or 
autophagy inhibition from the 80S assembly. 
In the polysome fraction inhibition of autophagy led to an increased exchange of RPS3A and 
RPS26 (Figure S11C). In order to understand if the exchange of proteins from the 80S and the 
polysome fraction differed, we compared them directly within the identical treatment 
regimen (Figure S11D-F). Without any treatment after six hours of ribosome biogenesis 
inhibition the two fractions looked very similar in terms of new protein being incorporated 
into them (Figure S11C). If inhibition of ribosome biogenesis was continued, there was a 
stronger exchange of small and large subunit components from the 80S fraction (Figure S11E). 
The same was true if ribosome biogenesis was impaired along with autophagy, however, three 
strongly exchanging proteins emerged again – RPS3A, RPS26 and RPS15 (Figure S11F). These 
three proteins exchanged at intriguingly similar rates from both fractions. Importantly, in the 
40S fraction heavy RPS15 was not detected and RPS3A exchanged to a very different degree 
(Figure S11G, right). 
In summary our experiments showed that there was significant exchange of ribosomal 
proteins from mature ribosomes. Figure 11H summarizes this observation for 80S ribosomes 
in the 80S and the polysome fractions, where persistent inhibition of ribosome biogenesis 
heavily increased exchange of proteins, which was even more increased when autophagy was 
blocked in addition. Proteins subject to this exchange could be categorized using the degree 
to which it occurred and the protein degradation machinery involved. Our findings were 
integrated into the model presented in Figure 11I. Whereas details to this model will be 
discussed below, we will summarize the key findings from Figure 11, which led to it. Three 
ways for the turnover of ribosomal proteins were identified, the first of which was free 
exchange from the complex as observed in all experiments for the proteins RPS27A, RACK1, 
RPL10, RPLP2 and to a lesser degree RPL38. The second one was proteasomal degradation, 
whose inhibition had prevented exchange of a number of proteins from the 80S fraction 
(Figure 11D&F). The third one was bulk destruction of 80S assemblies through autophagy. 
Inhibition of autophagy had led to increased exchange of ribosomal proteins from 80S 
assemblies (Figure 11E), indicating that old ribosomes had accumulated and components had 
been exchanged, when under conditions of functional autophagy these 80S assemblies would 
have been destroyed in bulk. Comparing 80S assemblies between the 80S and polysome 
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fraction under inhibition of autophagy had shown remarkably similar exchange rates for the 
three proteins RPS3A, RPS26 and RPS15. This suggested that the pool of translating 80S 
assemblies in the polysome fraction had been replenished by assemblies of the 80S fraction. 
Additionally, there was a group of proteins, which only had exchanged from the 80S fraction 
(Figure S11D & E), but not from the polysome fraction. The members of this group and the 
degree to which they exchanged depended on the functionality of autophagy, however, the 
exchange pattern was not passed on to the polysome fraction. This suggested the existence 
of a second population of 80S ribosomes, which had lost their ability to replenish the pool of 
translating 80S ribosomes in the polysome fraction. We distinguished these two populations 
as a maintenance state, which exchanges components for repair, and a decommissioned state, 
which exchanges components in preparation or on the way to destruction. While we had 
observed a passing-on of an exchange pattern between the 80S fraction and the polysome 
fraction (Figure S11D-F), we had seen no such propagation between the 40S and the 80S, or 
the 60S and the 80S or vice versa (Figure S11G&H). Remarkably, this indicated that most of 
the translating ribosomes in the polysome fraction had re-initiated translation within their 
polysome or had been replenished by empty 80S ribosomes of the 80S fraction and not from 
free 40S or 60S assemblies. 
 
COMPARING HALF-LIVES OF NON-RIBOSOMAL PROTEINS IN POLYSOME FRACTIONS TO THE TOTAL 
PROTEOME 
The emerging concept of ‘ribosome heterogeneity’ has fostered efforts to define an extended 
ribo-interactome, i.e. non-ribosomal proteins, which become part of the ribosomal assemblies 
in order to direct or regulate their behavior (for review see179) . Two recent publications have 
used orthogonal methods for the identification of ribosome interactors. The first approach 
was to express ribosomal proteins carrying an affinity-tag in order to immunoprecipitated the 
entire 80S assembly from mouse embryonic stem cells. Interactors of the assembly were co-
immunoprecipitated and detected by MS, which identified approximately 400 proteins.180 The 
second approach was to perform polysome profiling in human cells, in order to find proteins 
with similar abundance profiles between the polysome fractions, which resembled the ones 
observed for ribosomal proteins themselves.181  This identified 145 interactors of polysomes, 
many of which had been known before, however, 84 of which were new. 
Comparing protein half-lives from polysome profiling fractions to the total proteome, we had 
noticed a strong stabilization of ribosomal proteins in the 80S and polysome fraction (Figure 
10). Following the notion that proteins in a functional complex are more stable98, we 
anticipated that protein half-lives could add another dimension to the classification of 
proteins interacting with ribosomal assemblies. For the first dimension of separation we used 
deep total proteomic data from MCF7 cells as a background in order to calculate the relative 
enrichment of proteins within each of the polysome fractions (Figure 12). This clearly 
highlighted ribosomal proteins already, however, also separated some highly enriched 
proteins from the background. As a second dimension of separation we added how much the 
half-life of a protein was stabilized in comparison to its half-life in the total proteome.  
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Interestingly, this identified a small but defined set of proteins for each fraction, which showed 
similar behavior to the control of ribosomal proteins. Proteins enriched and stabilized in the 
40S and 60S fractions were especially amino-acyl tRNA ligases, which are known interactors 
of the ribosome (Figure 12A&B).179,181 Interestingly, these proteins were enriched in the 40S 
and 60S, but not the 80S and polysome fractions. Furthermore, proteins especially enriched 
and stabilized in the 40S and 60S fraction were mitochondrial components involved in 
oxidative phosphorylation, which likely were contaminations of co-migrating mitochondria in 
our polysome profiling experiments. Still, it was interesting to see for those proteins, too, that 
being part of a functional complex, their half-lives were strongly increased. Remarkably, in 
both the 40S and 60S fractions, one of the most severely stabilized proteins was Basigin, which 
is known to get stabilized very significantly after an initial phase, where the protein is very 
unstable.98 Furthermore we found PNO1 enriched in the 40S fraction, which has been 
reported to mediate methylation of the 18S rRNA182. In the 80S fraction a number of proteins 
associated with translation were heavily stabilized along with proteins involved in ribosome 
biogenesis, i.e. RSL1D1, BRIX1 and SMARCA5. However, since the 90S pre-ribosome is a 
precursor potentially contaminating the 80S fraction177, we could not infer with certainty that 
these biogenesis factors associated with 80S ribosomes. Other proteins showing strong 
stabilization along with enrichment were the mitochondrial ribosomal protein MRPS26 and 
the nuclear pore complex component NUP210. The proteins PABPC1 and PABPC4, which are 
known to bind poly(A) tails of mRNA, were strongly stabilized and enriched along with proteins 
of the ERLIN complex in both the 80S and polysome fraction. ERLIN2 has been linked to cell 
cycle progression and is often amplified in breast cancer183, which could link translational 
control to cell cycle control. Notably, neither one of the above-mentioned studies had 
reported ERLINs within their ribo-interactome.180,181 Beside the ERLIN complex we found a 
strongly stabilized group of proteins associated with splicing in the polysome fraction, which 
replicated findings of a recent report in HeLa cells184. 
Our analysis showed that half-life data for polysome profiling fractions could add another 
dimension of separation in the classification of potential ribosome interactors. While we only 
focused on proteins, which were enriched over the total proteome along with being stabilized 
in their half-lives, we suspect many of the heavily stabilized proteins, which occurred 
substoichiometrically compared to the total proteome also to be true interactors of ribosomal 
assemblies. However, the strong double-enrichment for example for ERLIN proteins 
implicated a direct and important biological function, which future studies should be 
dedicated to. 
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DISCUSSION 
XRNAX ALLOWS FOR A PLETHORA OF NOVEL APPLICATIONS IN RNA 
BIOLOGY 
In the past UV-crosslinking has proven an invaluable tool for the study of protein-RNA 
interactions in vitro and in vivo.42 With XRNAX we present a new way of applying this tool with 
maximal force. We demonstrate that XRNAX extracts contained a distinct subset of the 
proteome, which was remarkably diverse and not dominated by any abundant class of RNA-
binding protein. Surprisingly, the RNA content of XRNAX extracts was more diverse than that 
of TRIZOL extracted total RNA. This indicated that XRNAX enriched protein-RNA complexes in 
a way that allowed for greater proteomic and transcriptomic sequencing depth, thereby 
making the detection of low abundant protein-RNA interactions possible. 
We used protein-crosslinked RNA extracted through XRNAX for proteomic and transcriptomic 
applications. These applications would have been impossible using previous methods because 
of their limitation to polyadenylated RNA, their inability to scale and other complications 
arising from the impurity of crude lysates. During the development of these applications 
XRNAX revealed some inherent features that underlined its general usefulness in studying 
RNA biology. Specifically, isolating nucleotide-crosslinked peptides proved its scalability, when 
XRNAX easily produced milligrams of RNA, from which RNA-crosslinked peptides could be 
isolated and fractionated for MS. In comparison, interactome capture, apart from being 
limited to polyadenylated RNA, does not scale easily because of its dependence on magnetic 
beads. Our experiments on RNA-crosslinked peptides showed that current standard MS is 
capable of detecting hybrids that carry up to three nucleotides. While in this study we used 
these peptides only to locate protein-RNA interfaces in a protein-centric way, we are 
confident that in the future XRNAX will become key technology for simultaneous sequencing 
of peptides and RNA from UV-crosslinked peptide-RNA hybrids. As purification of RNA-peptide 
hybrids and MS detection methods will advance, XRNAX will give easy access to starting 
material, which previously was not readily available. Next, XRNAX proved highly reproducible 
even in challenging applications such as the quantification of RNA-binding in a time course 
experiment. Despite stringent filtering the measurements quantified the association of almost 
800 proteins with RNA during the response to arsenite. Additionally, XRNAX delivered robust 
and reproducible results when applied to different cell lines. While MCF7, HEK293 and HeLa 
cells did have slightly different RNA-binding proteomes, methodologically there was no 
problem in capturing all of them. Lastly, owing to the initial organic phase extraction and 
subsequent washing steps XRNAX delivered extracts that were very pure, i.e. only contained 
protein and RNA. Only this degree of purity allowed us to generate small RNA fragments by 
sonication for our CLIP-seq experiments. Furthermore, it allowed us to perform enzymatic 
reactions on the RNA content of XRNAX extracts. For example, we were able to label RNA in 
XRNAX extracts using biotinylated ribonucleotides and poly(U) polymerase (data not shown). 
In another application we enriched the lincRNA MALAT1 using biotinylated oligonucleotide 
probes from XRNAX extracts and identified its protein interaction partners using MS (data not 
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shown) – an application usually greatly impaired by genomic DNA and other cellular debris in 
crude lysates. Furthermore, our proof-of-concept experiments for PEPseq demonstrated that 
the purity of XRNAX extracts offers the entry point for advanced applications in chemical 
biology on protein-crosslinked RNA. These examples illustrated that XRNAX extracts could be 
used for a variety of applications, only a fraction of which we explored in this thesis. XRNAX 
and the above-mentioned OOPS81 are methodologically similar, however, differ in the product 
they produce. OOPS relies on RNase digestion to release protein crosslinked to RNA from the 
interphase of the TRIZOL extraction. Therefore, OOPS never presents protein-crosslinked RNA 
as its own entity, which ultimately makes it less versatile. However, for its proteomic 
applications OOPS refrains from additional silica enrichment and therefore is able to use 
smaller amounts of starting material (10 instead of 50 million cells). In principle, OOPS could 
be combined with XRNAX simply by adding two more rounds of TRIZOL extraction to the 
XRNAX protocol. At any rate, both protocols have proven to be a valuable addition to the 
toolkit, which interrogates protein-RNA interactions. 
Today’s challenge in RNA biology is to reconcile proteomic and transcriptomic data in a 
meaningful way. We demonstrated here that XRNAX is the versatile, reproducible and scalable 
fundament onto which future applications can build. 
 
FUNCTIONS OF NON-CODING RNA ARISING FROM THE INTEGRATED HUMAN 
RNA-BINDING PROTEOME 
We used XRNAX and silica enrichment to derive RNA-binding proteomes from MCF7, HEK293 
and HeLa cells. Among the novel RNA binders we unexpectedly found enrichment for 
chromatin remodelling proteins, especially proteins carrying bromodomains. Many of those 
proteins, like BRD4, are heavily investigated due to their implication in cancer 185. Only 
recently it was shown that the bromodomain of BRD4 and other bromodomain proteins bind 
enhancer RNA (eRNA), recruiting them to enhancers186. Other chromatin modifying 
complexes such as PRC2, CoREST or SMCX have been found to interact with a large number of 
lincRNAs 187, which in some cases were shown to modify their behaviour as described in the 
Introduction. In the future it will be important to quantify the interaction of chromatin 
modifying proteins with their cognate ncRNA in order to understand their combined function. 
We have shown that XRNAX can quantify the association of proteins with RNA including any 
known kind of ncRNA (and especially including non-polyadenylated ncRNA) thereby paving 
the way for a better understanding of genomic regulation. Remarkably in this context, we 
identified a cluster of proteins involved in the DNA-damage response, some of which had not 
been described as RNA-binding before. Two of those proteins, MDC1 and TP53BP1 are 
reportedly involved in an RNA-dependent DNA damage pathway 94. We also found the direct 
interactor of TP53BP1, RIF1, which is recruited to DNA-double strand breaks (DSBs) upon 
ATM-dependent phosphorylation of TP53BP1. Both proteins have been shown to promote 
non-homologous end joining. We discovered BRCA1 as RNA-binding, too, which promotes 
homologous recombination and expels RIF1 from DSB sites188. Several recent studies have 
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found nascent transcripts involved in transcript-templated DNA repair 95,189,190, however, 
mechanistic details remain elusive. Our findings pinpoint, which proteins involved in DNA 
repair bind RNA and might make for promising targets in upcoming studies. 
 
DIFFERENTIAL QUANTIFICATION OF PROTEIN-RNA INTERACTIONS PROVIDES 
UNSEEN MECHANISTIC INSIGHT 
XRNAX coupled to silica enrichment allowed us to quantify RNA-binding differentially in MCF7 
cells. This way we were able to follow the consequences of arsenite-induced translational 
arrest on the level of protein-RNA interactions. Interestingly, overall RNA-binding remained 
unchanged, however, there were some proteins that did show significant changes. TP53BP1 
was the protein that increased its association with RNA the most after 30 minutes. As 
mentioned above the protein has been described to participate in an RNA-dependent repair 
mechanism for DSBs.94 Arsenite has been reported to induce DSBs comparable to γ-irradiation 
at the concentrations used in our experiments191. RNA binding of TP53BP1 increased steadily 
over time suggesting that it followed an accumulation of DSBs and increased recruitment of 
the repair machinery.  
Among the proteins with the most prominent decrease in RNA-binding was the stress granule 
marker USP10. Arsenite has been reported to induce oxidative stress, which USP10 
counteracts by an unknown mechanism.192 In order to do so, USP10 needs to leave its direct 
interactor and inhibitor G3BP1. Our data showed that upon arsenite stress RNA binding of 
G3BP1 remained unaltered, whereas RNA binding of USP10 was decreased. This suggested 
that RNA might serve as the regulatory platform that brings the two proteins together, so that 
upon arsenite stress USP10 left RNA, resulting in reduced inhibition by G3BP1 and the 
opportunity for USP10 to exert its antioxidative effect. Notably, USP10 is next to USP13 one 
of the two known targets of the autophagy inhibitor spautin-1, which prevents 
deubiquitination of BECN1, resulting in its degradation thereby limiting induction of 
autophagy137. By serendipity we discovered an autophagy-dependent degradation 
mechanism of the translational machinery upon arsenite-induced translational arrest, which 
could be inhibited by spautin-1. In yeast it has been shown that starvation can lead to a form 
of autophagy that eliminates the cytosolic ribosome in a process termed ‘ribophagy’170. 
Interestingly, this process was dependent on Ubp3 and Bre5 – the yeast homologues of USP10 
and G3BP1. Deng et al. had shown that USP10 is part of a feed-forward loop during the 
induction of AMP-activated protein kinase (AMPK)193, which can be induced by arsenite 
stress194. As AMPK has been shown to induce translational arrest as well as autophagy (for 
review see 195), the axis between G3BP1, USP10 and AMPK could link stress granule formation 
and the autophagic process we observed. We propose a model in which arsenite stress 
releases USP10 from RNA, putatively by AMPK phosphorylation, which made it more 
accessible and could trigger the feedforward loop described by Deng et al.. In how far the 
above-mentioned antioxidative effect of USP10 was a result or an independent effect of 
USP10-amplified AMPK activation remains subject to future studies. 
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As one well-established effect of arsenite stress is translational arrest we were especially 
interested in the the RNA-binding behaviour of the translation initiation machinery during this 
process. During canonical translation initiation the EIF2 complex assembles into a ternary 
complex with guanosine triphosphate (GTP) and the initiator methionine transfer RNA 
(tRNAmet). This complex combines with the 40S ribosomal subunit to form the 43S preinitiation 
complex, which combines with the cap-binding complex on an mRNA to form the 48S 
preinitiation complex and scans along the mRNA in search for the initiator AUG codon.129 The 
current model for translational arrest upon arsenite stress is based on the observation that 
EIF2 gets phosphorylated, which inhibits formation of the ternary complex, thereby inhibiting 
translation initiation. Unresolved, however, remains the observation that arsenite-induced 
stress granules accumulate all the components of 48S preinitiation complexes, although 
conceptually formation of 48S preinitiation complexes (and even the 43S preinitiation 
complex for that that matter) should be inhibited through phosphorylation of EIF2.123 
Nevertheless, current state of the literatures has it that arsenite-induced stress granules 
contain stalled 48S preinitiation complexes (for review see196). This suggests that the 48S 
preinitiation complexes that accumulated on mRNA upon arsenite stress included EIF2. 
Consequently, translation initiation must have been inhibited downstream of 48S assembly, 
which could have happened on the level of EIF5. EIF5 activates the GTPase activity of EIF2 
after recognition of the start codon, leading to its departure and joining of the 60S ribosomal 
subunit.129 EIF5 is absent from stress granules, what had led Buchan and Parker to speculate 
that this might be how 48S preinitiation complexes could retain their stalled state in 
them.123,197 Interestingly, in our data the EIF2 component EIF2-b increased RNA-binding, 
which indeed suggested an additional block of translation initiation downstream of EIF2 
phosphorylation. 
In summary, quantifying RNA-binding recapitulated many known phenomena during 
translational arrest, but also revealed surprising details, which were previously unknown. 
Within the analysis it became apparent that the core strengths of our approach were its prior 
impartiality and that it was able to follow binding kinetics of proteins over time. 
 
STABILIZATION OF PROTEIN IN PROTEIN-RNA COMPLEXES IS CONTEXT-
DEPENDENT 
Our comparative analysis of half-lives had revealed that proteins in protein-RNA complexes 
were overall more stable (Figure 8). This confirmed the observation by McShane et al., who 
had correlated proteins in complexes with higher stability. More specifically, McShane et al. 
had found protein degradation kinetics for proteins in complexes, which would be best 
explained by a two-state model, describing fast decay when the protein is young and slow 
decay when the protein has aged. Our data added experimental evidence to this correlative 
finding, because we found increased half-lives within some well-defined protein-RNA 
complexes such as the spliceosome. Vice versa, looking at all spliceosomal proteins in a cell, 
we found their half-life on average only half as long as assembled on RNA. While on average 
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this observation was true, i.e. on average the half-life of protein on RNA was 1.75 fold higher 
than in the total proteome (Figure 8D), we found some interesting variation within our data. 
For example, the half-life of the RNA-binding protein SERBP1 was found very much decreased 
on RNA from 14 hours in the total proteome to 2 hours on RNA. The yeast orthologue of 
SERBP1, Stf1, has been reported to sequester non-translating 80S ribosomes upon stress-
induced translation termination, thereby keeping them in a state of so-called 
hibernation.198,199 Structurally, SERBP1 is known to act as a clamp fixing the 40S and 60S 
subunits together. In fact, the first cryo-EM structure of the human 80S ribosome was 
recorded stabilized through SERBP1.200 More recently, a cryo-EM study of ribosomes from 
rabbit reticulocytes showed that SERBP1-clamped ribosomes make up for the vast majority of 
non-translating ribosomes and actually the majority of all ribosomes in this cell type. We 
derived half-lives for SERBP1 in all fractions of our polysome profiling data except for the 
polysome fraction. Interestingly, in the 80S fraction its half-life was also heavily decreased to 
4 hours from 14 hours in the total proteome. In yeast it has been reported that the majority 
of SERBP1 is associated with 80S ribosomes.199 This could explain why the destabilization of 
SERBP1 in the 80S fraction recapitulated our findings for the protein on RNA in general (as 
assessed by XRNAX), because if interacting with RNA the protein was presumably clamping 
80S ribosomes. Moreover, its instability on RNA suggests that SERBP1 might be removed as a 
clamp by degradation. The example of SERBP1 as an RNA-binding protein, which was 
destabilized on RNA, illustrated well how ribosomal RNA introduced exceptions to the rule 
that RNA-binding leads to increased protein stability. Moreover, it gave another interesting 
insight into the elusive share of empty or hibernating ribosomes within the 80S fraction, which 
will be further discussed in the following.  
Half-lives on RNA, which we had derived through XRNAX, had shown for most proteins very 
robust stabilization. However, for ribosomal proteins half-lives varied seemingly at random or 
at least not predictive of the defined complex they were supposed to participate in. This was 
explained by our polysome profiling experiments, where only the 80S and polysome fractions 
showed stabilization of protein half-lives. Ribosomal proteins in the 40S and 60S fractions 
were not stabilized, so that their superposition created the inconsistent pattern observed in 
our XRNAX data. This observation along with the observation that the actual size of the 
protein-RNA interface did not inform about protein stability within the 80S complex 
(Figure10C&D), led us to the conclusion that it had to be functionality, which led proteins to 
be more stable in the 80S complexes. Functionality in the realm of the ribosome means the 
ability to successfully undergo translation initiation, followed by protein biosynthesis and 
translation termination.129 Translation initiation requires the small subunit to assemble with 
a number of translation initiation factors on the start codon of an mRNA. Only subsequent to 
this, the large subunit is joined and translation ensues. Anyway, prerequisite to translation 
initiation is that the large and small subunits are separated. That means after translation 
termination, the 80S assembly should fall apart and its subunits should join the pool of free 
subunits in the 40S and 60S fractions. Our half-live data for ribosomal proteins in the 40S and 
60S fractions did not comply with this model, because the stabilization of proteins in the 80S 
or polysome fraction was not transferred to the 40S and 60S fraction. If after translation 
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termination 80S assemblies fell apart, their small subunit would end up in the 40S fraction and 
their large subunit in the 60S fraction. This would raise the average half-life of ribosomal 
proteins in those fractions, too. However, half-lives we observed for the 60S fraction were 
basically identical to the total proteome and half-lives in the 40S fraction only slightly 
increased (Figure 10A). As visible from the UV-traces in our polysome profiling experiments, 
whose area under the curve quantifies RNA, the amount of ribosomal subunits in the 80S or 
polysome fraction was very similar to the amounts of ribosomal subunits in the 40S or 60S 
fractions (Figure 9A). Consequently, the contribution of small and large subunits from 
terminating 80S assemblies would have been expected to lift the average half-lives in these 
fractions very significantly, if those assemblies fell apart and mixed with the 40S and 60S 
fraction. This suggested that – although translation initiation requires small and large subunit 
to be separate – two pools of subunits existed. Conceptually, it makes sense that the cell 
would retain subunits, which have proven functionality by successfully completing translation, 
as a distinct pool from subunits, which have just emerged from ribosome biogenesis and are 
potentially dysfunctional. Ribosome biogenesis is a well-concerted and heavily regulated 
process, which in dividing cells has a massive energy expenditure (for review see177,201). 
However, to our knowledge the current literature does not report a quality control mechanism 
for ribosomes, which checks their functionality. Our data seemed to suggest a separation 
between ribosomal subunits, which had proven to be functional, and subunits which had not 
yet engaged in translation. Furthermore, this separation was defined by different assembly 
states, separating 80S from 40S and 60S subunits, which offered an intriguing role for empty 
80S ribosomes. We integrated our model in the scheme presented in Figure 10E. Here, 
functionality of new ribosomal subunits is tested in action: If 40S and 60S subunits successfully 
engage in translation they remain engaged in order to signal their functionality. This creates a 
pool of ‘licensed’ 80S assemblies, which have proven to be functional and are kept apart from 
new and free subunits by virtue of their engagement. Translation initiation requires that an 
80S ribosome is assembled on mRNA from a small and large subunit (for review see129). On 
the basis of our model this means that new 40S and 60S subunits have to go through at least 
one successful round of translation initiation and 80S assembly in order to get stabilized. This 
makes sense in terms of quality control, where new ribosomal assemblies have to prove their 
functionality. As soon as functionality was proven, i.e. the 80S ribosome has successfully 
initiated translation, the assembly gets stabilized. This concept could also assign a role to 
empty, SERBP1-clamped 80S assemblies because a way to flag small and large subunits, which 
have successfully engaged in translation, would be to clamp them together so that they can 
be distinguished from free subunits, which have not yet proven functionality. This hypothesis 
is supported by polysome profiling in yeast166 and mice202, where puromycin collapses the 
polysome fraction, however, not to the benefit of the 40S and 60S fraction but the 80S 
fraction. In fact, the 40S and 60S fractions stay unchanged upon puromycin treatment, 
whereas there is a tremendous increase in ribosomal subunits in the 80S fraction. Puromycin 
is incorporated into nascent peptides, thereby leading to chain termination and premature 
translation termination.203 This suggests that after translation 80S ribosomes are indeed not 
split but remain in their 80S conformation, where they are stored as empty 80S ribosomes. As 
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puromycin-induced translation termination is premature the accumulation of 80S ribosomes 
could be an artefact of this specific drug. However, another inhibitor of protein biosynthesis, 
harringtonine, which does not interfere with translation elongation and leads to production 
of full-length protein and normal translation termination, has the same effect. Harringtonine 
stalls ribosomes after translation initiation, so that they cannot enter elongation and are 
stalled on translation start sites. Thereby subsequent rounds of translation initiation and 
protein production from the mRNA transcript are blocked, so that effectively no translation is 
going on and all ribosomes which are not stalled in initiation complexes have undergone 
natural translation termination as their last action.204–206 Polysome profiling in human207 or 
mouse208 cells shows that harringtonine treatment also leads to collapse of the polysome 
fraction into the 80S fraction, again without any increase in the 40S or 60S fractions. In yeast 
it has been shown that glucose starvation leads to collapse of the polysome fraction into the 
80S fraction, which then primarily contains empty 80S ribosomes.164 The same study 
demonstrates that the same ribosomes, which collapsed into the 80S fraction upon starvation, 
are recycled into the polysome fraction after starvation when glucose is added again. 
Interestingly, this recycling required the Dom34-Hbs1 complex, which splits the 80S ribosomes 
in order for them to re-engage in translation. This mechanistic detail is remarkable in the 
context of our proposed model, where an open question was in how far splitting of the 80S 
complex was required in order for translation to occur again. The findings in yeast suggest 
that, indeed, splitting is required and a specialized mechanism for this purpose exists. The 
mammalian homologue of Dom34 is the protein PELO (also known as pelota). Knockout of 
Pelo in mice is embryonic lethal, however, very recently a conditional Pelo knockout mouse 
for epidermal stem cells was described.209 The authors find significant changes in epidermal 
translation after the knockout was induced. Interestingly, their polysome profiling data 
suggests that Pelo knockout cells did not have a pool of empty ribosomes, but only translating 
80S ribosomes and polysomes. Consequently, they find their translation was heavily increased 
and that overall the epidermis was not viable and became scaly. This indicated that Pelo was 
necessary to create a pool of resting empty 80S ribosomes and if it did not, 80S ribosomes 
were stuck in continuous translation, reading into 3’ UTRs where they could not be removed. 
Interestingly, induction of autophagy through rapamycin partially rescued the phenotype, 
indicating that an alternative way for removing 80S assemblies from mRNA was ribophagy. 
Notably, this was different to data in yeast, where Dom34 knockout heavily increases the pool 
of empty 80S ribosomes.164 Albeit, in yeast Dom34 knockout was not lethal, indicating that 
there might be differences for mammals in the exact mechanism by which 80S ribosomes are 
taken off the mRNA after translation termination. 
Measuring half-lives of proteins on RNA gave experimental evidence to the paradigm that 
proteins in complexes are more stable. Seemingly, an exception to this rule was the ribosome, 
where simply looking at half-lives of ribosomal proteins on RNA with XRNAX showed no clear 
pattern for stabilization. However, an in-depth analysis of half-lives of ribosomal proteins 
through polysome profiling suggested that complex formation was necessary but not 
sufficient for proteins to become stabilized in a complex. Free, small and large ribosomal 
subunits were not stabilized whereas the combined 80S complex was. This suggested that a 
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paradigm describing stability of proteins in complexes might need an amendment introducing 
yet another requirement. In the case of ribosomal proteins, what seemed necessary and 
sufficient in order to become stabilized, was becoming part of a protein-RNA complex and 
demonstrating function. As the ribosome is probably one of the most complicated protein-
RNA assemblies in the cell, this amendment might be unique to its case. Nevertheless, it will 
be interesting to see in future studies if functionality is also required for stabilization of other 
protein-RNA complexes such as the spliceosome. 
 
RIBOSOMAL ASSEMBLIES ARE MORE DYNAMIC THAN PREVIOUSLY 
POSTULATED 
Examining protein half-lives in different ribosomal assemblies had revealed an overall strong 
stabilization for 80S ribosomes. However, within the 80S complex half-lives differed almost 
one order of magnitude (Figure 10). Starting from the assumption that the assembly of an 80S 
ribosome and its destruction were quantized, this was impossible to explain. What could have 
been explained under this assumption were differences in half-lives between the subunits, 
because mechanistically each round of translation requires assembly and disassembly of 
physically separate subunits, thereby allowing for different turnover times between the two. 
While that seemed to be the case for ribosomal proteins in the polysome fraction, where the 
small subunit had an overall faster turnover than the large subunit, this was not the case for 
the 80S fraction, where both small and large subunit proteins were equally stabilized. 
Nevertheless, for proteins of either subunit, small or large, the intra-subunit variability of half-
lives within the 80S assembly was similarly large (Figure 10A). The same was true for proteins 
in the polysome fraction. Considering the fact that 80S ribosomes are assembled from 40S and 
60S subunits, this variability could have arisen from variability of half-lives within these smaller 
subcomplexes. In this case one would expect the same pattern of variability when comparing 
half-lives between the 40S or 60S and the 80S assemblies. For example, the most stable 
protein within the 40S fraction should be among the most stable ones in the 80S fraction and 
the same should be the case for the least stable protein. This kind of propagation of half-lives 
was not observed so that the half-life of a protein in the 40S or 60S fraction was not 
informative for its half-life in the 80S or polysome fraction (Figure S10E&F). This suggested 
that our starting assumption must have been flawed. This could have been the case in two 
ways, either the assumption was wrong that the 80S ribosome was always assembled from 
the same proteins, or that proteins in the 80S ribosome were not always destroyed in bulk. 
There were indications for both possibilities in the literature. The entire concept of ‘ribosome 
heterogeneity’ is built on the hypothesis that ribosomes can assemble into complexes of 
different stoichiometry, thereby allowing for specialization of ribosomes (for review see179). 
In fact, Shi et. al have shown for a very limited number of ribosomal proteins in mouse 
embryonic stem cells that they were represented substoichiometrically in polysomes.168 
Similar observations were made in yeast.210 Our label-free quantification of absolute 
abundances for ribosomal proteins in polysome profiling fractions had indicated an analogous 
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finding for a whole number of proteins (Figure 9C). However, we did not use spike-in peptide 
standards for our quantification and therefore could not exclude that this might have been an 
artefact of iBAQ quantification. At any rate, the total number of proteins that showed a clear 
stoichiometric deviation within ribosomes of the 80S or polysome fraction was small. This 
meant that most of the variance of protein stability within 80S assemblies was caused by 
differences in half-lives between proteins that were assembled in perfect stoichiometry. The 
other possibility for how our initial assumption could have been flawed was that proteins in 
80S ribosomes were not necessarily destroyed in bulk, but that they could be exchanged from 
the translation-competent assembly, i.e. even after ribosome biogenesis. Conceptually, this 
was the more powerful hypothesis because it could explain both, sub-stochiometric 
occurrence of ribosomal proteins and differences in turnover within the 80S assembly. For 
ribosomes purified from E.coli it has been shown that chemically damaged ribosomes can be 
rendered functional again when incubated with functional ribosomal protein in vitro.176 This 
showed that in principle exchange was possible and that this exchange could serve a repair 
function.  We mention here another, more recent study, which claimed to show protein 
turnover from assembled ribosomes in vivo using deuterium labelling in mice in a timecourse 
of 32 days.174 Ribosomal assemblies were purified from liver tissue in bulk during 12 hours of 
sucrose density centrifugation. Notably, this should also purify all pre-ribosomal 
intermediates. The study is problematic for a number of reasons, the most pressing of which 
is its ignorance towards ribosome biogenesis. While its claims are far-reaching, apparently 
demonstrating the ‘mechanism of in vivo maintenance’ of ribosomes, we fail to extract any 
information on the mechanism or information on the maintenance of ribosomes from the 
presented data. As a detailed review of this report would go beyond the scope of this 
discussion we mention it here only for completeness. By inhibiting ribosome biogenesis we 
could show that there was in fact exchange of ribosomal proteins from translation-competent 
ribosomes in the 80S and polysome fractions, which could be amplified by inhibition of 
autophagy and reduced by inhibition of the proteasome. This indicated that exchange of 
ribosomal proteins from 80S assemblies was an active process driven by the proteasome. The 
amplification caused through inhibition of autophagy was probably caused by the 
accumulation of old 80S assemblies, which usually would have been subject to ribophagy. 
Interestingly, in MCF7 cells either inhibition of autophagy or inhibition of the proteasome 
significantly increased the size of the 80S fraction (data not shown), indicating that both might 
be necessary for the efficient disassembly and degradation of 80S ribosomes. Therefore, it is 
possible that the proteasome fulfils two roles in respect to 80S assemblies, one of which is 
disassembly in preparation for autophagic destruction. The other could be targeted extraction 
of proteins, which are subsequently exchanged, in order to maintain damaged ribosomes. This 
was supported by the increased exchange of ribosomal protein when autophagy was 
inhibited, presumably leading to the accumulation of old ribosomes, which were more likely 
damaged. 
We found a small group of proteins – RPS27A, RPL10, RPLP2 and RACK1 – showing very strong 
exchange independent of ribosome biogenesis. RPL10 is an essential component of the 
ribosome, and its knockdown diminishes the assembly of 80S complexes.211 In eukaryotic 
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ribosome biogenesis RPL10 is only added to the large subunit in the cytoplasm during the very 
late steps of cytosolic maturation. Studies in yeast indicate that the protein is essential in the 
so-called 60S ‘test-drive’, where the fidelity of the complex is tested before biogenesis factors 
are released and the large subunit allowed to join with the small subunit.212,213 Our data 
showed frequent exchange of RPL10, suggesting that the 60S ‘test-drive’ could be a regular 
check-up, which is performed not only once during ribosome biogenesis but regularly 
between rounds of translation. RPS27A is transcribed from a fusion gene, representing one of 
the three genes in the human genome encoding ubiquitin. Consequently, RPS27A is a 
ribosomal protein that is born with its own ubiquitination. Interestingly, the most extreme 
exchange of RPS27A was under inhibition of the proteasome. We speculate that this was 
because higher amounts of RPS27A accumulated when the proteasome was inhibited, so that 
the protein exchanged more frequently. Interestingly, in yeast expression of RPS27A or its 
yeast paralogue RPS27B influence cells’ budding behaviour, indicating that the protein has 
regulatory functions, too.214 For RACK1 many functions have been reported dependent or 
independent of the ribosomes. RACK1 is a constitutive component of the small ribosomal 
subunit, that has been described as signalling hub for the regulation of translation (for review 
see215). Its exchange was not as extreme as that seen for RPL10 or RPS27A but similar to that 
of RPLP2. RPLP2 is part of the so-called ribosomal stalk, another signalling centre of the 
ribosome mainly responsible for interacting with translation-associated GTPases (for review 
see216) and binding site of some infamous AB toxins such as Ricin217 or Shiga218 toxin. The 
ribosomal stalk is made up from the proteins RPLP0, RPLP1 and RPLP2 of which we detected 
RPLP2 in all experiments and RPLP1 in only some, however, always strongly exchanging.  Of 
all the ribosomal stalk proteins only RPLP0 interacts with rRNA, whereas RPLP1 and RPLP2 
form heteromers that only interact with the 60S subunit via RPLP0.216 Interestingly, because 
of their unique acidic features biochemical purification of RPLP1 and RPLP2 was established 
very early so that in vivo exchange of the two proteins from cytosolic ribosomes could be 
demonstrated in rat liver through radioactive pulse-chase experiments.219 In summary these 
findings indicated that ribosomal proteins strongly exchanging from 80S assemblies fulfilled 
regulatory roles involved with functional control of the ribosome. 
Apart from the small group of strongly exchanging proteins there was weaker but significant 
exchange of other proteins from both ribosomal subunits, especially if ribosome biogenesis 
was blocked (Figure 11H). The pattern of protein exchange was much more similar between 
the 80S and polysome fraction than between the 40S or 60S fraction and the polysome (Figure 
S11D-H), adding evidence to our model that empty 80S assemblies formed a reservoir of 
translation-approved ribosomes, which would rather engage in translation and become part 
of the polysome fraction, than nascent subunits in the 40S and 60S fractions (Figure 10E). 
Despite the similarity it is hard to say if protein exchange only occurred on empty 80S 
ribosomes, which were then recycled into the translating pool, or if exchange also occurred 
on actually translating ribosomes. However, exchange of proteins was markedly stronger from 
the 80S fraction. In HeLa cells it has been shown that the 80S fraction mainly contains empty 
80S ribosomes, yet, not during mitosis, where the 80S fraction only contains 80S assemblies 
on mRNA.220 Interestingly, in this study pool size of 80S assemblies on mRNA seems constant, 
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so that the difference between dividing cells and non-synchronized cells in the 80S fraction is 
the addition of a large amount of empty 80S ribosomes. Consequently, this large amount of 
empty 80S ribosomes is apparently not essential for survival of a cell. As ribosome biogenesis 
is energetically very expensive (for review see201) ribosomes themselves store a considerable 
amount of energy. We speculate here that another purpose of empty 80S ribosomes, besides 
providing a functional pool of translation-competent ribosomes, might be energy, amino acid 
and nucleotide storage. This store can be used up in times of massive energy and material 
consumption, such as cell division. This hypothesis is supported by findings in C.elegans, 
where autophagic degradation of rRNA was found essential to maintain nucleotide-
homeostasis during growth.221 Along this line, an important connection might be the one 
between empty 80S ribosomes and autophagy. Interestingly, another drug apart from 
puromycin and harringtonine interfering with translation and leading to the collapse of the 
polysome fraction into the 80S fraction in HeLa cells is arsenite222. We have shown that 
arsenite induces ribophagy in human cells (Figure 4), suggesting that autophagy might act on 
empty 80S ribosomes (Figure 11I). 
Our experiments propose an intriguing model, which could close the long-postulated 
connection between the ribosome – translation – autophagy – and energy homeostasis. This 
connection has found support by a lot of circumstantial evidence, however, could so far not 
be integrated into a unified model (for review see223). Future studies will have to show what 
happens if the pool of empty 80S ribosomes is manipulated. For example, an open issue is if 
arsenite-induced ribophagy specifically degrades the pool of empty 80S ribosomes created 
upon translational arrest. Furthermore, the question arises if induction of autophagy under 
these circumstances is a consequence of translational arrest or of the tremendously increased 
pool of empty 80S ribosomes. In this context it might be helpful to elucidate the effect of other 
substances like puromycin or harringtonine, which have been shown to collapse polysomes 
into 80S ribosomes. It will be interesting to see if these compounds trigger ribophagy as well 
and if yes, what population of ribosomes will be affected. 
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MATERIALS AND METHODS 
The first part of the following methods section is adapted from the publication Trendel et al., 
The Human RNA-binding Proteome and Its Dynamics During Translational Arrest, Cell, 201882. 
In the latter publication data produced from these methods and the methods themselves were 
originally presented in a peer-reviewed format. This data is presented again in the first chapter 
of the Results section of this thesis, i.e. “XRNAX As Platform for Interrogating Protein-RNA 
Interactions”. The second part of the method section has not been published and describes 
additional methods used in the second chapter of the Results section of this thesis, i.e. 
“Comparing Protein Half-Lives Inside and Outside of Protein-RNA Complexes”. 
 
METHODS FOR CHAPTER 1 
 
RESOURCE TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Lamin B1 rabbit polyclonal antibody proteintech 12987-1-AP, 
RRID:AB_2136290 
EXOSC2 rabbit polyclonal antibody proteintech 14805-1-AP, 
RRID:AB_2101837 
EXOSC2 mouse monoclonal antibody proteintech 66099-1-Ig 
Goat anti-mouse Cy5 abcam ab6563, 
RRID:AB_955068 
Anti-FLAG M2 Magnetic Beads Sigma M8823, 
RRID:AB_2637089 
HA-tag antibody proteintech 51064-2-AP, 
RRID:AB_11042321 
Chemicals, Peptides, and Recombinant Proteins 
Dialysed FBS Gibco 26400-044 
Pen-Strep Gibco 15140-122 
DMEM for SILAC Silantes 280001300 
SILAC heavy L-lysine (13C6,15N2-L-Lysine HCl) Silantes 211604102 
SILAC heavy L-arginine (13C6,15N4-L-Arginine HCl) Silantes 201604102 
GlutaMAX Gibco 35050061 
TRI reagent Sigma T9424 
GlycoBlue Ambion AM9515 
4-thiouridine (4SU) biomol Cay-16373 
SYBRSafe invitrogen S33102 
EDTA-free protease inhibitor Sigma (Roche) 11873580001 
Benzonase Novagen 70664 
SP3 beads GE 44152105050250 
Trypsin/LysC Promega V5073 
NEB DNase buffer 10 x NEB B0303S 
NEB DNase NEB M0303L 
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RNASin Plus RNase inhibitor Promega N2615 
RNase A Thermo EN0531 
RNase I Ambion AM2295 
RNase T1 Thermo EN0541 
Sodium arsenite (50 mM solution in water) Santa Cruz sc-301816 
Spautin-1 Sigma SML0440 
Rapamycin (2.5 mg/ml in DMSO) Sigma R8781 
Ethynyl-uridine (EU) Jena Biosciences CLK-N002 
RNA polymerase I inhibitor CX5461 Millipore 509265 
sulfo-Cy5-azide Jena Biosciences CLK-AZ118 
HOECHST33342 (20 mM in water) Thermo 62249 
ProlongGold antifade mountant invitrogen P36934 
Proteinase K Thermo EO0491 
FastAP Thermosensitive Alkaline Phosphatase Thermo EF0651 
T4 Polynucleotide Kinase Thermo EK0032 
Protein G Magnetic Beads Pierce 88847 
Lipofectamine 3000 invitrogen L3000008 
Turbo DNase Ambion AM2238 
Critical Commercial Assays 
Quiagen RNeasy Midi Kit Quiagen 75144 
NEXTflex Small RNA Sequencing Kit Bioo Scientific NOVA-5132 
Deposited Data 
RNA sequencing data EMBL-EBI ENA PRJEB26441 
XRNAX CLIP-seq data EMBL-EBI ENA PRJEB26442 
Proteomics data ProteomeXchange PXD010520 
Human proteome (search term: ‘reviewed:yes 
AND proteome:up000005640’, 20216 entries, 
retrieved 11 September 2017) 
Uniprot UP000005640 
Human reference genome hg19 GENCODE Release 19 (GRCh37.p13) 
Human reference genome hg38 GENCODE Release 29 (GRCh38.p12) 
HeLa poly(A)-binding proteome 78 NA 
HEK293 poly(A)-binding proteome 65 NA 
MCF7 poly(A)-binding proteome 80 NA 
Deep MCF7, HeLa, HEK293 proteomes 89 NA 
Cryo-EM structure of human ribosome 11 PDB: 4UG0 
Experimental Models: Cell Lines 
Human (female): MCF7 cells ATCC RRID:CVCL_0031 
Human (female): HEK293 cells Laboratory of Rolf 
Sprengel (MPI 
Heidelberg) 
RRID:CVCL_0045 
Human (female): HeLa cells ATCC RRID:CVCL_0030  
   
Recombinant DNA 
pcDNA5 FRT TO c7orf50 full length FLAG-HA c-ter This laboratory NA 
pcDNA5 FRT TO DUF2373 FLAG-HA c-ter This laboratory NA 
pcDNA5 FRT TO DUF2373_K120G FLAG-HA c-ter This laboratory NA 
pcDNA5 FRT TO c7orf50 full length FLAG-HA n-ter This laboratory NA 
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pcDNA5 FRT TO DUF2373 FLAG-HA n-ter This laboratory NA 
pcDNA5 FRT TO DUF2373_R156G FLAG-HA n-ter This laboratory NA 
Software and Algorithms 
GOrilla 224 http://cbl-
gorilla.cs.technion.ac.il/ 
BBMap (37.68) JGI http://sourceforge.net/p
rojects/bbmap 
Je (version 1.2) 225 https://git.embl.de/grp-
gbcs/Je 
STAR (version 2.5.0a) 226 https://github.com/alexd
obin/STAR, 
RRID:SCR_015899 
Bowtie2 227 http://bowtie-
bio.sourceforge.net/bow
tie2/index.shtml 
HTSeq 228 https://htseq.readthedo
cs.io/en/release_0.9.1/, 
RRID:SCR_005514 
UCSF Chimera (1.12) 229 https://www.cgl.ucsf.ed
u/chimera/, 
RRID:SCR_004097 
MaxQuant (1.5.1.2) 230 http://www.biochem.mp
g.de/5111795/maxquant
, RRID:SCR_014485 
MSFragger 231 http://www.nesvilab.org
/software.html 
R R Core Team 
(2016). R: A 
language and 
environment for 
statistical 
computing. R 
Foundation for 
Statistical 
Computing, 
Vienna, Austria. 
https://www.r-
project.org/, 
RRID:SCR_001905 
RStudio (0.99.903, RRID:SCR_000432) RStudio: Integrated 
Development for R. 
RStudio, Inc., 
Boston, MA 
http://www.rstudio.com
/, RRID:SCR_000432 
csaw (R) 232 http://bioconductor.org/
packages/csaw/ 
DESeq2 (R) 233 http://bioconductor.org/
packages/DESeq2/, 
RRID:SCR_015687 
Additional Resources 
Advanced online documentation for XRNAX 
protocols 
82 https://www.xrnax.com/ 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
MAMMALIAN CELL CULTURE AND STABLE CELL LINES 
The cell lines MCF7, HEK293 and HeLa (all human, female) were maintained in Dulbecco’s 
Modified Eagle’s Medium (DMEM) for SILAC supplemented with 10% dialysed FBS and Pen-
Strep (100 U / ml penicillin, 100 mg / ml streptomycin) at 37 °C, 5 % CO2. DMEM for SILAC was 
supplemented with 1 mM L-lysine and 0.5 mM L-arginine of the individual SILAC labels as well 
as 1.7 mM light L-proline and 1 x GlutaMAX. The heavy SILAC label was introduced during six 
passages in heavy DMEM for SILAC. 
All experiments were performed on MCF7 cells, except when deriving the integrated human 
RNA-binding proteome (ihRBP), where MCF7, HEK293 and HeLa cells were used as indicated 
in the text.  
 
METHOD DETAILS 
 
GUANIDINIUM THIOCYANATE–PHENOL–CHLOROFORM (TRIZOL) EXTRACTION 
Up to 10 million MCF7 cells were lysed in 1 ml TRI reagent by pipetting up and down. For 
phase-separation, 200 µl chloroform was added and samples mixed by turning tubes upside 
down several times. After 5 minutes incubation at room temperature, samples were spun 
down with 12000 g for 10 minutes at 4 °C. Approx. 400 µl of the aqueous phase was 
transferred to a fresh tube, NaCl was added to a final concentration of 300 mM along with 1 
µl GlycoBlue. Samples were combined with 500 µl isopropanol, mixed by inversion and RNA 
precipitated by centrifugation with 18000 g for 15 minutes at -10 °C. 
The supernatant was removed and the RNA pellet washed with 1 ml of 70 % ethanol before 
resuspension in the desired volume of nuclease-free water. 
 
UV-CROSSLINKING OF CELLS 
All cells were grown in 245 mm x 245 mm dishes to the desired confluence. For the 
incorporation of 4-thiouridine (4SU) into RNA, cells were incubated with 100 µM 4SU for 16 
hours prior to UV-crosslinking. Media was decanted and cells washed with 50 ml ice-cold PBS. 
In order to remove as much liquid as possible dishes were propped up straight and residual 
PBS drained onto a paper towel through gravity. UV-crosslinking occurred on ice with 200 mJ 
/ cm2 at 254 nm wavelength with a BIO-LINK UV-crosslinker (Vilber). Cells that had 
incorporated 4SU were UV-crosslinked at 365 nm wavelength. Subsequently, cells were 
harvested into ice-cold PBS, pelleted and either directly subjected to XRNAX or stored at -80 
°C for up to 14 days. 
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PROTEIN-CROSSLINKED RNA EXTRACTION (XRNAX) 
Up to 100 million cells (typically one confluent 245 mm x 245 mm dish of UV-crosslinked MCF7, 
HEK293 or HeLa cells combined with one confluent 245 mm x 245 mm dish of non-crosslinked 
cells) were lysed in 8 ml TRI reagent by pipetting up and down. Cell clumps were disintegrated 
by flushing the lysate repeatedly against the wall of the tube. Lysis was further facilitated by 
incubation on a rotating wheel for 5 minutes at room temperature. Lysates were combined 
with 1.6 ml chloroform, mixed by inversion and incubated for 5 minutes at room temperature. 
Tubes were spun down with 7000 g for 10 minutes at 4 °C.  
The aqueous phase was removed and the interphase transferred to a 2 ml tube. The 
interphase was gently washed twice with 1 ml low SDS buffer (tris-Cl 50 mM, EDTA 1 mM, SDS 
0.1 %), flushing protein off the walls of the tube while retaining the integrity of the interphase 
flakes. Flakes were spun down with 5000 g for 2 minutes at room temperature and the 
supernatant discarded. After the washing, flakes were disintegrated by pipetting into 1 ml of 
low SDS buffer. The disintergrated interphase was spun down with 5000 g for 2 minutes at 
room temperature and the supernatant saved as interphase eluate 1. Disintegration of the 
interphase was repeated with another 1 ml of low SDS buffer, then twice with 1 ml of high 
SDS buffer (tris-Cl 50 mM, EDTA 1 mM, SDS 0.5 %) each time yielding approx. 1 ml of 
interphase eluates.  
NaCl was added to a final concentration of 300 mM to each of the 4 interphase eluates, along 
with 1 µl GlycoBlue and 1 ml isopropanol before mixing by inversion. Samples were spun down 
for 15 minutes with 18000 g at -10 °C. The supernatants were discarded and pellets from all 
four elutes were combined in 2 ml of 70 % ethanol. The combined sample was again 
centrifuged for 1 minute with 18000 g at room temperature, supernatant discarded and all 
residual ethanol removed. The pellet was taken up in 1.8 ml of nuclease-free water and 
detached from the wall of the tube with a pipette tip. The pellet was allowed to swell for 1 
hour on ice with occasional mixing by inversion and eventually dissolved by pipetting.  
200 µl NEB DNase I buffer 10 x was added along with 2 µl RNasin Plus, 100 µl NEB DNase and 
incubated for 60 minutes at 37 °C and 700 rpm shaking. Subsequently, the sample was 
isopropanol precipitated as described above without further addition of GlycoBlue. Pellets 
were taken up in 1000 µl nuclease-free water and dissolved by pipetting. RNA concentration 
was estimated by UV-spectroscopy on a NanoDrop One UV photospectrometer (Thermo 
Scientific), neglecting adsorbtion by protein. Purification of protein-free RNA from XRNAX 
extracts after proteinase K digestion showed that this estimation was within 15 % of the actual 
RNA content. All amounts of XRNAX extracts mentioned in the following are given in µg of 
RNA referring to this estimation and do not take protein content into account.  
A detailed, photo-documented version of the XRNAX protocol is included as Methods S1. For 
updates on XRNAX and its applications visit www.XRNAX.com. 
 
COMPARISON OF RNA EXTRACTS USING AGAROSE GEL-ELECTROPHORESIS 
To verify the integrity of RNA extracted by TRIZOL or XRNAX, agarose-gel electrophoresis was 
performed using 1 % agarose in TBE and SYBRSafe staining. Specifically, for Figure 1B 0.05 % 
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of the total yield extracted from 10 million MCF7 cells using the indicated method was 
subjected to the indicated treatment. Samples were denatured in RNA gel loading dye 
containing formamide for 2 minutes at 85 °C and run for 40 minutes with 3 W. 
 
RNA SEQUENCING FOR QUANTIFYING THE RELATIVE COMPOSITION OF RNA EXTRACTS 
For RNA sequencing, 10 µg RNA (as determined by NanoDrop UV-spectroscopy neglecting the 
protein content of samples) were digested for 30 minutes at 55 °C in proteinase K buffer (50 
mM tris-Cl, EDTA 5 mM, NaCl 150 mM, SDS 1%) using 10 µl proteinase K. Note that both TRIZOL 
and XRNAX extracted samples were treated identically. Subsequently, RNA was cleaned-up 
using the RNeasy mini kit (Qiagen) and was ready for RNA-Seq library preparation. 
Specifically, for TRIZOL and XRNAX extracted RNA derived from MCF7 cells that were 
crosslinked at 254 nm wavelength (Figure 1C) RNA library preparation occurred with the 
TruSeq RNA Library Prep Kit v2 (Illumina, not stranded) after conditional depletion of 
ribosomal RNA (rRNA) using the Ribo-Zero rRNA Removal Kit (Illumina). Biological duplicates 
extracted with TRIZOL or XRNAX (4 samples in total) were barcoded to be sequenced in one 
lane on a HiSeq2000. 
For TRIZOL and XRNAX-extracted RNA from 4SU-labeled MCF7 cells, library preparation 
occurred with the TruSeq Stranded Total RNA kit (Illumina, stranded) after depletion of rRNA 
using the Ribo-Zero rRNA Removal Kit. Biological duplicates extracted with TRIZOL or XRNAX 
(4 samples in total) were barcoded to be sequenced in one lane on a HiSeq2000. 
 
PROTEOMIC SAMPLE PREPARATION 
For mass spectrometry (MS) sample preparation, a modification of the SP3 protocol described 
by Hughes et al. 167 was used. For total proteome analysis approx. 1 million cells were lysed 
and reduced in 1 ml lysis buffer (tris-Cl 50 mM, DTT 10 mM, SDS 0.05%) at 95 °C, 700 rpm 
shaking for 30 minutes. For samples other than cells, e.g XRNAX extracts, samples were 
brought to a total volume of 100 µl with MilliQ water and combined with 900 µl lysis buffer 
before reduction at 95 °C, 700 rpm shaking for 30 minutes. Magnesium chloride (final 
concentration of 5 mM), CAA (20 mM), and EDTA-free protease inhibitor were added and 
mixed before addition of 1 µl of benzonase. Subsequently, digestion of nucleic acids and 
alkylation occurred for 2 hours at 37 °C, 700 rpm shaking. 400 µl SP3 beads were 
preconditioned by washing with MilliQ water 3 times, before reconstitution in 1 ml MilliQ 
water. EDTA was added to 10 mM final concentration along with 1 % SDS and 20 µl SP3 beads. 
Samples were vortexed vigorously and subsequently combined with 1 ml acetonitrile. Samples 
were mixed again and incubated for 15 minutes at room temperature for protein binding to 
occur. The beads were collected on a magnetic stand for 2 minutes and supernatants 
decanted. While on the magnetic stand beads were then washed 3 times with 2 ml ethanol 70 
%, which was added for 1 minute and subsequently decanted. Residual ethanol was removed 
and beads were taken up in the desired digestion volume of TEAB 20 mM and adequate 
amounts of trypsin/LysC added to the solution (for total proteomes from 1 million cells 1 µg 
trypsin/LysC in 100 µl TEAB). Samples were digested at 37 °C, 700 rpm shaking overnight. For 
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single run analysis formic acid was added to a final concentration of 1 % and samples spun 
down for 5 minutes with 20000 g. Supernatants were transferred to fresh tubes without 
disturbing the pellet and analysed by high-pressure, liquid chromatography (HPLC). 
High pH reversed-phase fractionation occurred under standard settings described below. Of 
the 40 collected fractions the initial 8 fractions up to approx. 18 % B were discarded, the 
following 32 fractions were combined to 8 using the scheme 1+9+17+25/…/8+16+24+32. The 
combined fractions were dried by SpeedVac and taken up in 1 % formic acid before analysis 
by HPLC-MS. 
 
HIGH PH REVERSED-PHASE FRACTIONATION OF PROTEOMIC SAMPLES 
Fractionation at high pH occurred on an Agilent Infinity 1260 LC system (Agilent) using a 
Phenomenex Gemini 3 µM C18, 100 x 1 mm column (Phenomonex). Buffer A was NH4COOH 
20 mM, buffer B was 100 % acetonitrile. The following gradient was used for all applications 
described in this manuscript: 0-2 minutes 0 % B, 2-60 minutes linear gradient to 65 % B, 61-62 
minutes linear gradient to 85 % B, 62-67 minutes 85 % B, 67-85 minutes 0 % B. Eluates were 
collected in 40 fractions and combined as described in the individual paragraphs. 
 
HPLC-MS FOR THE ANALYSIS OF NUCLEOTIDE-CROSSLINKED PEPTIDES, DISCOVERY OF RNA-
BINDING PROTEINS OR THE DIFFERENTIAL QUANTIFICATION OF RNA-BINDING 
Separation by HPLC prior to MS occurred on an Easy-nLC1200 system (Thermo Scientific) using 
an Acclaim PepMap RSCL 2 µM C18, 75 µm x 50 cm column (Thermo Scientific) heated to 45 
°C with a MonoSLEEVE column oven (Analytical Sales and Services). Buffer A was 0.1 % formic 
acid, buffer B was 0.1 % formic acid in 80 % acetonitrile. The following gradient was used for 
all applications described in this manuscript: 0 minutes 3% B, 0-4 minutes linear gradient to 8 
% B, 4-6 minutes linear gradient to 10 % B, 6-74 minutes linear gradient to 32 % B, 74-86 
minutes linear gradient to 50 % B, 86-87 minutes linear gradient to 100 % B, 87-94 minutes 
100 % B, 94-95 linear gradient to 3 % B, 95-105 minutes 3 % B. 
Single-run, total proteome analysis was performed on a Fusion Orbitrap mass spectrometer 
(Thermo Scientific). MS1 detection occurred in orbitrap mode at 60000 resolution, AGC target 
1E6, maximal injection time 50 ms and a scan range of 375-1500 DA. MS2 detection occurred 
with an HCD collision energy of 33 in ion trap top20 mode with an isolation window of 1.6 Da, 
AGC target 1E4 and maximal injection time of 50 ms. 
Detection of XRNAX-derived nucleotide-crosslinked peptides, XRNAX-derived RNA-binding 
proteomes and XRNAX-derived differential analysis of RNA-binding upon arsenite stress, as 
well as all analysis of fractionated total proteome samples was performed on a QExactive HF 
mass spectrometer (Thermo Scientific). MS1 detection occurred at 120000 resolution, AGC 
target 3E6, maximal injection time 32 ms and a scan range of 350-1500 DA. MS2 occurred with 
stepped NCE 26 and detection in top20 mode with an isolation window of 2 Da, AGC target 
1E5 and maximal injection time of 50 ms. 
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ISOLATION OF NUCLEOTIDE-CROSSLINKED PEPTIDES FROM XRNAX EXTRACTS 
For the isolation of nucleotide-crosslinked peptides, 1000 µg of XRNAX extract were produced 
from MCF7 cells using the extraction method described above (from 2 confluent 245 mm x 
245 mm dishes). Two aliquots of 500 µg of XRNAX extract were brought to 950 µl final volume 
containing 50 mM tris-Cl, 0.1 % SDS and 10 mM DTT. 10 µg trypsin/LysC was added to each 
aliquot to a final volume of 1 ml and digestion occurred for 1 hour at 37 °C, 700 rpm shaking. 
CAA was added to a final concentration of 20 mM and digestion continued for another hour. 
Purification of peptide-crosslinked RNA from the digests occurred by silica column purification 
using the Qiagen RNeasy Midi Kit with modified protocol (refer to kit manual for buffer 
descriptors). 1 ml digest was combined with 3.5 ml buffer RLT in a 15 ml falcon tube, mixed 
by inversion and heated to 60 °C for 15 min. The sample was allowed to reach room 
temperature. 2.5 ml of 100 % ethanol was added, the sample mixed by inversion and applied 
to an RNeasy Midi column by centrifugation with 3000 g for 5 minutes. Washing occurred 
twice with 2.5 ml buffer RPE, buffer RW1 was not used. Elution occurred twice with 250 µl 
nuclease-free water. All eluates combined to approx. 900 µl, which were transferred to a fresh 
tube. NaCl was added to a final concentration of 300 mM along with 1 µl glycoblue, 1 ml 
isopropanol, the sample mixed by inversion and incubated for 1 hour at -20 °C. Precipitation 
occurred by centrifugation with 18000 g at -10 °C for 60 minutes. The supernatant was 
discarded and the pellet washed with 70 % ethanol. All residual ethanol was removed and the 
pellet taken up in 60 µl tris-Cl 10 mM. The sample was heated to 85°C for 5 minutes and cooled 
on ice before addition of 1.5 µl of RNase A, RNase I and RNase T1. RNA digestion occurred for 
12 hours at 37 °C, 700 rpm shaking before the sample was heated to 85 °C again for 5 minutes 
and cooled on ice. Another 1.5 µl of RNase A, RNase I and RNase T1 was added and the sample 
digested for another 12 hours.  
High pH reversed-phase fractionation occurred under standard settings described above. The 
initial peak with high adsorption up to approx. 18 % B containing RNA contaminations was 
discarded, the following fractions combined, completely dried by SpeedVac, taken up in 1 % 
formic acid and analyzed by HPLC-MS. 
A detailed version of this protocol is included as Methods S2. For updates on downstream 
applications of XRNAX visit www.XRNAX.com/applications. 
 
EXPRESSION AND PURIFICATION OF C7ORF50 AND DUF2373 FROM E. COLI 
Synthetic genes encoding full-length C7orf50 and the C7orf50 domain-of-unknown-function 
(DUF2373, residues 94-194) with a C-terminal HA-tag were ordered from GenScript. Both 
genes were codon optimized for expression in E. coli and subcloned into the pETM11-Sumo3 
vector (EMBL). The expression plasmids were transformed into E. coli BL21 (DE3) cells 
(Novagen). Cells were grown in LB supplemented with 30 µg / ml kanamycin at 25°C until 
OD600 ~ 0.6. The temperature was then lowered to 18 °C and expression was induced by the 
addition of 0.5 mM IPTG. The cells were grown further overnight at 18 °C and harvested by 
centrifugation. The cell pellets were resuspended in running buffer (tris-Cl 50 mM pH=8.0, 
NaCl 800 mM, imidazole 20 mM and glycerol 10 %) supplemented with 1 x protease inhibitors, 
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benzonase and 10 µg / ml lysozyme (Sigma). The cells were lysed via sonication and the cleared 
lysates were loaded onto a 5 ml Protino Ni-NTA column (Macherey-Nagel). The His6-Sumo3-
c7orf50 and His6-Sumo3-c7orf50_94/194 fusion proteins were eluted in running buffer 
containing 300 mM imidazole. To remove the N-terminal fusion tag, His6-tagged SenP2 
protease was added to the elution fractions in a 1:100 ratio. The samples were digested 
overnight at 4°C while being dialysed to a buffer containing tris-Cl pH=8.0, NaCl 250 mM, 
imidazole 20 mM and glycerol 10 %. The dialyzed samples were loaded again onto a 5 ml 
Protino Ni-NTA column and the C7orf50 and C7orf50_94/194 proteins without the N-terminal 
fusion tag were collected in the flow through. These flow through fractions were then loaded 
onto a 5 ml HiTrap Heparin HP column (GE Healthcare) equilibrated with tris-Cl 50 mM pH=8.0, 
NaCl 250 mM and glycerol 10 % in order to remove RNA. Proteins were eluted from the 
heparin column in a gradient to tris-Cl 50 mM pH=8.0, NaCl 1.5 M and glycerol 10 %. The full 
length C7orf50 eluted at approximately 800 mM NaCl in the gradient, while C7orf50_94/194 
eluted around 500 mM NaCl. After SDS-PAGE analysis, the elution fractions containing full-
length C7orf50 or C7orf50_94/194 were pooled and adjusted to 0.5 mg / ml concentration 
using tris-Cl 50 mM pH=8.0, glycerol 10 % and NaCl 800 or 500 mM, respectively. Proteins 
were stored at -80 °C. 
 
IN VITRO VALIDATION OF RNA-BINDING BY NATIVE AGAROSE GEL ELECTROPHORETIC MOBILITY 
SHIFT ASSAY 
Total RNA was extracted from MCF7 cells using the conventional TRIZOL procedure (see 
above). RNA was diluted to 1000 ng / µl in nuclease-free water, heated to 85 °C for two 
minutes and immediately transferred onto ice before use. An assay dilution of 4 µg RNA / 70 
µl assay buffer (tris-Cl 50 mM, NaCl 100 mM) was prepared and stored on ice until use. 
Dilutions of C7orf50 and DUF2373 (C7orf50_94/194) expressed in E. coli (see above) were 
prepared in 10 µl of their respective storage buffer (tris-Cl 50 mM pH=8.0, glycerol 10 % and 
NaCl 800 or 500 mM, respectively). Protein dilutions were combined with 70 µl of the RNA 
assay dilution for a total volume of 80 µl and mixed by pipetting. RNA-binding was allowed to 
occur for 5 minutes at 37 °C, 300 rpm shaking before samples were transferred onto ice again. 
20 µl of the samples were combined with 4 µl purple gel loading dye (SDS-free, NEB) and 
immeadiately run on a 1 % agarose gel (TBE) with SYBRSafe staining at 4 W for 45 minutes. 
 
IN VIVO VALIDATION FOR RNA-BINDING BY PNK ASSAY OR IP-MS 
Per construct approximately ten million MCF7 cells were transfected for 24 hours with 15 µg 
plasmid DNA using Lipofectamine 3000 according to the manufacturer’s instructions.  
For the T4 polynucleotide kinase (PNK) assay cells were crosslinked as described above and 
harvested into 2 ml immunoprecipitation (IP) buffer (tris-Cl 50 mM, NaCl 100 mM,  MgCl2 1 
mM, CaCl2 0.1 mM, NP40 1 %, SDS 0.1 %, sodium deoxycholate 0.5 %, 1 x EDTA-free protease 
inhibitor) by scraping. Of the lysates 1 ml was sonicated with a Sonifier (Branson) and treated 
with 3 units Turbo DNase and 5 µg RNase A for 15 minutes at 37 °C. 15 µl of anti-FLAG M2 
beads slurry was used for one hour of IP at 4 °C on a rotating wheel, followed by three washes 
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with IP buffer and two washes with PNK buffer (tris-Cl 50 mM, NaCl 50 mM,  MgCl2 10 mM, 
NP40 0.5 %). The PNK labeling reaction was then performed on-bead for 15 minutes at 37 °C 
by addition of 30 µl hot PNK mix (27 µl PNK buffer supplemented with DTT 5 mM, 3 µl T4 PNK, 
0.3 µl γ-ATP (0.03 µCi)), followed by four washes with PNK buffer. Complexes were eluted 5 
minutes at room temperature into 50 µl elution buffer (glycine 0.1 M, pH=3). The pH of eluates 
was neutralized by addition of 7.5 µl tris-Cl 1 M, samples combined with 12.5 µl NuPAGE 
loading dye supplemented with DTT 200 mM and the sample run on an SDS-PAGE (NuPAGE 
Bis-Tris, MOPS buffer) at 180 V for 45 minutes. Protein-RNA complexes were blotted onto a 
nitrocellulose membrane for one hour at 1 mA / cm2 and exposed a phosphorimaging screen 
over night before imaging on a Typhoon scanner (GE healthcare).  Subsequently, anti-HA 
Western-blot was performed on the same membranes. 
For analysis by MS cells were crosslinked and extracted through XRNAX as described above. 
The entire yield of the XRNAX extract was dissolved in 200 µl of 50 mM tris-Cl and digested 
over night at 37 °C, 700 rpm shaking, by addition of 2.5 µl RNase I and 2.5 µl RNase A. The 
digest was combined with 250 µl IP buffer 2 x (tris-Cl 100 mM, NP40 1 %, LiCl 300 mM, LiDS 
0.2 %). 50 µl anti-FLAG M2 beads were washed twice with 1 ml IP buffer 1 x (tris-Cl 50 mM 
pH=7.5, NP40 0.5 %, LiCl 150 mM, LiDS 0.1 %) and reconstituted in 50 µl IP buffer 1 x before 
addition to the XRNAX digest in 2 ml tubes. IP occurred for 4 hours at room temperature on a 
rotating wheel. Beads were washed three times with 500 µl IP buffer 1 x, each time 
resuspending 5 minutes on a rotating wheel. All residual IP buffer was removed and elution 
occurred twice for 30 minutes at 37 °C, 700 rpm shaking into µl 200 elution buffer (Tris-Cl 50 
mM, SDS 10 %). Eluates were combined and subjected to SP3 protein cleanup as described 
above with following alterations. No alkylation or reduction was performed, 10 µl SP3 beads 
were added to the eluates along with 500 µl ACN 100 %. Samples were digested in 20 µl TEAB 
20 mM and 100 ng trypsin/LysC over night at 37 °C, 700 rpm shaking. Beads were captured on 
a magnet and digests transferred to a fresh tube before addition of formic acid to a final 
concentration of 1 %. Samples were spun down for 5 minutes at 20000 g, supernatants 
transferred to a fresh tube and analyzed on a QExactive HF MS as described above. 
A detailed version of this protocol is included as Methods S3. For updates on downstream 
applications of XRNAX visit www.XRNAX.com/applications. 
 
SILAC-CONTROLLED DISCOVERY OF RNA-BINDING PROTEINS FROM XRNAX EXTRACTS 
To maximize coverage of the RNA-bound proteome, we produced XRNAX extracts from half-
confluent and confluent cells (~40 million cells per condition), each of which were subjected 
to silica purification after 15 or 30 minutes of partial tryptic digestion. Cells of one SILAC label 
were crosslinked with UV-light of 254 nm wavelength as described above, while control cells 
of the complementary label stayed non-crosslinked. Crosslinked and non-crosslinked cells 
were combined and extracted by XRNAX as described above.  
Per replicate, 930 µg of XRNAX extract (in 930 µl) was further processed. Therefore tris-Cl was 
added to a final concentration of 50 mM, DTT to 10 mM and SDS to 0.1 % before 20 minutes 
of incubation at 60 °C, 700 rpm shaking. CAA was added to a concentration of 20 mM and 
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samples incubated for 20 minutes at room temperature. For predigestion, 100 ng trypsin/lysC 
was added and samples were pre-digested at 37 °C, 700 rpm shaking for 15 or 30 minutes, 
respectively.  
Purification of protein-crosslinked RNA from the digests occurred by silica column purification 
using the Qiagen RNeasy Midi Kit with modified protocol (refer to kit manual for buffer 
descriptors). Predigestion was stopped by combining the sample (approx. 1 ml) with 3.5 ml 
buffer RLT. The sample was mixed by inversion and heated to 60 °C for 15 minutes. 2.5 ml of 
100 % ethanol was added, the sample mixed by inversion and applied to an RNeasy Midi 
column by centrifugation with 3000 g for 5 minutes. The flow-through was saved for additional 
rounds of purification. Washing occurred twice with 2.5 ml buffer RPE. Elution occurred with 
with 250 µl nuclease-free water. The purification was repeated 3 times, each time using the 
saved flow through and reusing the same RNeasy Midi column for the individual sample. To 
the combined eluates (approximately 900 µl total volume) NaCl was added to a final 
concentration of 300 mM along with 1 µl glycoblue and 1 ml isopropanol. The sample was 
mixed by inversion and incubated for 1 hour at -20 °C. Precipitation occurred by centrifugation 
with 18000 g at -10 °C for 30 minutes. The supernatant was discarded and the pellet washed 
with 70 % ethanol and taken up in 65 µl tris-Cl 50 mM. The sample was heated to 85°C for 5 
minutes and cooled on ice before 2.5 µl of RNase A, RNase I and RNase T1 was added. RNA 
digestion occurred over night at 37 °C, 700 rpm shaking. 500 ng trypsin/LysC were added for 
16 hours digestion at 37 °C, 700 rpm shaking.  
High pH reversed-phase fractionation occurred under standard settings described above. The 
initial fractions up to approx. 18 % B containing RNA contaminations and few peptides were 
discarded, the following eluate was collected in six consecutive fractions, which were 
subsequently dried by SpeedVac and taken up in 1 % formic acid before analysis by HPLC-MS. 
A detailed version of this protocol is included as Methods S4. For updates on downstream 
applications of XRNAX visit www.XRNAX.com/applications. 
 
QUANTIFICATION OF NASCENT PROTEIN UPON ARSENITE STRESS USING AZIDOHOMOALANINE-
LABELING 
MCF7 cells with heavy and light SILAC labels were expanded for three days on 15 cm dishes 
until 80 % confluent. Cells of one SILAC label were treated with 400 µM sodium arsenite for 5, 
10, 20, 30 or 60 minutes, while cells of the complementary label were left untreated. 
Azidohomoalanine-labeling (AHA-labeling) and protein purification using click-chemistry for 
MS quantification was performed as described before 125. In brief, cells were deprived of 
methionine using methionine-free media for 30 minutes. Labeling started with the addition of 
AHA-containing media, which occurred simultaneously with the addition of arsenite. After 
labeling, cells were immediately transferred onto ice, washed with ice-cold PBS and harvested 
by scraping. Protein enrichment was performed using the Click-iT Protein Enrichment Kit 
(Thermo Scientific) using the manufacturer’s instructions. Protein captured on agarose beads 
was subjected to tryptic digestion using 500 ng trypsin/LysC in 200 µl TEAB 50 mM and 
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peptides were cleaned up using an Oasis PRiME HKB µElution Plate (Waters). HPLC-MS 
detection occurred on an Orbitrap Fusion MS using the parameters described above. 
 
DIFFERENTIAL QUANTIFICATION OF RNA-BINDING UPON ARSENITE STRESS 
For the differential quantification of RNA-binding upon arsenite stress, MCF7 cells were 
expanded for three days to approx. 70 % confluence.  30 million cells of one SILAC-label were 
exposed to 100 µM sodium arsenite for 0, 5, 10, 20, or 30 minutes, while control cells of the 
complementary label remained untreated. Duplicate experiments were performed for each 
time point, which included SILAC-label swap. Both treated and control cells were UV-
crosslinked, combined and subjected to XRNAX and silica-enrichment as described above with 
the only difference that the predigestion time was kept constant at 30 minutes for all samples. 
Samples were high pH reversed-phase fractionated into 8 fractions as described above. 
Total proteomes where analyzed from cells treated with arsenite at the identical time points, 
in duplicates and with SILAC label-swap. After treatment the media was discarded and cells 
were immediately put on ice and washed with ice-cold PBS. Cells were harvested by scraping 
and subjected to the standard proteomic workflow described above before fractionation into 
8 fractions at high pH. Importantly, for the quantification only peptides were used, which 
previously had been discovered as super-enriched during the generation of the ihRBP. Refer 
to the ‘Quantification and Statistical Analysis’ section below for further elaboration.  
A detailed version of this protocol is included as Methods S5. For updates on downstream 
applications of XRNAX visit www.XRNAX.com/applications. 
TOTAL PROTEOME ANALYSIS OF ARSENITE-INDUCED PROTEIN DEGRADATION 
For total proteome analysis of MCF7 under controlled cell culture conditions 0.5 x 106 cells 
were seeded in 10 cm dishes and cultured for 3 days. Inhibition of autophagy through 10 µM 
spautin-1 was induced 24 hours prior to arsenite stress. Sodium arsenite was applied at 400 
µM concentration. Cells were harvested and subjected to the standard proteomic workflow 
described above.  
We note here that the degree to which autophagic degradation was induced heavily 
depended on the growth state that the cells were in: During the initial lag-phase of cell culture 
one day after seeding, arsenite-induced protein degradation was minor compared to the 
effect observed in the following days of culture (data not shown). For cells seeded at a density 
to reach confluence after 5 days of culture the most pronounced effect was observed after 3 
days. 
 
ETHYNYL-URIDINE INCORPORATION AND CONFOCAL MICROSCOPY FOR MONITORING RNA 
TURNOVER UPON ARSENITE STRESS 
For the visualization of nascent transcripts using ethynyl-uridine (EU), MCF7 cells were grown 
on glass cover slips for 3 days. EU was applied at 1 mM, sodium arsenite at 400 µM and the 
RNA polymerase I inhibitor CX5461 at 10 µM concentration. Treatment occurred for 30 or 60 
minutes, the media was discarded and cells washed once with PBS. Fixation occurred with 3 
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% paraformaldehyde in PBS at room temperature for 10 minutes subsequent to washing with 
PBS. Cells were permeabilized using 0.5 % Triton-X 100 in PBS for 15 minutes at room 
temperature and washed again with PBS. The copper-catalyzed click reaction occurred in 100 
mM HEPES pH=8, 150 mM NaCl, 5 mM sodium ascorbate, 100 µM CuSO4, 500 µM THPTA and 
20 µM sulfo-Cy5-azide for 30 minutes at room temperature. This and all following steps 
occurred under protection from light. The reaction solution was discarded and slides washed 
once with TBST (50 mM tris-Cl, 150 mM NaCl, 0.1 % Tween-20). HOECHST33342 was applied 
at a concentration of 10 µM in TBSP for 10 minutes, slides again washed twice with TBST and 
mounted using ProlongGold antifade mountant. 
Imaging was performed on a Leica SP5 (Leica) using a 63x oil emersion objective. Detection of 
sulfo-Cy5-EU occurred using the default Leica Cy5 filter settings with excitation at 633 nm and 
detection at 650-750 nm wavelength. 
 
IMMUNOFLUORESCENCE STAINING AND CONFOCAL MICROSCOPY FOR MONITORING EXOSC2 
LOCALIZATION UPON ARSENITE STRESS 
For the visualization of EXOSC2, MCF7 cells were grown on glass cover slips for 3 days. Sodium 
arsenite was applied at 400 µM for 0, 5 or 30 minutes, the media was discarded and cells 
washed once with PBS. Fixation occurred with 3 % paraformaldehyde in PBS at room 
temperature for 10 minutes subsequent to washing with PBS. Cells were permeabilized using 
0.5 % Triton-X 100 in PBS for 15 minutes at room temperature and washed again with PBS. 
The antibody was diluted 1:100 in TBST (50 mM tris-Cl, 150 mM NaCl, 0.1 % Tween-20) and 
binding allowed to occur over night at 4° C. Slides were washed twice with TBST before the 
secondary antibody (goat anti-mouse Cy5) was applied at a 1:500 dilution in TBST for 2 hours. 
Slides were stained with HOECHST33342 and imaged as described above. 
 
XRNAX CLIP-SEQ FOR THE DETECTION OF EXOSC2 RNA TARGETS 
For crosslinking and immunoprecipitation followed by sequencing (CLIP-seq) from XRNAX 
extracts we first validated antibodies for normal IP by MS using the IP buffer 1 x (tris-Cl 50 mM 
pH=7.5, 0.5 % NP40, 150 mM LiCl, 0.1 % LiDS) later used for the CLIP-seq experiment. 
For each sample XRNAX extracts were prepared from MCF7 cells as described above. For RNA 
fragmentation 10 mM tris-Cl and 5 mM EDTA were added to 100 µg XRNAX extract, which 
were sonicated in microTUBEs with AFA fiber (Covaris, 520045) using a S220 focused-
ultrasonicator (Covaris) with the settings: 900 seconds, peak power 175, duty factor 50, cycles 
/ burst 200 and average power 87.5. 
For the size-matched input control (SMI-control) 5 μg of the sonicated XRNAX extract (approx. 
2 μl) were mixed with 33 μl MilliQ water, 5 μl FastAP buffer 10 x and 10 μl FastAP. 
Dephosphorylation occurred for 15 minutes at 37 °C, then FastAP was inactivated for 5 
minutes at 80 °C and the sample transferred to ice. 5 μl PNK buffer 10 x, 10 μl ATP 10 mM, 25 
μl MilliQ and 10 PNK were added and incubated another 15 minutes at 37 °C. 15 μl of the SMI-
control (approx. 200 ng RNA) was combined with 5 μl SDS-loading dye 5 x (tris-Cl pH=6.8 250 
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mM, SDS 10 %, 0.02 % bromphenol blue, glycerol 30 %) and 5 μl DTT 1 M. Samples were heated 
to 70 °C for 15 minutes before they were run on an SDS-PAGE along with the IP samples. 
For the IP 100 µg sonicated XRNAX extract in approx. 125 µl was combined with 125 µl IP 
buffer 2 x (tris-Cl 100 mM pH=7.5, 1 % NP40, 300 mM LiCl, 0.2 % LiDS). 1 μg antibody was 
added for 4 hours at 4 °C on a rotating wheel before antibody capture with 100 µl protein G 
beads overnight. The beads were collected on a magnetic stand and the supernatant 
discarded. The beads were washed three times with 1 ml IP buffer, each time carefully turning 
the tube upside down until the beads were completely resuspended. Subsequently, beads 
were washed twice with 1 ml TBST while on the magnet. For end-repair the beads were 
resuspended in 100 μl dephosphorylation mix (80 μl MilliQ, 10 μl FastAP buffer 10 x, 8 μl 
FastAP, 2 μl RNASin) and incubated for 15 minutes at 37 °C, 1000 rpm shaking. Beads were 
collected on a magnetic stand, the supernatant discarded and the beads washed twice with 1 
ml TBST while on the magnet. Subsequently, the beads were resuspended in 100 μl PNK mix 
(70 μl MilliQ water, 10 μl ATP 10 mM, 10 μl PNK buffer A 10 x, 8 μl PNK, 2 μl RNASin) and 
incubated for another 15 minutes at 37 °C, 1000 rpm shaking. Beads were collected on a 
magnetic stand and the supernatant discarded. Protein-RNA complexes were eluted into 5 μl 
SDS loading dye 5 x (NuPAGE), 5 μl DTT 1 M and 15 μl MilliQ for 15 minutes at 70 °C. Beads 
were collected on a magnetic stand and the IP sample transferred to a fresh tube.  
IP and SMI control were run alongside on a 4-12 % SDS-PAGE (NuPAGE BisTris, MES buffer) 
and blotted onto nitrocellulose with 500 mA for one hour at 4 °C. The area corresponding to 
the molecular weight of the protein of interest plus 75 kDA were excised, cut into pieces and 
transferred to a fresh tube. RNA was released by digestion with 50 µl proteinase K in 200 µl 
proteinase K buffer (tris-Cl 50 mM, EDTA 10 mM, NaCl 150 mM, SDS 1 %) at 55 °C for 30 
minutes. 250 µl PCI for RNA was added, the sample mixed by inversion, incubated 10 minutes 
on ice and spun down 10 minutes with 12000 g at 4 °C. 200 µl of the aqueous phase were 
transferred to a fresh tube, NaCl added to a final concentration of 300 mM, combined with 1 
µl GlycoBlue and 200 µl isopropanol. Samples were mixed and precipitated for 2 hours at -20 
°C before centrifugation with 18000 g at -10 °C for 1 hour. Pellets were washed with 80 % 
ethanol and resuspended in nuclease-free water. 
RNA produced by this protocol was approx. 30-80 nt in size, carried a 5’ phosphate and a 3’ 
hydroxyl. For generation of sequencing libraries, we used the NextFlex Small RNA 3.0 kit and 
gel-based size-selection of RNA fragments from 30-50 nt according to the manufacturer’s 
instructions. Samples were barcoded so that twelve samples could be run in one lane on a 
HiSeq2000 (Illumina). 
A detailed version of this protocol is included as Methods S6. For updates on downstream 
applications of XRNAX visit www.XRNAX.com/applications. 
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QUANTIFICATION AND STATISTICAL ANALYSIS 
 
MS DATABASE SEARCH 
All MS raw files were searched using MaxQuant, except for data of nucleotide-crosslinked 
peptides. The database searched was the reviewed UniProt human proteome (search term: 
‘reviewed:yes AND proteome:up000005640’, 20216 entries, retrieved 11 September 2017) 
and the default Andromeda list of contaminants. All settings were used at their default value, 
except for specifying SILAC configurations and indicating the appropriate number of fractions 
per sample. For the differential quantification of RNA-binding during arsenite stress the 
match-between-runs option was activated, for all other searches this was explicitly not the 
case. 
MS data of nucleotide-crosslinked peptides was searched with MSFragger using the same 
UniProt database as mentioned above. Precursor mass tolerance was set to 1000 Da and the 
export format set to tsv, otherwise all settings were used at their default value. 
 
PROCESSING AND ANALYSIS OF MS DATA 
Cyclic-U crosslinked peptides were selected from peptide-spectrum matches (PSMs) carrying 
a modification within 306-307 Da, as detected by MSFragger. 
For the analysis of RNA-binding proteins from XRNAX extracts, the MaxQuant peptides.txt 
table was filtered to remove entries in ‘potential contaminants’ and ‘reverse’. Furthermore 
only peptides that matched the category ‘Unique Groups’ were used. To derive RNA-binding 
proteins for the individual cell lines, peptides from the four replicates were combined and 
filtered with the condition (SILAC intensity crosslinked +1) / (SILAC intensity non-crosslinked 
+1)>1000. Pseudo-counts were added to include peptides where the non-crosslinked channel 
had zero intensity. Proteins (‘Leading razor protein’) identified with two or more unique 
peptides were included in the RNA-binding proteome of the individual cell line.  
K-mer frequencies in proteins of the ihRBP were determined using the R package biostrings. 
Global protein sequence features were computed using the R package ‘peptides’ with the 
scales ‘Kyte-Doolittle’ for hydrophobicity, ‘EMBOSS’ for isoelectric point and ‘EMBOSS’ for 
charge. 
For differential quantification of RNA-binding upon arsenite stress, the MaxQuant peptides.txt 
table was filtered to remove entries in ‘potential contaminants’ and ‘reverse’. Furthermore, 
only peptides that matched the category ‘Unique Groups’ and which occurred in the list of 
ihRBP super-enriched peptides were used. The latter was essential for proper quantification, 
as demonstrated in Figure S1G. Note that a protein can contribute super-enriched and 
background proteins, so that combining the SILAC ratios of all peptides, the ones with the 
highest intensity, or similar approaches in a differential XRNAX experiment, will lead to wrong 
quantification. As an example, consider a protein with one super-enriched peptide and one 
background peptide in a differential XRNAX experiment with identical cell numbers for each 
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of the two SILAC channels. If the SILAC ratio of the super-enriched peptide is 0.1 but the 
background peptide 0.9, the median of the two will be 0.5. As the super-enriched peptide 
reflects the true change, its integration with a background peptide will falsely adjust the 
outcome by 500 % (i.e. 0.1 x 5 = 0.5). A list of super-enriched peptides collated from the cell 
lines MCF7, HEK293 and HeLa during generation of the ihRBP can be downloaded from 
www.XRNAX.com/applications. Subsequently to filtering, the median of normalized SILAC 
Ratios was computed in order to integrate peptide ratios to individual proteins (‘Leading razor 
protein’). Here, a minimum of two super-enriched peptides quantified over all time points was 
required.  
Control total proteome data for the experiment was analyzed identically, except for filtering 
for ihRBP super-enriched peptides, which was omitted. The combined data presented in this 
manuscript was the mean of biological replicates for each time point filtered for a variance of 
15 % or smaller. 
For the analysis of the arsenite-induced degradation normalized ratios from the MaxQuant 
proteinGroups.txt table were used. Dose-dependence was analysed using the R package ‘drc’. 
 
GENE-ONTOLOGY (GO) ENRICHMENT ANALYSIS 
GO enrichment analysis was performed using the GOrilla web interface and uniprot identifier 
as input. Type (ranked or background controlled) of the enrichment and background control 
(if applicable) are indicated in the text. 
 
VISUALIZATION OF THE HUMAN 80S RIBOSOME 
Nucleotide-crosslinked peptides from ribosomal proteins and ribosomal proteins affected in 
their RNA-binding upon arsenite stress were located in the cryo-EM structure of the human 
ribosome 11 (PDB 4UG0) using UCSF Chimera. 
 
PROCESSING AND ANALYSIS OF RNA SEQUENCING DATA 
For the estimation of the rRNA content of libraries, which had not been RiboZero depleted, 
reads were aligned to a collection of human ribosomal sequences of the hg19 assembly 
retrieved using the UCSC table browser. The table used was ‘rmsk’ and filtering was applied 
so that ‘repClass does match rRNA’. All reads were aligned to those sequences using bowtie2 
and reads that failed to align were written to a new file. Reads in this file were aligned to the 
complete hg19 assembly. Percentages of the rRNA content were estimated by comparing the 
number of reads aligning to hg19 rRNA sequences and residual reads aligning to the complete 
hg19 assembly. 
For estimating the content of RNA biotypes in RiboZero depleted libraries, reads were aligned 
to the hg19 assembly using bowtie2. Subsequently, counting was performed with HTSeq-
count using the geneset annotated by GENCODE 19 (release 12.2013) and using the GTF 
feature ‘gene’ for counting. 
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PROCESSING AND ANALYSIS OF XRNAX-CLIP-SEQ DATA 
Unique molecular identifiers (UMIs) were extracted using Je. Exact PCR duplicates were 
removed using BBMap. Adapters were trimmed using cutadapt and processed reads 
sequentially aligned to the 45S pre-ribosomal RNA (NR_046235.3), Repbase 234 and the hg38 
genome with STAR, reusing reads which escaped previous alignment efforts. Non-exact PCR 
duplicates were removed with Je. The csaw library was used to calculate 20 nt coverage 
windows for the 45S rRNA for each individual time point. Subsequently, the DESeq2 library 
was used to calculate fold changes from this coverage between duplicates of the IP and 
duplicates of the SMI control. P-values were corrected for multiple testing with Benjamini-
Hochberg. 
 
STATISTICAL ANALYSIS AND DATA VISUALIZATION 
All data handling apart from what is mentioned above was performed in RStudio and 
visualized using the ggplot2 library. Microscopy, Western blot and phosphor images were 
processed in Photoshop (CC, Adobe 2015) and figures arranged in Illustrator (CC, Adobe 2015). 
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ADDITIONAL METHODS FOR CHAPTER 2 
 
POLYSOME PROFILING FOR PROTEOMICS 
 
PURIFICATION OF RIBOSOMAL COMPLEXES BY POLYSOME PROFILING 
For one polysome profiling experiment approx. 10 million MCF7 cells grown on a 15 cm dish 
were used. The media was discarded and residual media removed by tapping the culture dish 
onto a paper towel. Cells were rinsed with 10 ml ice-cold harvest buffer (10 mM MgCl2, 100 
µg/ml cycloheximide in PBS), which was subsequently discarded and again residues removed 
by tapping the culture dish onto a paper towel. The dish was transferred onto ice and cells 
scraped into 100 µl ice-cold lysis buffer (5 % NP40, 250 mM tris-Cl, 50 mM MgCl2, 700 mM KCl, 
500 µg/ml cycloheximide, 5 mM DTT, 1 x EDTA-free protease inhibitor, to 100 µl add 15 µl 
DNase I and 1.5 µl RNASin Plus before use). Lysates were transferred to a fresh tube, vortexed 
and incubated on ice for 10 minutes before passing through a 26 gauge needle 10 times in 
order to shear genomic DNA. Consequently, samples were cleared by centrifugation with 
20000 g at 4 °C for 5 minutes. Sucrose gradients of 5-45 % were prepared in sucrose buffer 
(final concentration 50 mM tris-Cl, 10 mM MgCl2, 140 mM KCl, 1 x EDTA-free protease 
inhibitor, 100 µg/ml cycloheximide) on a BIOCOMP153 gradient station (biocomp 
instruments). Supernatants were transferred onto the sucrose gradients and subjected to 3.5 
hours of ultracentrifugation with 35000 rpm in Sorvall WX90 ultracentrifuge (Beckman) and 
the rotor SW40Ti. Gradients were then collected into 60 fractions using a BIOCOMP153 
gradient station. Subfractions representing the 40S, 60S, 80S and polysome fractions were 
combined according to the UV trace. For one experiment series identical subfractions were 
combined, however, the exact fraction numbers varied slightly between experiments series 
and were adapted accordingly. 
 
MODIFIED PROTEOMIC SAMPLE PREPARATION FOR POLYSOME PROFILING FRACTIONS 
As the sucrose cushion in the polysome fractionation contained KCl, which precipitates SDS, 
we used a modification of the SP3 protocol presented above. The total volume of the 
combined fractions amounted to approx. 1 ml for the 40S, 60S and 80S fractions, of which 900 
µl were transferred to a 2 ml tube. 10 µl DTT 1 M was added and samples were reduced at 90 
°C for 30 minutes and then cooled on ice. 20 µl CAA 1 M was added along with 1 µl benzonase 
and samples incubated 2 hours at 37 °C, 700 rpm shaking. 100 µl denaturation solution (EDTA 
200 mM, 20 M guanidinium chloride) was added and samples vigorously vortexed. 400 µl SP3 
beads were preconditioned by washing with MilliQ water 3 times, before reconstitution in 1 
ml MilliQ water. 20 µl preconditioned SP3 beads were mixed to the samples by vortexing, 
before addition of 1 ml acetonitrile. Binding of proteins occurred for 15 minutes at room 
temperature. Beads were captured on a magnetic rack, supernatants discarded and beads 
washed three times with 2 ml EtOH 70%, while attached to the magnet. An additional round 
of washing was performed were beads were taken off the magnet and disintegrated into 1 ml 
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EtOH 70 %. Samples were put back onto the magnet in order to remove all EtOH. Beads were 
taken up in 100 µl TEAB 20 mM containing 500 ng trypsin/LysC and digested for 16 hours at 
37 °C, 700 rpm and peptides cleaned up using a Oasis PRiME HKB µElution Plate. Peptides 
were taken up in 20 µl formic acid 1 % and subjected to HPLC-MS on a QExactive MS using a 
2 hour gradient and the parameters outlined above. 
An exception was the polysome fraction, where the combined volume of the subfractions was 
approx. 4 ml. These 4 ml were collected in a 15 ml falcon tube and treated analogously to the 
other fractions. Volumes were adjusted except for benzonase and SP3 beads, for which 
volumes were kept the same. After collecting the SP3 beads on a 15 ml magnetic rack and 
discarding the supernatant, beads were taken up in two times 1 ml EtOH 70 % in order to be 
transferred to a fresh 2 ml tube. From that point on samples were treated identically to the 
other fractions. 
 
PROTEIN HALF-LIFE MEASUREMENTS 
DETERMINATION OF PROTEIN HALF-LIVES BY PULSED SILAC 
For all protein half-life measurements two replicates were generated from MCF7 cells that 
included a SILAC label swap. Explicitly, one replicate was produced from SILAC heavy cells 
switched to light SILAC media and another replicate from SILAC light cells switched to heavy 
SILAC media.  
For determining half-lives of the total proteome and half-lives on RNA (as assessed by XRNAX) 
seven timepoints were generated. In the case of half-lives of the total proteome 1 million 
MCF7 cells of one SILAC label were seeded on 15 cm dishes and expanded for 3 days. 
Subsequently, the media was discarded, cells were washed twice with PBS to remove residual 
media before addition of new media with the complementary SILAC label. Cells were 
harvested after additional 0, 1, 2, 4, 8, 16 and 32 hours of culture after switching the SILAC 
media. Therefore, the media was discarded, cells put on ice and scraped into 10 ml ice-cold 
PBS and transferred to a falcon tube. Residual cells were scraped into another 10 ml ice-cold 
PBS, combined with the rest and spun down for 5 minutes with 1000 g at 4 °C. Proteins were 
purified from the cells using the normal SP3 protocol detailed above and digested in 100 µl 
TEAB 20 mM containing 1 µg trypsin/LysC. Peptides were cleaned up using an Oasis PRiME 
HKB µElution Plate (Waters) and taken up in 20 µl MilliQ water.  
In the case of half-lives of proteins on RNA two 245 mm x 245 mm dishes per timepoint were 
used onto which 3 million MCF7 cells of one SILAC label were seeded and expanded for 3 days. 
Timepoints were produced as described for the total proteomes, however, cells were UV-
crosslinked before harvest as outlined above. XRNAX and silica enrichment was performed on 
cells from each timepoint as described above. After silica enrichment and isopropanol 
precipitation pellets were taken up in 100 µl TEAB heated to 85 °C for 5 minutes and 
subsequently cooled on ice. 2.5 µl of the RNases A, I and T1 were added and samples 
incubated over night at 37 °C, 700 rpm shaking. 500 ng trypsin/LysC were added for 16 hours 
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digestion at 37 °C, 700 rpm shaking, peptides cleaned up using an Oasis PRiME HKB µElution 
Plate and taken up in 20 µl TEAB 50 mM.  
For determining half-lives of proteins in polysome fractions again two replicates with label-
swap were generated. However, in order to increase the resolution of our analysis nine 
timepoints were taken. As the quality of polysome profiling suffers if samples are frozen, all 
cells were harvested at the same time. This required that the SILAC media was changed at 
appropriate time distances towards the common harvest point. Therefore, 1.3 million MCF7 
cells of one SILAC label were seeded onto 15 cm dishes and harvested after a total of 4 days 
in culture. Cells were washed twice with PBS and switched to the complementary SILAC label 
0, 2, 4, 8, 12, 16, 20, 24 and 32 hours before those 4 days had passed. Polysome profiling and 
protein clean-up occurred as described above. Peptides were cleaned up using an Oasis PRiME 
HKB µElution Plate and taken up in 20 µl TEAB 50 mM. 
 
TMT-SILAC STRATEGY FOR DETERMINATION OF PROTEIN HALF-LIVES 
In the case of the total proteome and XRNAX the first 2-7 TMT channels were occupied by the 
timepoints 1-32 hours, the TMT channel 8 and 10 by replicates of the infinity timepoint (for 
the replicate starting from SILAC light cells the infinity timepoint were SILAC heavy cells and 
vice versa) and the channels 1 and 9 by replicates of the timepoint 0. Replicate channels were 
produced from the same peptides in order to assess the reproducibility within one 
experiment. The reproducibility was found very good for all replicates so that for the polysome 
profiling experiments all channels were used for timepoints, i.e. for polysome proifiling 
fractions the timepoints 0-32 hours were allocated to the TMT channels 1-9 and the infinity 
timepoint to TMT channel 10. 
In order to label identical amounts of peptides for each TMT channel, peptide concentrations 
were assessed using a Quantitative Colorimetric Peptide Assay (Pierce). The amount of 
peptides that were labeled was oriented by the sample with the lowest peptide concentration 
in one particular experiment series. In the case of the total proteome 10 µg peptides per 
timepoint were used, in the case of XRNAX 2 µg per timepoint were used and in the case of 
the polysome fractions 5 µg of peptides were used. Identical amounts of peptides for each 
timepoint were adjusted to a total volume of 20 µl in TEAB 50 mM. Consequently, 5 µl of TMT 
labeling reagent (Thermo Scientific) in acetonitrile was added and labeling allowed to occur 
for 1 hour at room temperature. Labeling was quenchend by addition of 1.5 µl hydroxylamine 
5 % and another 15 minutes of incubation. Samples for all 10 TMT channels of one experiment 
were combined, completely dried by SpeedVac and fractionated at high pH as described 
above. In the case of the polysome profiling experiments, samples were analyzed in 8 
fractions, which were combined as described above. In the case of the total proteome and 
XRNAX samples were analysed in 16 fractions. Therefore, the first 8 of the 40 collected 
fractions were discarded and the following combined to 16 fractions using the scheme 
1+17/…/16+32. Fractions were again dried down completely and taken up in formic acid 1 % 
before analysis by MS. HPLC-MS occurred on a Fusion MS using a 2 hour gradient as described 
above, however, with the standard SPS-MS3 method provided by the manufacturer. 
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PULSED SILAC FOR MONITORING EXCHANGE OF RIBOSOMAL PROTEINS 
To detect exchange of ribosomal proteins from different ribosomal assemblies we inhibited 
ribosome biogenesis by inhibiting rRNA synthesis with 10 µM CX5461 for 6 hours in SILAC 
heavy MCF7 cells. Cells were washed with PBS twice and then switched to light SILAC media. 
Control cells received light SILAC media without any additional supplements. Continued 
inhibition of ribosome biogenesis was achieved by addition of 10 µM CX5461 to the light SILAC 
media. Additional inhibition of autophagy was prepared earlier when spautin-1 was added at 
10 µM concentration already 12 hours before switching to light SILAC media. Spautin-1 
treatment continued in the light SILAC media throughout the rest of the experiment. 
Additional inhibition of the proteasome was prepared earlier when bortezomib was added at 
500 nM concentration 1 hour before switching to light SILAC media. Bortezomib treatment 
continued in the light SILAC media throughout the rest of the experiment. Cells were subjected 
to polysome profiling and MS as described above. 
 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
 
MS DATABASE SEARCH FOR TMT-SILAC DATA 
TMT-SILAC data was searched with MaxQuant 1.6.0.16 and parameters adapted from Zecha 
et al.157. TMT isotope impurities were specified in Andromeda according to the information 
provided by the manufacturer. In the type section reporter ion MS3 and TMT 10plex was 
selected and reporter mass tolerance set to 0.01 Da. lysine 8 and arginine 10 were defined in 
Andromeda as variable modifications and subsequently selected as such in MaxQuant 
modifications section next to Oxidation and N-terminal acetylation. Peptide mass tolerance in 
the instrument section was set to 5 ppm. In the identification section the minimum score for 
modified peptides and the minimum delta score for modified peptides were set to 0. In the 
MS/MS – ITMS section the MS/MS – ITMS match tolerance was set to 0.4 Da and water loss 
was deselected. All other settings were used at their default value. 
 
PROCESSING AND ANALYSIS OF TMT-SILAC DATA 
Quantitative data for the determination of all protein half-lives was extracted from the 
‘evidence’ table provided by MaxQuant. PSMs in the evidence table were filtered to remove 
‘Potential contaminants’ and ‘Reverse’ matches to the decoy database. Because of their 
uncertain TMT labeling status PSMs of acetylated N-terminal peptides (‘Acetyl’ in the 
‘Modification’ column) were removed as well. For all following steps corrected reporter ion 
intensities were used (‘Reporter intensity corrected’). We refer to the evidence table 
processed in this way as ‘cleaned-up evidence’ table. 
Pseudo-equilibrium-normalization (PEN) transforms the TMT intensities of each peptide, so 
that the intensity of each TMT channel is the same, irrespective of SILAC labels. Therefore, 
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correction factors need to be calculated, which normalize the intensity of every channel 
towards one reference channel. Which channel is the reference channel is in principle 
arbitrary. However, we chose the 32 hour timepoint for this purpose because it had the most 
complete data for either SILAC channel and therefore allowed to calculate the most complete 
list of correction factors. Data was processed in two independent rounds, during the first of 
which the cleaned-up evidence table was used to sum up reporter intensities for each TMT 
channel from all PSMs of one peptide, independent of SILAC label. The resulting table 
contained for each peptide ten reporter ion intensities, which were now used to calculate for 
each TMT channel a correction factor towards the TMT channel of the 32 hour timepoint. The 
resulting table contained for each peptide ten correction factors, which in the case of the 32 
hour timepoint was always 1 (because all values had been normalized towards this timepoint). 
This table of correction factors was stored for later use. In the second round of data 
processing, the cleaned-up evidence table was split by SILAC channel. Therefore, any PSM in 
the cleaned-up evidence table containing a lysine 8 or arginine 10 modification was assigned 
to the SILAC heavy dataset, whereas any PSM that did not carry any such modification was 
assigned to the SILAC light dataset. Just as during the first round of processing, PSMs were 
collapsed into peptides by summing up the reporter ion intensities for each TMT channel from 
all PSMs of a peptide. However, this time the SILAC channels were treated independently. The 
resulting tables contained for each peptide ten reporter ion intensities, which quantified 
synthesis or degradation (depending on SILAC heavy or light). Additionally, each peptide was 
annotated with the uniprot identifier (‘Leading razor protein in the cleaned-up evidence table) 
so that peptides from the same host protein could be merged later on. Consequently, this raw 
data was intersected with the previously stored correction factors. Each raw reporter ion 
intensity for each peptide was corrected by multiplication with its specific correction factor. 
Importantly, the identical set of correction factors were used for the SILAC heavy or light 
dataset, so that the sum of the two datasets generated the identical reporter ion intensity in 
each TMT channel for each peptide. Note that for the control data (“raw”) we present in Figure 
7C&D the table of stored correction factors was substituted by a table with the identical 
dimensions only containing the entries 1. Thereby, the control data could be treated 
identically to the PEN-corrected data in all of the following steps of the analysis. As SILAC 
heavy or SILAC light denotes to either synthesis or degradation, depending on the replicate in 
our experiment, we refer to the resulting table after these steps as ‘PEN corrected synthesis’ 
or ‘PEN corrected degradation’ table, which now contained for each peptide ten corrected 
reporter ion intensities. 
PEN corrected data was further processed and filtered in order to exclude peptides, which did 
not follow the expected increase or decrease in intensity, respectively, over time.  Note that 
degradation and synthesis were treated differently. In the case of degradation, the PEN 
corrected reporter ion intensities from the PEN corrected degradation table were normalized 
to timepoint 0, where the maximum amount of protein was expected to exist. Peptides with 
resulting ratios larger 0.99 at timepoint infinity were discarded. Subsequently, the background 
at timepoint infinity was subtracted from all other timepoints. Peptides with resulting ratios 
smaller 0 or larger 1 were discarded. In the case of synthesis, the PEN corrected reporter ion 
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intensities from the PEN corrected synthesis table were normalized to timepoint infinity, 
where the maximum amount of protein was expected to exist. Peptides with resulting ratios 
larger 0.99 at timepoint 0 were discarded. Subsequently, the background at timepoint 0 was 
subtracted from all other timepoints. Peptides with resulting ratios smaller 0 or larger 1 were 
discarded. The resulting tables contained for each peptide ten normalized ratios of reporter 
ion intensities and additionally the uniprot identifier of their host protein.  
Normalized peptide ratios were collapsed into protein ratios in order to fit degradation or 
synthesis functions to them. For each timepoint the normalized peptide ratios from all 
peptides of a protein (‘Leading razor protein’) were collapsed into one ratio using their 
median. The resulting table contained the uniprot identifier of a protein and 8 (in the case of 
the total proteome and XRNAX) or 10 (in the case of the polysome profiling data) normalized 
protein ratios. In the synthesis case, entries for timepoint 0 were always 0 and entries for 
timepoint infinity always 1. In the degradation case, entries for timepoint 0 were always 1 and 
entries for timepoint infinity always 0. We refer to these tables in the following as ‘normalized 
protein synthesis ratio’ or ‘normalized protein degradation ratio’ table. 
For curve fitting we used the model introduced by Welle et al.156, which Zecha et al.157 had 
adapted. For curve fitting we used the library minpack.lm (Elzhov et al., https://CRAN.R-
project.org/package=minpack.lm), which overcomes the zero-residual problem of 
exceptionally well-fitting data. Synthesis was modelled using the function: y ~ (Bsyn - Asyn)*exp(-
Ksyn * x) + Asyn, with the starting values Asyn = 1, Bsyn=0.3, Ksyn=0.01, the lower modelling 
constraints Asyn = 0, Bsyn= -2, Ksyn= -1 and the upper modelling constraints Asyn = 3, Bsyn= 2, Ksyn= 
5. Degradation was modelled using the function: y ~ (Adeg - Bdeg)*exp(-Kdeg * x) + Bdeg with the 
starting values Adeg = 1, Bdeg = 0.3, Kdeg = 0.01, , the lower modelling constraints Adeg = 0, Bdeg= 
-2, Kdeg= -1 and the upper modelling constraints Adeg = 3, Bdeg= 2, Kdeg= 5. Pseudo R2 for the 
fitted functions was assessed with the library rcompanion (Mangiafico et al., https://CRAN.R-
project.org/package=rcompanion), using the Nagelkerke method for comparing a non-linear 
model towards a null model. The null model was created by fitting a null function with the 
minpack.lm library for the same timepoints as for the actual experiment: y ~ function(x, m){m} 
with the starting value m=1. Fitting results were discarded if the fitting parameters did not 
meet the constraints 0.5 ≤ A ≤ 2, -1 ≤ B ≤ 1, K > 0 and R2 ≥ 0.8 for either synthesis or degradation. 
The quality of the curve fits, i.e. R2 values, often differed greatly between replicates and some 
proteins could not be fitted at all in one replicate or the other. Instead of compromising very 
good fits from one replicate by averaging them with mediocre fits from another replicate we 
decided to use fits from the replicate with the best quality. Therefore, we computed for each 
protein in each replicate the mean R2 from the R2 for fitting the synthesis function and the R2 
for fitting the degradation function. If a fit for one of the two did not exist, the existing R2 was 
averaged with 0.8. For each protein the synthesis and degradation parameters were only kept 
for the replicate with the better mean R2. Synthesis and degradation half-lives were calculated 
from the parameter K using the formula: HL = log(2) / K. Synthesis and degradation half-lives 
of a protein were regarded as technical replications (Figure 7D) and their mean was used for 
all following analysis. 
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SIZING PROTEIN-RNA INTERFACES WITHIN THE HUMAN 80S RIBOSOME 
For determination of the interphase size between ribosomal proteins and rRNA Pymol 2.2.3.1 
(Schrödinger) and the plugin PDIviz235 was used. Subunits were analyzed separately. The entire 
rRNA of one subunit was defined as one distinct molecule object and each ribosomal protein 
as another. Subsequently, the ‘Backbone and Bases Surfaces’ function in PDIviz was used to 
compute the ‘Interface Area’ between rRNA and one ribosomal protein at a time. 
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Figure S1: Proteomic and transcriptomic features of XRNAX-extracts.
                   Adapted from Trendel et al., 2018.82
A) Relative abundance of proteins in the total proteome and XRNAX-extracts of MCF7 cells, estimated from iBAQ values. Bar 
     graphs display contribution of the top-30 proteins to the combined iBAQ intensity of all detected proteins. 
B) Scatterplot comparing normalized read counts for all GENCODE-annotated transcripts in RNA obtained by XRNAX and 
     TRIZOL. MCF7 cells were exposed to 4SU for 16 hours before UV-crosslinking at 365 nm and processing via XRNAX, or 
     without crosslinking and conventional TRIZOL extraction. Reads were counted per gene and normalized to the total 
     number of counts. Each point represents one gene and displays the mean of two replicates. Contour lines indicate highest 
     density of the points in the plot. Dashed lines indicate fold-changes of 1, 10 and 100. Sequencing for all replicates was 
     performed in one lane and read count for all libraries was within 10 % deviation from the average read-count. 
C) Comparison of normalized read counts for all GENCODE genes between XRNAX and TRIZOL-extracted RNA. Same data 
     as in B shown as cumulative distribution.
D) Ranked scatterplot (left) and boxplot (right) for RNA-crosslinked protein in XRNAX extracts before and after silica 
     enrichment. Percentages of crosslinking were computed using peptide SILAC intensities and the formula percent Xlinked 
     = (Xlink/control) / (Xlink/control +1).
E) Dotplot showing the enrichment of five well-studied RNA-binding proteins through XRNAX. Each dot represents one
     peptide of the indicated protein and how much of it occurs in the crosslinked SILAC channel (using the formula from D). 
     Blue coloring shows this percentage after XRNAX only, whereas red coloring after XRNAX and subsequent silica enrichment.
F) Density plot showing the enrichment of peptides from XRNAX-extracts with intact RNA over XRNAX-extracts where RNA was 
     degraded. For details see text.
G) Proof-of-concept for the differential quantification of RNA-binding using XRNAX and silica enrichment. Heavy SILAC-labeled 
     MCF7 cells were UV-crosslinked and mixed with non-crosslinked heavy MCF7 cells in 5 defined ratios. These mixtures of 
     heavy cells were combined with the identical amount of UV-crosslinked, light cells and subjected to XRNAX followed by silica 
     enrichment and MS quantification. Histogram displays SILAC ratios without normalization. Peptides that were found 
     super-enriched in previous experiments using a non-UV-crosslinked control (Figure 1F) showed discrete fold-changes 
     corresponding to mixing ratios (grey arrows), whereas peptides that were not super-enriched before showed a 1:1 ratio 
     (black arrow).
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